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Livestock-associated methicillin resistant Staphylococcus aureus (LA-MRSA) and extended-
spectrum β-Lactamase (ESBL)-producing Enterobacteriaceae (ESBL-PE) are amongst the 
main resistant bacteria of serious public health concern worldwide. Between March and 
October 2016, MRSA and ESBL-PE were identified from 288 nasal and rectal pooled samples 
collected from 432 pigs as well as from nasal and hand swabs sampled from 82 humans in five 
abattoirs in both Cameroon and South Africa. Carriage, risk factors, antibiotic resistance 
profiles, genotypic characteristics and clonal relatedness of circulating MRSA and ESBL-PE 
in pigs and humans were investigated using various microbiological (selective agar, 
biochemical testing, VITEK 2 system) and molecular methods (REP-PCR, ERIC-PCR and 
whole genome sequencing) and compared with statistical tools.  
Of the 288 pooled samples, methicillin resistant staphylococci (MRS) were isolated from 
108/144 (75%) and 102/144 (70%) of the pooled nasal and rectal samples, respectively. Only 
one (0.07%) and four (16.66%) MRSA were detected from pigs in Cameroon and South Africa, 
respectively. None of the workers were colonized by MRSA. Genome analysis revealed that 
all circulating MRSA isolates belonged to the clonal lineage ST398.  
ESBL-PE were isolated from 75% (108/144) and 71% (102/144) of the pooled nasal and rectal 
samples, respectively. ESBL-PE prevalence in animal samples from Cameroon was higher than 
for South Africa whereas human ESBL-PE carriage was observed in Cameroonian workers 
only. Some E. coli and K. pneumoniae isolates detected in humans were highly related to those 
isolated from pigs within and across countries. The circulating K. pneumoniae strains were 
dominated by the sequence types (ST) 14 and 39. The “high-risk” ST307 clone and two novel 
STs assigned ST2958 and ST2959 were also detected.  
LA-MRSA ST398 is already present in both Cameroon and South Africa and is probably 
underestimated in the absence of molecular epidemiological studies. The high prevalence of 
ESBL-PE in pigs in both countries as well as in humans in Cameroon highlights their active 
dissemination in the farm-to-plate continuum. LA-MRSA and ESBL-PE are serious food safety 
and public health threats requiring the urgent implementation of multi-sectorial, multi-faceted, 
and, sustainable interventions among all stakeholders involved in this continuum to contain 
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After saving countless lives and being available for the last 80 years, antibiotics are now facing 
extinction through the worldwide emergence of antimicrobial resistance (AMR). Included in 
the One Health Agenda as one of the most important priorities of the “Tripartite alliance”, 
AMR has been recognized has a global health crisis which no government can counter alone 
(FAO et al., 2012; WHO, 2014a, 2015a; OIE, 2016). AMR kills, hampers the control of 
infectious diseases, increases the costs of health care, jeopardizes health care gains in the 
society, and has the potential to threaten health security, and weaken trade and economies. It 
also raises mortality, morbidity, duration of hospitalization, treatment and expenses (WHO, 
2014a, 2015a). The occurrence and spread of AMR differs greatly with geographical 
distribution –between continents and inside countries. In developed countries, multi-drug 
resistant bacteria induce infections which lead to increased therapeutic cost whereas in 
developing nations, the same pathogens considerably enhance mortality and morbidity (WHO, 
2014a).  The emergence of AMR can occur in commensal bacteria as well as in pathogenic 
bacteria of humans, animals, and the environment (Marshall and Levy, 2011; Berendonk et al., 
2015; Holmes et al., 2016). AMR is considered as a cross-sectoral issue because antibiotics are 
widely used in aquaculture, livestock production, and horticulture, where antibiotic resistant 
bacteria (ARB) and antibiotic resistant genes (ARGs) can easily spread into the human 
population via the food chain including farming, slaughtering processes, food storage and 
transportation.  
Livestock-associated methicillin resistant Staphylococcus aureus (LA-MRSA) and extended-
spectrum β-Lactamase (ESBL)-producing Enterobacteriaceae (ESBL-PE) are amongst the 
main resistant bacteria of serious public health concern globally (Chen, 2013, 2014). S. aureus 
became a worldwide health problem due to the emergence of multidrug-resistant strains named 
methicillin resistant Staphylococcus aureus (MRSA) (Chen, 2013). The recent detection of a 
new Clonal Complex (CC) MRSA CC398 in Dutch pigs has increased the concern (Voss et al., 
2005; Price et al., 2012). This finding suggests pigs as the true reservoir of LA-MRSA even if 
other livestock animals –poultry, cattle, calves, rabbits, etc.- have also been identified as 
reservoirs of LA-MRSA. Generally, they act as reservoir of LA-MRSA and enhance the risks 
of zoonotic transmission among persons exposed to them as well as for other animals and the 
environment, contributing by this way, to the complex exchanges, variations and hosts 
                                                 
1 The reference list of this chapter is combined with that of Chapter 8 at the end of the thesis. 
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adaptabilities of different strains (van Loo et al., 2007; van Den Broek et al., 2008; Price et al., 
2012). Similarly, ESBL-PE have emerged following chromosomal mutation, acquisition of 
new resistance genes into the chromosome or by transferable genetic elements (Bradford, 2001; 
Liebana et al., 2013). ESBL-producing bacteria are resistant to the majority of the beta-lactam 
class of antibiotics with a few exceptions: cephamycins, carbapenems, and virtually all beta-
lactamase inhibitors which are hydrolysed by other enzymes such as Amp-C enzyme; 
Klebsiella pneumoniae carbapenemase (KPC), metallo-beta-lactamase enzyme, OXA beta-
lactamase and inhibitor-resistant enzymes respectively (Bradford, 2001; Liebana et al., 2013). 
They are found in commensal as well as in pathogenic strains of Escherichia coli, Klebsiella 
spp., Proteus spp., Salmonella spp., etc., and can occur in non-fermentative organisms such as 
Acinetobacter baumannii and Pseudomonas aeruginosa (Liebana et al., 2013; Revathi et al., 
2013). The spread of these resistant bacteria in human and animal health is a considerable 
problem not only because their increase treatment failures, mortality and treatment expenses, 
but also because resistance genes can be transferred among different bacteria and because they 
could ultimately lead to pre- or post- antibiotic era where minor infections and injuries could 
once again kill.  
Cameroon and South Africa are peculiar countries with evidence of several factors that lead to 
the emergence and dissemination of AMR. Additionally, in these countries the sub-optimal 
health systems and programs able to control and lessen infectious diseases and resistant bacteria 
further increase difficulties for the prevention and monitoring of AMR in human and veterinary 
medicine as well as in agriculture. This study illustrates the zoonotic transmission of AMR in 
the One Health context. 
II. Background and rationale  
Given the recent isolation of LA-MRSA and ESBL-PE in pigs and exposed workers (including 
farmers, slaughterers and veterinarians who are highly associated with LA-MRSA and/or 
ESBL-PE colonization/infection), the high level of antibiotic consumption and prevalence of 
infectious diseases in Sub-Saharan African countries, together with sub-optimal monitoring, 
prevention and control measures it is inevitable that dissemination of ARB does occur at the 
human-animal interface on the continent. In Africa, the prevalence of ARB in food animals is 
not well known and may probably be underestimated due to the gaps encountered in their 
detection. The importance of Cameroonian and South African food safety is not only national 
but more importantly sub-regional and even continental due to their geographic location and 
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as they are both among principal pig producers in Africa. Despite the gaps evidenced and to 
the best of our knowledge, studies focusing on the direct exposure and zoonotic transmission 
of ARB, especially MRSA and ESBL-PE from animals to humans have not been undertaken 
concomitantly in human and animal populations in these two nations. This study was thus 
designed to correlate the genetic diversity of resistant bacteria associated with human and 
animal populations as well as to show the potential of zoonotic dissemination in the farm-to-
plate continuum; this in order to elucidate the potential public health risk of these resistant 
pathogens. It will also provide evidence to agricultural practitioners, policy makers, scientific 
communities and health policy-makers, about the dangers posed by the emergence of ARB in 
the food chain. It will finally suggest effective prevention measures to contain AMR and 
behavioural changes for better antimicrobial usage in agricultural practice and in human health 
to successfully combat infectious diseases and preserve the efficacy of antibiotics around the 
world in general and particularly in Africa.  
III. Literature review 
The following sections discuss the role of animals as source of (resistant) human infectious 
diseases and the different initiatives promoting and improving human and animal health. The 
literature review is expanded further in Chapters Two and Three in the form of one published 
and one unpublished review papers. 
 Animal origin of infectious diseases 
Malaria, highly pathogenic avian Influenza (HPAI H5N1), Human immunodeficiency virus 
infection and acquired immune deficiency syndrome (HIV/AIDS), Severe Acute Respiratory 
Syndrome (SARS) and Ebola haemorrhagic fever are known mainly for their worldwide 
devastating impact on human health but less so for their common characteristic of their animal 
origin (Woolhouse and Gowtage-Sequeria, 2005; Calistri et al., 2013; Gibbs, 2014; Travis et 
al., 2014). Since many decades, pathogens affecting the human population have been 
associated with animal exposure. About 60% of the global human infectious diseases and 75% 
of new emerging pathogens have an animal origin and are thus zoonotic infectious diseases 
(Woolhouse and Gowtage-Sequeria, 2005; Calistri et al., 2013; Gibbs, 2014; Travis et al., 
2014). “Zoonosis”, “anthropo-zoonosis” and “zoo-anthroponosis” are general terms used to 
define any disease or infection naturally transmitted from vertebrate animals to humans and 
vice versa (Woolhouse and Gowtage-Sequeria, 2005; Messenger et al., 2014). Globally, “hot 
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spot” regions including the Congo Basin, Amazonia and Mexico, the Ganges plain and South-
East Asia have principally been identified as high-risk areas for the emergence or re-emergence 
of zoonotic infectious diseases (Woolhouse and Gowtage-Sequeria, 2005; Mersha and 
Tewodoros, 2012; Messenger et al., 2014). The understanding of the ecology of emerging 
diseases forms the basis for strategies designed to contain new pathogens and pandemic 
situations (Woolhouse and Gowtage-Sequeria, 2005; Gibbs, 2014 ; Messenger et al., 2014; 
Travis et al., 2014). Modern public health issues are now becoming increasingly complex with 
the international transport systems. A resistant pathogen can easily go across the world via 
people, animals, plants and food products in less than 24 hours (Woolhouse and Gowtage-
Sequeria, 2005; Mersha and Tewodoros, 2012; Messenger et al., 2014). The process of bringing 
a foreign disease into a new area due to human involvement has been termed “pathogen 
pollution” in an effort to describe the spread of pathogens around the world (Woolhouse and 
Gowtage-Sequeria, 2005; Mersha and Tewodoros, 2012; Messenger et al., 2014). The high 
level of mobility of microorganisms, and the worldwide emergence and dissemination of 
zoonotic infectious diseases led to several concerns for the global economy and especially for 
public health in both developed and developing countries. With the major implication of 
animals in this universal problem, there is a need to follow multidisciplinary and inter-sectorial 
strategies exhorted by the “One Health” approach which is crucial to the sustainable prevention 
of potentially pandemic infectious diseases to assure global health (Woolhouse and Gowtage-
Sequeria, 2005; Mersha and Tewodros, 2012; Messenger et al., 2014; Gibbs, 2014; Travis et 
al., 2014). 
For effective and efficacious actions, strong synergies amongst all sectors, good governance 
and political will are essential. In keeping with this, the World Health Assembly (WHA) of the 
World Health Organization (WHO) urged the revision of the International Health Regulations 
(IHR) (1995), considered a central element of the One Health approach (Nutall et al., 2014). 
The revised IHR (2005) offer a more supportive and legally binding framework for the 
assessment of public health emergencies in general, and infectious disease risk, in particular. 
The IHR (2005) are not limited to the human health sector, but encourage integrated and 
coordinated risk responses, and thereby represent an ideal environment for the implementation 
of the One Health approach towards the prevention and containment of disease outbreaks, 
including those of zoonotic nature (FAO et al., 2008; Nuttall et al., 2014). 
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The Global Health Security Agenda (GHSA) initiated in February 2014 by the United States 
(US), several partner nations, international organizations and civil society as a 5-year plan to: 
- Increase global efforts for prevention, detection, and response to infectious disease 
threats.  
- Promote global security as a worldwide priority 
- Support progress towards complete implementation of the WHO IHR (2005) (Toner et 
al., 2015) 
In 2014, 11 actions packages were developed and the emergence and spread of AMR was one 
of the key challenge recognized by the GHSA. The action packages on AMR form an inclusive 
and multipronged “prevent, detect, respond” 5-year framework with international public-
private efforts to curb spread of resistance. The five-years action package on AMR seeks to 
develop activities to combat it across animal, human, agriculture, food and environmental 
aspects (Toner et al., 2015). 
 The “One Health” approach 
An alliance of a few international organizations including the British Royal Society, Food and 
Agriculture Organization of the United Nations (FAO), WHO, World Organization for Animal 
Health (OIE), World Bank, United Nations System Influenza Coordination (UNSIC), World 
Small Animal Veterinary Association (WASAVA), the US Army Medical Department have 
mobilized to develop and promote One Health (Mersha and Tewodoros, 2012; Calistri et al., 
2013; Gibbs, 2014; Travis et al., 2014). The One Health approach, defined as ‘...the 
collaborative effort of multiple disciplines –working locally, nationally, and globally – to attain 
optimal health for people, animals and our environment…’’(AVMA, 2008) acknowledges that 
a human being is an entity which does not exist in isolation but is the central element of the 
total living ecosystem where activities and status of each member directly affect the others 
(Mersha and Tewodoros, 2012; Calistri et al., 2013; Gibbs, 2014; Travis et al., 2014). Indeed, 
healthy livestock animals and healthy environment, lead to healthy human population because 
humans, animals and environment are inexorably connected. Furthermore, livestock dynamics 
are considered a major determinant of global health. In fact, the potential emergence and spread 
of new pathogens from animals to human is favoured by changes in animal production. Thus, 
the key element of this approach which addresses a manifold of interconnected health risks is 
the animal-human-environment interface (Mersha and Tewodoros, 2012; Gibbs, 2014).  
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The One Health approach seeks to improve the diagnosis and prevention of zoonotic infectious 
diseases as well as the early detection of environmental health risks at this interface (Mersha 
and Tewodoros, 2012; Calistri et al., 2013; Gibbs, 2014; Travis et al., 2014). This original 
initiative has expanded to a set of holistic and integrated policies, programs and interventions, 
which improve the global health of humans, animals and the environment and promote the 
involvement, improved coordination and suitable cooperation between several scientific 
specialities, practitioners, scientists locally, nationally and internationally (AVMA, 2008; 
Mersha and Tewodoros, 2012; Calistri et al., 2013; Gibbs, 2014; Travis et al., 2014). It takes 
place in developed and developing countries, where the targets are populations subject to risk 
factors such as poor health, unsafe or limited water, lack of hygiene, insecure food, and 
proximate contact with animals. It has been recognized as the most productive method to 
prevent, identify, contain and control zoonotic infectious diseases (Mersha and Tewodoros, 
2012; Calistri et al., 2013; Gibbs, 2014; Travis et al., 2014). One Health is strengthened by the 
coalition between the WHO, OIE and FAO with their specialized skills to ensure coordinated 
international efforts, to implement effective facilities, policies, and efficient behavioural 
change towards the mitigation of health threats related to the human-animal-environment 
interface (Mersha and Tewodoros, 2012; Calistri et al., 2013; Gibbs, 2014; Travis et al., 2014). 
The success of this action will be determined by our understanding of the different factors that 
drive the emergence and spread of emerging infectious diseases. Among those factors is the 
microbial adaptation with AMR as one of the most challenging consequence. 
 Antimicrobial resistance—a worldwide threat 
AMR is the ability of pathogens to grow despite the presence of antimicrobial agents usually 
effective for treatment of infections caused by these pathogens (WHO, 2014a, 2014b). It is a 
general term including resistance to antibiotics that treat infections caused by bacteria (e.g. E. 
coli), parasites (e.g. Plasmodium spp.), viruses (e.g. HIV), and fungi (e.g. Candida spp.) while 
antibiotic resistance (ABR) is the specific term used to describe resistance to antibiotics that 
occurs in commensal, pathogenic and zoonotic bacteria (WHO, 2014a, 2014b). These 
resistance mechanisms are not a new finding but rather a natural evolutionary process that 
affects humans, animals, and the environment (plants, soil and water). Indeed, during his Nobel 
Prize allocution in 1945, Alexander Fleming, who discovered the first antimicrobial drug, had 
already mentioned the possible acquisition of resistance by bacteria (WHO, 2014a, 2014b). 
Microorganisms are becoming increasingly resistant to antibiotics with worldwide evolution 
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as a result of the selective pressure induced through extensive consumption of antibiotics 
whether appropriate or inappropriate use (Founou et al., 2016). 
According to the Review on Antimicrobial Resistance chaired by O’Neill, AMR claims more 
than 50,000 deaths every year across US and Europe and is expected to prematurely kill 300 
million people by 2050, with 2 to 3.5% losses of the world’s Gross Domestic Product (GDP) 
by the same period (O'Neill, 2015). Sixty to 100 trillion USD worth of the economic output 
will be lost if AMR is not considerably contained (O'Neill, 2015). The WHO indicated 
“antimicrobial resistance” as the topic of its annual World Health Day in 2011 confirming 
AMR as a significant worldwide health concern (WHO, 2014a, 2014b) including AMR in food 
animal production throughout the “No action today, no cure tomorrow” WHO’s slogan (WHO, 
2014a, 2014b).  
The occurrence and spread of AMR differ greatly with geographical distribution between 
continent and within countries (Laxminarayan et al., 2013). In developed countries, multi-drug 
resistant (MDR) bacteria cause infections which result in increasing cost of therapy whereas in 
developing ones, the same pathogens considerably enhance mortality. Antimicrobial usage is 
strictly controlled in human as well as in animal health in developed countries through several 
initiatives and the strategies established for the prevention and containment of AMR illustrate 
the significance of this threat in the developed world (Laxminarayan et al., 2013). The risk of 
emergence and spread of AMR is worsened in developing countries because treatment of 
bacterial infections is empirical and there is usually sub-optimal policy, monitoring and 
surveillance systems, diagnosis capability and control of infectious diseases, antibiotic 
consumption and AMR detection as well as numerous issues related to the quality and 
accessibility of antibiotics (Vila, 2010; Laxminarayan et al., 2013; WHO, 2014b). Indeed, 
several factors have been incriminated in the speedy emergence and spread of AMR. These 
include poverty, overcrowding, hygiene status, education level, self-medication, poor and 
limited supply chain, lack of knowledge about antibiotics, inappropriate use misuse of 
antibiotics and chronic diseases –such as tuberculosis, hepatitis, asthma, HIV/AIDS which 
enhance the proportion of immune-compromised population who are more prone to infection, 
requiring frequent antibiotic treatment resulting in selection pressure for the development or 
exacerbation  of antibiotic resistance (Vila, 2010; Laxminarayan et al., 2013; WHO, 2014b). 
AMR is of paramount importance because many common infectious diseases in the developing 
world, especially malaria, HIV/AIDS, respiratory infections (influenza, asthma, tuberculosis, 
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etc.) and sexual transmissible infections raise the risk of acquisition of resistant pathogens 
(Vila, 2010; Laxminarayan et al., 2013; WHO, 2014a, 2014b). Given the important ability of 
microorganisms to adapt to their environment, a comprehensive strategy involving key 
stakeholders promoting the “One Health” approach is likely to succeed in containing AMR. 
 Tripartite Alliance in the containment of antimicrobial resistance 
At the 2011’s High Level Technical Meeting held in Mexico City, AMR was recognized, as 
one of the three priorities for the control of health risks under the auspices of the coalition 
between the WHO, OIE and the FAO, referred as the “Tripartite Alliance” (Mersha and 
Tewodoros, 2012; FAO et al., 2012; Gibbs, 2014). During this meeting, the need to improve 
multidisciplinary cooperation through recognized mechanisms and standards such as the IHR 
(2005), the FAO-WHO Codex Alimentarius and the FAO-WHO-OIE Global Early Warning 
System (GLEWS) platform was strengthened from both human and animal health sectors (FAO 
et al., 2012).  
Following several initiatives such as the World Health Assembly resolution WHA 58.27, the 
global strategy for containment of AMR, the World Health Day policy package in 2011 and 
several international conference proceedings agree that essential systematic multi-sectoral and 
coordinated efforts, collaboration and cooperation as recommended by the One Health 
approach are required to curb the spread of AMR worldwide (WHO, 2014a, 2014b). By 
endorsing the One Health approach, the FAO, WHO and OIE with their specialized skills, 
reinforce, facilitate, and enhance international efforts, implement adequate framework, 
policies, and efficient behavioural change towards the mitigation of health threats related to the 
human-animal-environment interface (FAO et al., 2012; FAO, 2015; WHO, 2015a; OIE, 
2016). 
The recent Global Action Plan (GAP) on AMR developed by the WHO in collaboration with 
the FAO and the OIE, and published in 2015 in response to the resolution WHA 67.25 aims at 
ensuring sustainable efficacious treatment and prevention of infectious diseases using efficient, 
safe and proper quality of drugs, consumed appropriately and accessible to all needy persons 
(WHO, 2015a). It highlights the necessity to contain the emergence and spread of AMR across 
sectors and outline several measures under five strategic objectives (WHO, 2015a): 




- Strengthen evidence base and knowledge via surveillance and research  
- Decrease the incidence of infection by implementing effective sanitation, hygiene and 
infection prevention and control measures (IPC) 
- Optimize rational antibiotic use in human and animal health  
- Promote sustainable investment considering the needs of all countries, and increase 
investment in the creation of new medicines, vaccines diagnostic tools, and other 
alternatives to antibiotics (WHO, 2015a). 
The GAP therefore underscores the importance of an effective One Health approach 
encompassing cross-sectoral and interdisciplinary coordination among all stakeholders (WHO, 
2015a). The WHA 68.25 resolution further strengthened the Tripartite Alliance and made 
requisite for Member States to adapt this strategic document to their realities and develop and 
implement their own National Action Plans (NAPs) on AMR within the subsequent two years 
upon this endorsement viz. mid-2017.  
Similarly, the FAO’s 39th Conference held in June 2015, endorsed the Resolution 4/2015 on 
AMR recognizing it as a growing serious threat for public health and sustainable food 
production and consumption, and confirming that involvement of all sectors of government 
and society are required for its effective containment. The FAO released its “Action Plan on 
Antimicrobial Resistance 2016–2020” in September 2016 to assist Member States in the 
development and implementation of their multi-sectorial NAP by May 2017 and mitigate the 
impact of AMR. It supports the food and agricultural sectors to implement the WHO-led GAP 
and emphasizes the necessity to adopt the One Health approach, with the participation of 
veterinary and public health authorities, food and agriculture sectors, environmental specialists, 
financial planners, and consumers (FAO, 2016). The FAO Action Plan on AMR addressed four 
main focus areas including:  
- Improvement awareness on AMR and related threats 
- Development of capacity for monitoring and surveillance of AMR and antimicrobial use 
in food animals and agriculture 
- Strengthening of governance associated with antimicrobial use and AMR in food and 
agriculture 
- Promotion of good practices in food and agricultural systems and the prudent use of 
antimicrobials (FAO, 2016).  
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The OIE also calls for curbing AMR in keeping with the One Health approach and, during its 
83rd general Assembly in 2015, all 180 Member States committed themselves to support the 
WHO GAP on AMR, and develop NAPs. The Resolution 36, mandating OIE to compile AMR 
activities into a strategy was unanimously adopted at its 84th General Assembly (OIE, 2016). 
Its “Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials” which is 
aligned with the WHO GAP objectives and recognize the importance of the One Health 
approach was published in November 2016 (OIE, 2016). The OIE’s strategy on AMR outlines 
strategies and goals to support Member States and encourage national implementation and 
ownership. It further reflects the mandate of the OIE as outlines in its Basic Texts and Strategic 
Plans, through four principal objectives:  
- Improve awareness and understanding  
- Strengthen knowledge using surveillance and research 
- Support capacity building and good governance 
- Encourage implementation of international standards (OIE, 2016).  
Finally, in September of the same year, the foremost advancement in the fight against AMR, 
was the adoption of a resolution at the 71st Session of the United Nations General Assembly to 
strengthen implementation of NAP in line with the One Health concept and as advocated by 
the Tripartite partners (UN, 2017). Consequently, an Intergovernmental Ad Hoc Group 
encompassing Tripartite Partners and others international agencies was thereafter created in 
March 2017 for effective containment of AMR globally (UN, 2017). 
 Antimicrobial resistance in the food chain –a serious food safety issue 
The emergence of ARB and ARGs and their spread in the farm-to-plate continuum (viz. from 
the farm to the end consumer) via direct and indirect contact, exacerbate health and socio-
economic repercussions of AMR globally. Direct contact, that occurs through immediate 
exposure of humans with contaminated food animals and biological substances, enhances the 
rapid and easy dissemination of ARB and ARGs from host-to-host. It increases the likelihood 
of ARB and ARGs of animal origin to enter and spread into the human communities and 
hospital settings where substantial exchanges are possible, thereby jeopardizing healthcare 
systems (Marshall and Levy, 2011; Woolhouse et al., 2015; Founou et al., 2016). The human 
population may also be indirectly exposed to ARB and ARGs via contact with or consumption 
of contaminated food products (Marshall and Levy, 2011; Founou et al., 2016). This indirect 
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transmission is often more dangerous and far-reaching contamination, allows the spread of 
AMR at each step in the food chain, and has been associated with several foodborne infection 
outbreaks globally (WHO, 2015b; EFSA and ECDC, 2016). Moreover, with the globalisation 
of trade in animals and food products as well as international travel, there are neither species, 
ecological nor geographical boundaries to contain AMR. Resistance emerging in one 
geographical location or bacterial species can easily spread or spill-over into several bacteria 
at each stage in the farm-to-plate continuum and AMR may thus similarly affect all countries, 
regardless of the income level (Founou et al., 2016; Holmes et al., 2016). In fact, the presence 
of these bacteria in commensal micro-flora and pathogenic bacteria of animals implies that they 
could act as reservoirs for AMR and be a source of contamination for the human population 
(Smet et al., 2010). There are multiple examples of resistant bacteria which are major public 
health concerns, but bacteria causing infections in humans including antibiotic-resistant 
infections and originating (partially) from food animals, are frequently Staphylococcus aureus 
and the members of the Enterobacteriaceae family.  
5.1. Methicillin Resistant Staphylococcus aureus  
S. aureus has become a worldwide health problem due to the emergence of drug-resistant 
strains named Methicillin Resistant Staphylococcus aureus (MRSA) (Price et al., 2012). 
MRSA has developed its resistance to methicillin following the acquisition of the mobile 
genetic element, Staphylococcal Cassette Chromosome (SCCmec), carriers of the mec 
resistance gene (IWG-SCC, 2009). SCCmec is a DNA fragment that has integrated the S. 
aureus chromosome near the origin of replication and has conferred to this bacterium a 
methicillin resistance as well as a large spectrum resistance to the beta-lactam family (IWG-
SCC, 2009).  
The first detection of MRSA Clonal Complex (CC) CC398 in Dutch pigs suggested that this 
animal is the true reservoir of LA-MRSA even if other livestock animals –poultry, cattle, 
calves, rabbits, etc.- have also been identified as reservoirs of LA-MRSA (Voss et al., 2005; 
van Loo et al., 2007; van den Broek et al., 2008; Price et al., 2012; Chen, 2013). Several reports 
have focused on the history and evolution of MRSA and its spread among the animal 
population as well as its transmission from animals to humans and vice-versa (van Loo et al., 
2007; van Den Broek et al., 2008; Wulf and Voss, 2008; Wulf et al., 2008a; Price et al., 2012; 
Chen, 2013). In an international study including nine countries, Wulf et al., (2008) reported a 
12.5% (34/272) prevalence of MRSA in professionals (other than farmers and veterinarians) in 
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contact with pigs. They showed that 91% (31/34) of these strains were multilocus sequence 
type (ST) 398, and were previously isolated from Dutch pigs, pig farmers and veterinarians 
(Wulf et al., 2008a). They further concluded that if the spread of these strains is not 
considerably curbed, they could represent an important source of community-acquired MRSA 
(CA-MRSA) not only in Europe, but also worldwide (Wulf et al., 2008a). Price et al., (2012) 
revealed that livestock-associated MRSA CC398 emerged as methicillin susceptible S. aureus 
in humans. They argued that this CC398 strain underwent a jump from humans to food animals 
where it has subsequently acquired methicillin and tetracycline resistance. They further 
highlighted the public health risks associated with the widespread use of antibiotic in food 
animal production (Price et al., 2012). The rise of carriage of LA-MRSA could therefore 
threaten epidemiology, national economies and global strategy for MRSA containment in 
communities and hospitals. It is further important to consider the extent to which these strains 
may have disseminate in the livestock, community and hospital settings. 
Animals are often colonized by LA-MRSA but clinical diseases linked to LA-MRSA have 
rarely been reported (van Loo et al., 2007; van Den Broek et al., 2008; Wulf et al., 2008a; 
Chen, 2013). Generally, they act as reservoirs of LA-MRSA and enhance the risks of zoonotic 
transmission among persons exposed to them as well as among other animals and the 
environment, contributing by this way to complex exchanges, variations and hosts 
adaptabilities of different strains (van Loo et al., 2007; van Den Broek et al., 2008; Wulf et al., 
2008a; Chen, 2013).  
Some risks factors have been associated with the colonization and spread of LA-MRSA in the 
human populations. These include pig exposure, living or working in farms with animals, 
recent hospitalization, living in rural areas, proximity to farm and human MRSA colonization 
or infection –individual carriers of MRSA are predisposed to LA-MRSA, since there is just a 
little difference between both strains (Lewis et al., 2008; Wulf and Voss, 2008; Graveland et 
al., 2011). These factors in addition to other elements such as lack of knowledge about good 
farming practices, limited education, poor hygiene, low income, easy accessibility to and 
extensive use (appropriate and inappropriate) of antibiotics facilitate the emergence and 
colonization of LA-MRSA (Van Cleef et al., 2011; Laxminarayan et al., 2013). Pig farmers, 
slaughterhouse workers, pig’s carriers and veterinarians, have high occupational risks for LA-
MRSA colonization and infection (Voss et al., 2005; van Loo et al., 2007; van Den Broek et 
al., 2008; Wulf et al., 2008a; Van Cleef et al., 2011; Price et al., 2012; Chen, 2013; van de 
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Vijver et al., 2014). LA-MRSA CC398 has been identified in humans in Dutch regions with a 
high density within animal farming areas (van Loo et al., 2007, van Den Broek et al., 2008; 
Van Cleef et al., 2011; van de Vijver et al., 2014). Several other clonal lineages of MRSA such 
as CC5, CC97, CC30, CC9 have been involved in livestock colonization, outbreaks and clinical 
illness in humans and identified as LA-MRSA (Wagenaar et al., 2009; Köck et al., 2013). This 
indicates that LA-MRSA could be associated with human infectious diseases and has a 
pandemic potential (Wagenaar et al., 2009; Price et al., 2012; Chen, 2013; Köck et al., 2013). 
The zoonotic transmission of MRSA from animal to human and vice-versa is then possible 
through various pathways and the isolation of the ST398 from pigs and other species has 
demonstrated their transmission between different animal reservoirs (Voss et al., 2005; Price 
et al., 2012; Mehndiratta and Bhalla, 2014). To confirm this, several studies have established 
the predominance of LA-MRSA in livestock around Europe including the Netherlands, 
Denmark, Germany, Belgium, France, etc. and its emergence in pig farms in Northern America, 
Latin America, and Asia (van Duijkeren et al., 2007; van Loo et al., 2007; van den Broek et 
al., 2009; de Boer et al., 2009; Kluytmans, 2010). In a case-control study, van Loo et al. (2007) 
showed that LA-MRSA colonized more frequently pig and cattle farmers. The study revealed 
that 32 out of 35 patients were colonized by MRSA ST398 whereas the remaining harboured 
ST9, ST752 and ST753 that are closely related to ST398. They further concluded that MRSA 
from animal origin spread to the human population and was responsible for > 20% of all MRSA 
cases in the Netherlands (van Loo et al., 2007). When comparing the prevalence of animal and 
human MRSA in Dutch pig farms, van den Broek et al. (2009) identified 28 out of 50 (56%) 
farms had MRSA positive pigs, while 15 out of 50 (30%) humans were identified as MRSA 
carriers. MRSA strains isolated from humans share similar spa-type as those found in pigs and 
were ST398 (van den Broek et al., 2009). Working in pig stables (OR=40, 95% CI: 8-209) and 
the presence of sows and finishing pigs (OR=9, 95% CI: 3-30) were identified through 
multivariate analyses as main risk factors for human MRSA carriage (van den Broek et al., 
2009). 
Some reports have further confirmed the emergence of MRSA and particularly of LA-MRSA 
in food of animal origin. For instance, a Dutch survey revealed a 11.9% prevalence of MRSA 
in a variety of meat with predominance (85%) of LA-MRSA (de Boer et al., 2009). In this 
study, MRSA strains were isolated mainly from 16.0% of turkey, 15.2% of veal, 10.7% of 
pork, 10.7% of chicken, 10.6% of beef (de Boer et al., 2009). This observation suggests that 
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contamination may occur during several steps of the food production process. In Africa, there 
is a lack of information about MRSA in food animal as well as in food of animal origin. This 
is due to the lack of research studies conducted in the domain. 
Besides the global dissemination and asymptomatic carriage, LA-MRSA have increasingly 
been incriminated in various human infections –such as endocarditis, necrotizing pneumonia, 
necrotising fasciitis, ocular infections, wound infections and even death- in Dutch and German 
hospitals particularly in regions with a high density of pig production activities (Wulf et al., 
2008b, Köck et al., 2013). Although LA-MRSA virulence is almost null or likely lesser than 
other human MRSA clones, it is nevertheless important to notice the reports of outbreaks and 
clinical illness in humans in hospitals due to a variety of clonal lineages of LA-MRSA such as 
ST398, ST9, ST5 and ST97 (Wulf et al., 2008b, Wagenaar et al., 2009). For instance, two 
hospital-acquired outbreaks of MRSA of livestock origin have recently been recognized in 
Dutch health care settings and in nursing homes demonstrating the putative spreading of LA-
MRSA in the general population (Wulf et al., 2008b).  
The constant evolvement, versatility, and virulence mechanisms of S. aureus as well as the 
potential for genetic exchanges between LA-MRSA and other bacteria among several hosts are 
of further great concern. Many reports have underlined the origin and evolution of MRSA of 
animal origin in the human population, enlightening its adaptation, its ability to switch among 
host species and subsequent spread of new clones widely into the general population (van Loo 
et al., 2007; van Den Broek et al., 2008; Graveland et al., 2011; Köck et al., 2013). In addition, 
the acquisition and arrangement by LA-MRSA of human virulence mechanisms such as 
Panton-Valentine leucocidin (PVL) toxin as well as the ability of this highly virulent strain to 
spread easily and quickly (via skin-to-skin contact) among human population is a worrying 
scenario.  
Resistant strains recognized as originating from animal, are serious threats to the world as they 
could lead to the emergence of new and more resistant, virulent, and mobile strains, unknown 
from the human immune system given their multiple hosts adaptability, virulence mechanisms 
and high genetic exchanges (Ewers et al., 2012; Price et al., 2012; Fernandes et al., 2016; Liu 
et al., 2016). This phenomenon termed “superbug” illustrates the main concern feared by the 
international scientific community (Wulf and Voss, 2008; Weese, 2010) and is a considerable 
worldwide issue.  
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Accordingly, studies are needed around the world and especially in low and middle-income 
countries (LMICs) where policies on antimicrobial use and antimicrobial stewardship 
programs are limited, to correlate the genetic diversity associated with the genetic exchange 
and spreading of resistant bacteria. The current study aims at exploring and monitoring the LA-
MRSA at its origin viz. in livestock animal, as well as in the human population exposed to it, 
viz. in slaughterhouse workers and veterinarians; thus providing valuable source of information 
to understand the potential public health impact associated with these bacteria in Cameroon 
and South Africa. 
5.2. Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae  
Among all antibiotics, the beta-lactam antibiotics are those which are most frequently used in 
the treatment of various infectious diseases caused by Enterobacteriaceae, that is a 
heterogeneous family and the most important bacteria encountered in human health clinically 
(Kayser, 2004). Indeed, the beta-lactam family involves numerous groups of antibiotics 
characterized by the presence of one special element, called the “β-lactam ring” (Bradford, 
2001; Kayser, 2004; Liebana et al., 2013). Beta-lactamases are enzymes produced by several 
bacterial species able to inactivate beta-lactam antibiotics by the hydrolysis and opening of the 
beta-lactam ring. Extended spectrum β-lactamases (ESBLs) have emerged following 
chromosomal mutation or following acquisition of new resistance genes into the chromosome 
or by transferable genetic elements. Thus, beta-lactamase-encoding genes are located on the 
chromosome as well as on genetic elements such as plasmids, insertion sequences, genomic 
islands, integrons, transposons, and phage-related elements (Bradford, 2001; Kayser, 2004; 
Liebana et al., 2013). These can yield bacteria that are resistant to the majority of beta-lactam 
antibiotics through the hydrolysis and opening of the beta-lactam ring. Indeed, ESBL-
producing bacteria are resistant to most of the beta-lactam class of antibiotics with a few 
exceptions: cephamycins, carbapenems, and virtually all beta-lactamase inhibitors which are 
hydrolysed by other enzymes such as Amp-C enzymes; class A, B and D carbapenemases and 
inhibitor-resistant enzymes respectively (Bradford, 2001; Liebana et al., 2013).  
They are found in commensal as well as in pathogenic strains of E. coli, Klebsiella spp., Proteus 
spp., Salmonella spp., and can occur in other Enterobacteriaceae species and in non-
fermentative organisms (Bradford, 2001; Liebana et al., 2013). The most important ESBLs 
enzymes involved in human infections-related to Enterobacteriaceae are TEM-, SHV- and 
CTX-M- enzymes (Bradford, 2001; Liebana et al., 2013).  
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As with MRSA, the emergence and spread of ESBL-producing Enterobacteriaceae in food 
animal is a worldwide public health issue due to their ability to disseminate among the human 
population. The latest worrying scenario is the emergence of carbapenem-resistant 
Enterobacteriaceae (CRE) in both humans and animals; especially with the detection ESBL-
producing E. coli resistant to carbapenems in German pigs. These strains harbour a 
carbapenemase enzyme called Verona integron-encoded metallo-β-lactamase (VIM)-1 
carbapenemase resistant to the beta-lactam antibiotics family plus additional co-resistance 
(Fischer et al., 2012). 
Emergence of ESBL-PE in food animal is a major public health issue worldwide since many 
studies have largely incriminated the most predominant species of Enterobacteriaceae, E. coli 
and Klebsiella spp., each one producing ESBL, in the colonization and infection of food 
producing animals (Cortés et al., 2010; Ben Sallem et al., 2012; Geser et al., 2012; Liebana et 
al., 2013; Blaak et al., 2015; Dahms et al., 2015; Dohmen et al., 2015; Iweriebor et al., 2015; 
Kilani et al., 2015; Chishimba et al., 2016). In human health, antibiotic use has been established 
as the most important risk factors for the colonization and spread of multidrug-resistant 
organisms, and the same evidence has been shown in animal health. In fact, the common use 
of antibiotics and particularly of broad spectrum cephalosporins in livestock as well as the 
administration of sub-therapeutic doses of these substances as growth-promoters to prevent 
rather than cure infections in different categories of food animal industries led to the emergence 
of ESBL-producers and increased their transmission risks to humans through various reservoirs 
(asymptomatic or sick humans and animals, and the environment) and through the food chain 
(Geser et al., 2012). The misuse and inappropriate use of antimicrobials agents, mainly broad-
spectrum antibiotics, may therefore contribute to the emergence and spread of ESBL-producer 
in animals (Geser et al., 2012). The emergence of ESBL-PE in animals seriously threatens the 
global health as there are no geographic borders to impede their worldwide dissemination. 
Prevention and containment measures should be applied locally, nationally, and regionally, to 
not compromise the efficacy and endanger ABR containment policies implemented in other 
parts of the world, the best-managed high-resource countries included. 
Different types of ESBLs (Class A, B, C and D) have been progressively found in food animal, 
food of animal origin and in the environment globally (Smet et al., 2008, 2010; Geser et al., 
2012; Liebana et al., 2013; Brower et al., 2017). Since 2000, ESBLs of animal origin 
particularly from pigs, poultry, cattle, rabbits, have retained the worldwide attention (Smet et 
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al., 2010; Geser et al., 2012; Liebana et al., 2013). Smet et al. (2008) reported 70% of ceftiofur 
resistant E. coli isolated from 489 cloacal samples collected at five Belgian broiler farms. Out 
of these, 45% and 43% of E. coli isolates were classified as ESBL and AmpC β-lactamase 
producers, respectively (Smet et al., 2008). Different resistance mechanisms were identified, 
including TEM-106 (2%), CTX-M-15 (2%), CTX-M-14 (5.9%), CTX-M-2 (7.8%), TEM-52 
(13.2%), CTX-M-1 (27,4%) and CMY-2 (49%) (Smet et al. 2008). The remaining isolates 
exhibited the combination of ESBL and AmpC β-lactamase phenotype (12%) in two farms. 
The authors concluded that the presence of ESBLs and AmpC genes in commensal 
Enterobacteriaceae of normal microbiota of food animals might pose a human health threat 
given the fact that they constitute an important reservoir of resistance genes for pathogenic 
bacteria (Smet et al., 2008). Likewise, A 2012 study, examining ESBL-PE in faecal samples at 
slaughterhouse and food products at dairy farms, revealed 1%, 8.6%, 13.7%, 15.3%, and 63.4% 
ESBL-PE prevalence in mastitis milk, sheep, cattle, pigs, and chicken, respectively (Geser et 
al., 2012). CTX-M group 1 (CTX-M-gr1) and CTX-M group 9 (CTX-M-gr9) genes were 
produced by 85.7% and 6.6% of strains, respectively; whereas 5.5% harboured SHV- and 2.2% 
TEM-type enzyme (Geser et al., 2012). In a survey on 18 poultry farms Punjab, India, Brower 
et al., (2017) detected 1,556 E. coli from 530 birds and reported that resistance profiles and 
prevalence of ESBL-PE significantly differed between farm types. They concluded that 
unregulated use of clinically important antibiotics in Indian broiler and layer farms might lead 
to the emergence of ABR and underline the need to limit the non-therapeutic use of these 
medically important substances in food animals (Brower et al., 2017).  
In Africa, knowledge about the epidemiology of colonization or infections related to these 
resistant bacteria in animals is relatively limited. Few studies have recognized the faecal 
carriage of ESBL producers in food animals. ESBL-producing E. coli strains harbouring CTX-
M-8 and SHV-5 have been detected in 13.8% of faeces of various healthy food animals in 
Tunisian farms (Ben Sallem et al., 2012). In Nigeria, 20.7% of bacteria mostly Salmonella spp., 
were identified as producers of ESBL enzymes in commercial poultry feeds (Oyinloye Jr. and 
Ezekiel, 2012). In South Africa, Iweriebor et al. (2015) detected 31.7% of E. coli O157 from 
faecal samples collected from cattle and dairy farms. The majority (88.42%) of isolates were 
shiga toxin produced with high prevalence of MDR. TEM (27%), CTX-M (65%), CMY (70%) 
and AmpC (90%) were the main β-lactamase gene identified (Iweriebor et al., 2015). Similarly, 
90 out of 150 chickens (60%) sampled from eight slaughterhouse/markets in Cameroon were 
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detected positive for Salmonella spp., with almost 40% of strains being MDR (Wouafo et al., 
2010). 
However, studies ascertaining the molecular epidemiology and zoonotic transmission of 
ESBL-PE concomitantly in food animals and occupationally exposed workers are rare in 
developing countries, including Cameroon and South Africa. Substantial studies considering 
risk factors, prevalence, genetic diversity, and transferability of resistance genes are therefore 
required and should thus be carried out to determine potential reservoir and estimate public and 
animal health threat associated with ESBL-PE in these nations. 
Given their high prevalence in human infections, and to their worldwide faecal carriage in 
healthy humans and animals, ESBL-PE could undoubtedly contaminate humans, food animals 
and products either during the farming (directly via person-to-person contact and indirectly via 
food, water, soil, air), slaughtering (stunning, cutting the throat, scalding, evisceration), storage 
or food transportation processes (Geser et al., 2012; Oyinloye Jr. and Ezekiel, 2012; Ewers et 
al., 2012; Liebana et al., 2013). Ewers et al., (2012) revealed that exposed humans and animals 
shared identical sequence type (ST) of ESBL/AmpC isolates suggesting that there is a potential 
transmission or parallel micro-evolution (Ewers et al., 2012). They also suggested that the role 
of animal ESBL/AmpC-producing isolates as major source of human infections is 
underestimated and that it is a highly serious issue (Ewers et al., 2012).  
This study seeks therefore to consider, ascertain, and monitor the ESBL-PE in livestock animal 
and occupationally exposed workers in order to provide information on the current status, 
molecular epidemiology and potential public health repercussions associated with these 
bacteria in Cameroon and South Africa. 
5.3. Concluding remarks 
ABR is a worldwide public health issue with serious health and socio-economics repercussions 
that is significantly influenced by antibiotic use in food animals. The World Bank recently 
estimated in its 2016 report that the annual cost of AMR could be as high as those of the 2008’s 
global financial crisis and that LMICs would be most affected with the largest economic 
shortfalls in economic growth (World Bank, 2016). It revealed that output and trade in food 
animals and products are especially vulnerable to AMR effects not merely because of reduced 
productivity associated with resistant infections, but also due to international trade disruption 
in the wake of disease outbreaks (World Bank, 2016). Indeed, consequences related to food 
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contamination will drain national economy as country’s economic losses associated with 
resistant foodborne infections will range from increase of national medical expenses, outbreak 
investigations and food recalls. The report estimated that decline in global food production 
could range between 2.6-7.5% of food products and LMICs will be the most affected with 11% 
loss in a simulation of worst AMR impact scenario (World Bank, 2016).  
These suggest that if nothing is done to significantly address this threat, the socio-economic 
development of several countries, particularly those in the developing world which relies 
mainly on agriculture and food production, and are not sufficiently implementing adequate 
measures to prevent and curb the spread of ABR from farm-to-plate, will be seriously hindered, 
along with the achievement of some world’s sustainable development goals (Laxminarayan et 
al., 2013; Årdal et al., 2016; Jasovsky et al., 2016; O'Neill, 2016). 
There is currently limited data on the molecular epidemiology of MRSA and ESBL-PE in 
Cameroon and South Africa, ascertaining risk factors, resistance and virulence mechanisms, in 
the food chain. This study provides a food safety and One Health perspective in selected 
abattoirs in Yaoundé, Cameroon and KwaZulu-Natal Province, South Africa, which could be 
useful in motivating the development of effective prevention and containment measures in 
these settings, and to a certain extent to other African countries as some frontier nations could 
face similar realities. The relative limitation observed in terms of prevalence, risk factors, 
resistance and virulence mechanisms, and clonality in pigs and exposed workers is addressed 
in this study within and between countries, to provide a holistic overview of the current status 
of resistance burden related to carriage isolates and underscore the urgent need for efficient 
containment measures in the food chain in Cameroon and South Africa. 
IV. Research aims and objectives of the study 
1. Overarching aim 
The overarching aim of this study is set to estimate the prevalence and determine the 
phenotypic and genotypic characteristics including but not limited to the clonal relatedness, 
genetic diversity, virulence factors and resistance mechanisms of circulating MRSA and 
ESBL-PE in pigs and occupationally exposed humans in Cameroon and South Africa; this in 
order to improve knowledge about risks factors associated with the emergence and spread of 
MRSA and ESBL-PE as well as their zoonotic transmission in the food chain. 
2. Specific objectives  
More specifically, the study aims: 
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i. To evidence the danger of antibiotic resistance in the food chain and particularly in 
developing countries as a serious global public health threat by means of a review paper. 
ii. To describe the distribution of ARB in food animals in Africa, in order to highlight the 
need to restrict the use of antibiotics in agriculture, and provide evidence for the 
implementation of the One Health approach to contain the emergence and spread of ABR 
on the continent by means of a systematic review and meta-analysis of published literature. 
iii. To detect MRSA/ESBL-PE strains from nasal and rectal swabs of pigs from five selected 
slaughterhouses, using selective media, followed by delineating the bacterial characteristics 
(morphology after Gram staining, appearance of colonies on culture media) and 
biochemical tests as well as the Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France) 
automated method, in order to ascertain the colonization and spread of these pathogens in 
occupationally exposed humans involved in the pig production in Yaoundé, Cameroon and 
KwaZulu-Natal, South Africa by original experimental research. 
iv. To detect MRSA/ESBL-PE strains from nasal and hands swabs of exposed workers, using 
selective media, followed by delineating the bacterial characteristics (morphology after 
Gram staining, appearance of colonies on culture media) and biochemical tests as well as 
Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France) automated method, in order to 
ascertain the colonization and spread of these pathogens in occupationally exposed humans 
involved in the pig production in Yaoundé, Cameroon and KwaZulu-Natal, South Africa 
by original experimental research. 
v. To determine their antimicrobial resistance profiles through antibiotic susceptibility testing 
by minimum inhibitory concentration (MIC) determination using the broth microdilution 
with Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France) automated methods by 
original experimental research. 
vi. To compare the prevalence and resistance phenotypes of MRSA and ESBL-PE strains 
isolated from Cameroonian and South African slaughterhouses by original experimental 
research. 
vii. To delineate risk factors associated with the colonization and dissemination of ESBL-PE 
and/or MRSA among exposed workers, including demographic data (age, sex, profession, 
education level, socioeconomic considerations, monthly income, etc.), clinical data (recent 
hospitalization, recent antibiotic use, diabetes mellitus, hypertension, asthma, tuberculosis, 
HIV/AIDS, skin and nasal problems, etc.), as well as occupational factors (animal gender, 
intensity of contacts with pigs, slaughterhouse practices, hygiene and safety precautions 
measures implemented), in order to establish the possible route of transmission between 
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human and animal and vice versa, using a structured questionnaire by original experimental 
research.  
viii. To undertake molecular characterization of MRSA/ESBL-PE strains isolated from pigs and 
humans by whole genome sequencing (WGS) in order to provide information about the 
phylogenetic evolution, resistance and virulence genes and sequence type, as well as mobile 
genetic elements (MGEs) by original experimental research. 
ix. To summarize the current state of knowledge and potential public health risks associated 
with the presence of MRSA or ESBL-E in pigs, to act as food-borne pathogens by way of 
original experimental research.  
x. To suggest prevention and containment measures for antibiotic resistance in the food chain 
based on the original research conducted above and review papers. 
3. Study design and methodology 
Between March and October 2016, nasal and rectal swabs of pigs and nasal and hand swabs of 
occupationally exposed workers older than 21 years old were collected in five abattoirs in both 
Cameroon and South Africa. All samples were screened on selective media (MacConkey agar 
and Mannitol salt agar) supplemented with antibiotics (cefotaxime and cefoxitin) and 
identification was undertaken by colony morphology, catalase and oxidase tests, with 
confirmation by the Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France). The cefoxitin 
screening and double disk synergy tests were used for methicillin resistance and extended-
spectrum beta-lactamase production in staphylococci and Enterobacteriaceae, respectively. 
Repetitive-palindromic polymerase chain reaction (REP-PCR) and enterobacterial-repetitive-
polymerase chain reaction (ERIC-PCR) were used to ascertain the clonal relatedness of MRSA 
and ESBL-PE isolates, respectively. Genomic DNA of representative isolates were further 
subjected to whole genome sequencing (WGS) using an Illumina MiSeq platform to delineate 
the molecular epidemiology, resistance genes, virulence factors, phage-related regions and 
circulating clonal lineages of these isolates. Generated reads were assembled with CLC 
Genomics Workbench and SPAdes, annotated with PGAP and RAST. ResFinder, 
VirulenceFinder, PlasmidFinder and PHAST were used to identify antibiotic resistance genes, 
virulence factors, plasmids and phage associated-regions. The multilocus sequence type 
(MLST) of the isolates was determined from the WGS data. Whole genome phylogenetic 
analysis was performed using the Rapid large-scale prokaryote pan genome analysis (Roary). 
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4. Thesis outline 
The present study is outlined in the form of published journal articles and unpublished 
manuscripts, and is delineated by the following seven chapters:  
▪ Chapter 2. Article I: Antibiotic Resistance in the Food Chain: A Developing Country-
Perspective. Front Microbiol. 7:1881. doi: 10.3389/fmicb.2016.01881. This review 
evidences the danger of ABR in the food chain and particularly in developing countries as 
a serious global public health threat by highlighting the transmission routes of ABR along 
the food chain and comparing the status of ABR in food animals in developed vs. 
developing countries. Prevention and containment measures of ABR from farm-to-fork are 
also delineated. This paper addresses objectives One and Ten. 
▪ Chapter 3. Article II: Antibiotic Resistance in Food Animals in Africa: A Systematic 
Review and Meta-Analysis. This systematic review analysed the published literature on the 
emergence/prevalence of ABR in food animals in Africa, in order to (1) describe the 
distribution of ABR-bacteria in food animals; (2) highlight the need to restrict the use of 
antibiotics in agriculture, and (3) provide evidence to follow the One Health approach to 
contain the emergence and spread of ABR on the continent. This manuscript addresses 
objectives Two and Ten. It has been submitted to Microbial Drug Resistance and is 
currently under review. 
▪ Chapter 4. Article III: Emergence and Spread of Extended Spectrum Beta-Lactamase 
(ESBL)-Producing Enterobacteriaceae in Pig Slaughterhouses and Exposed Workers: A 
Multicentre Comparative Study Between Cameroon and South Africa. This original 
research article reports on and compares the prevalence, risk factors as well as clonal 
relatedness of ESBL-PE circulating in Cameroonian and South African slaughterhouses 
and addresses objectives Three, Four, Five, Six, Seven, Nine and Ten. It has been submitted 
to PloS One and currently under review. 
▪ Chapter 5. Article IV: Mannitol-Fermenting Methicillin-Resistant Staphylococci (MRS) 
in Pigs and Abattoir Workers in Cameroon and South Africa: A Serious Food Safety Threat. 
It has been submitted to the International Journal of Food Microbiology and is currently 
under review. It reports on and compares the prevalence, risk factors as well as clonal 
relatedness of MRS circulating in Cameroonian and South African slaughterhouses and 
addresses objectives Three, Four, Five, Six, Seven, Nine and Ten. 
▪ Chapter 6. Article V: Genome Analysis of Methicillin-Resistant Staphylococcus aureus 
Isolated from Pigs: Emergence of the Clonal Lineage ST398 in Cameroon and South 
Africa. This original research article has been submitted to Frontiers in Microbiology and 
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is currently under review. It reports on antibiotic resistance genes, virulence factors, mobile 
genetic elements and genetic lineages of circulating MRSA strains isolated from pigs in 
Cameroonian and South African abattoirs using whole genome sequencing (WGS) and 
addresses objectives Eight and Nine. This paper will reference “Mannitol-Fermenting 
Methicillin-Resistant Staphylococci (MRS) in Pigs and Abattoir Workers in Cameroon and 
South Africa: A Serious Food Safety Threat” which is expected to be published first. 
▪ Chapter 7. Article VI: Whole Genome Sequencing of Circulating ESBL-producing 
Klebsiella pneumoniae Isolated from Pigs and Abattoir Workers in Cameroon. This 
original research article has been submitted to Frontiers in Microbiology and is currently 
under review. It reports on antibiotic resistance genes, virulence factors, mobile genetic 
elements, and genetic lineages of circulating ESBL-producing K. pneumoniae strains 
isolated in Cameroonian slaughterhouses using whole genome sequencing and addresses 
objectives Eight and Nine. This paper will reference the “Emergence and Spread of 
Extended Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae in Pig 
Slaughterhouses and Exposed Workers: A Multicentre Comparative Study Between 
Cameroon and South Africa” paper, which is expected to be published first. 
▪ Chapter 8. Conclusion: This chapter presents the extent to which the overarching aim was 
met by reviewing the key findings for each specific objective. It further delineates the 
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- Raspail Carrel Founou extracted and collated data and contributed to the writing of the 
manuscript.  
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Objectives met: This paper meets objective One (to evidence the danger of antibiotic 
resistance in the food chain and particularly in developing countries as a serious global public 
health threat) and Ten (to describe prevention and containment measures for antibiotic 


























































































Article II. Antibiotic Resistance in Food Animals in Africa: A 
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interpreted the results, prepared tables and figures, and drafted the manuscript.  
- Daniel Amoako, participated in the screening of titles and abstracts and undertook critical 
review of the manuscript. 
- Raspail Carrel Founou extracted and collated data, performed quality assessment and 
statistical analyses, interpreted the results, prepared tables and figures and contributed to 
the writing of the manuscript.  
- Sabiha Yusuf Essack, as principal supervisor, co-conceptualized the study, screened titles, 
abstracts and full-texts, and undertook critical revision of the manuscript. 
 
Objective met: This paper meets objective Two viz. to describe the distribution of ABR-
bacteria in food animals in Africa, in order to highlight the need to restrict the use of antibiotics 
in agriculture, and provide evidence to follow the One Health approach to contain the 












                                                 
2 This paper has been submitted to Microbial Drug Resistance and is currently under review. 
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Objectives: This study critically reviewed the published literature and performed a meta-
analysis to determine the overall burden of antibiotic-resistant bacteria in food animals in 
Africa. 
Methods: English and French published papers indexed in EBSCOhost, PubMed, Web of 
Science and African Journals Online were retrieved, with searches being conducted up to 
August, 2015. Data were pooled and meta-analysis performed using a random-effects model 
and the results are described as event rates. 
Results: According to the predefined inclusion and exclusion criteria, 17 articles out of the 852 
retrieved, were eligible for the qualitative and quantitative analysis. The studies included were 
mainly conducted in Nigeria, with E. coli, Salmonella spp., and Campylobacter spp. being the 
main bacteria. The pooled estimates showed high level of antibiotic resistance (86%; p<0.001) 
and multi-drug resistance (73%; p=0.003).  
Conclusion: Our results suggest that antibiotic resistance is substantively prevalent, and poses 
a serious threat for food safety and security in Africa. These findings shed light on areas for 
future research concerning antibiotic resistant and multi-drug resistant bacteria in food animals 
as etiological agents of infectious diseases in humans. They further yielded some interesting 
findings on the burden of antibiotic resistance, that could be useful in developing measures to 












Antibiotic resistance (ABR) is a worldwide public health concern, with serious health, 
economic and societal repercussions (1). Its emergence is attributed to the selective pressure 
exerted by antibiotic use in the community, hospitals, veterinary health, agriculture, 
aquaculture, and the environment. Additionally aggravating the situation, is the fact that very 
few new antibiotics have recently been produced by pharmaceutical companies. It is widely 
acknowledged that food animals are key reservoirs of antibiotic-resistant bacteria, and that 
antibiotic usage in this population favours the emergence, selection and spread of resistance 
among animals and humans (2-4), both via zoonoses (infectious diseases transmitted between 
animals and humans) and the food chain (4-6).  
Food animal production generally depends on the therapeutic and prophylactic use of 
antibiotics, and can be enhanced by the use of antibiotics for growth-promotion. Several 
antibiotic agents commonly used in food animals are either identical or linked to those 
administered in humans (7). This broad use of antibiotics in agriculture has increased the 
danger posed by the emergence and spread of ABR by selecting for new antibiotic-resistant 
(commensal and/or pathogenic) bacteria and infections caused by these bacteria (4, 6, 8, 9). 
Accordingly, the presence of ABR in food animals threatens food safety and by extension, 
global health. Given the sharing of bacteria between humans and animals, as well as the animal 
origin of 60% (10, 11) of emerging human pathogens, the Food and Animal Organization of 
the United Nations (FAO), World Organization for Animal Health (OIE) and World Health 
Organization (WHO) fully endorse the One Health approach as articulated in the WHO Global 
Action Plan on Antimicrobial Resistance (AMR) (12), the OIE Strategy on AMR and Prudent 
Use of Antimicrobials (13) and the FAO Action Plan on AMR (14).   
Notwithstanding the situation evidenced by this global health challenge, the dearth of 
information concerning ABR in food animals in Africa leads to an under-estimation of the 
nature and extent of ABR, as well as the associated health and socio-economic impacts on 
65 
 
human, animal and environmental health regionally and globally. This systematic review 
analysed the published literature on the prevalence of ABR in food animals in Africa. By 
summarizing the available data, our objectives were to (1) describe the dissemination of 
antibiotic-resistant bacteria in food animals; (2) highlight the need to reduce, replace and refine 
the use of antibiotics in agriculture, and (3) provide evidence to follow the One Health approach 
to contain the emergence and spread of ABR on this continent. 
3.2. Methods 
The Preferred Reporting Items for Systematic Reviews and Meta-analyses [PRISMA, (15)] 
and Meta-analysis of Observational Studies in Epidemiology [MOOSE; (16)] statements were 
followed.  
3.2.1. Outcomes of interest 
The primary outcome of interest was to identify the prevalence of antibiotic-resistant bacteria 
isolated from apparently healthy, sick or dead food animals, products thereof and exposed 
workers at farms, abattoirs/markets or both. Resistance to beta-lactams, aminoglycosides, and 
fluoroquinolones, described by the WHO (17) and OIE (18) as critically important antibiotics 
in humans and animals as well as tetracyclines listed as critically important veterinary 
antimicrobial agents in animals (18), were used as the basis to ascertain multi-drug resistance 
(MDR) in our study. The secondary outcome of interest was the prevalence of multidrug-
resistant bacteria, which, for the purpose of this review, is regarded as resistance to three or 
more classes of antibiotics. 
3.2.2. Ethics approval 
This systematic review and meta-analysis was based on an appraisal of published reports and 
was therefore exempted from ethical approval. Moreover, it did not involve any direct research 
on human participants and no informed consent was required. 
3.2.3. Sources and literature search 
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A multifaceted search was conducted in four electronic databases, namely Medline via 
PubMed, Web of Science, EBSCOhost and African Journals Online up to August, 2015, using 
a combination of boolean operators (AND/OR), Medical Subject Heading (MeSH) and pre-
defined keywords including ‘antimicrobial resistan*’, ‘antibiotic resistan*’, ‘drug* resistan*’, 
‘multi-drug resistan*’, ‘multi-drug resistan*’, ‘multiple-drug resistan*’, ‘multiple drug* 
resistan*’, ‘food animal*’, ‘farm animal*’, ‘domestic animal*’, ‘livestock animal*’, ‘poultry’, 
‘pig’, ‘cattle’, ‘sheep’, ‘goat’ and followed by refining terms: ‘Africa*’, ‘East* Africa*’, 
‘Western* Africa*’, ‘Southern* Africa*’, ‘Northern* Africa*’, ‘Central Africa*’, ‘Sub-
saharan Africa*’. The truncation mark (*) specifies that diverse extensions were used during 
the search. 
The reference lists of all included papers were further used to carry out a supplementary 
literature search. In addition, attempts were made to contact authors to obtain inaccessible 
abstracts and full-texts of included studies. Papers in English and French were retrieved and 
assessed for potentially relevant studies pertaining to antimicrobial resistance in food 
producing animals in Africa. The authors independently screened and evaluated the full texts 
of the papers following the first duplicated and blinded screening on the basis of titles and 
abstracts for relevance to the study objectives. Disagreements and inconsistencies among 
authors were resolved by consensus after discussion. 
3.2.4. Exclusion and inclusion criteria 
The authors individually assessed articles using pre-designed eligibility forms and according 
to pre-defined eligibility criteria (Table 1). Briefly, studies on parasites, viruses and fungi, as 
well as those dealing with ABR in aquatic, companion and wildlife animals, and the 
environment were excluded. Although, studies dealing with ABR in humans were excluded 
those reporting data of workers exposed to food animals and/or products thereof were included. 
Studies reporting data from outside Africa were further not selected, nor was grey literature 
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(foreign or domestic material usually inaccessible through relevant databases and indexes) and 
unpublished data.  
The selection of French and English published papers was based on clearly defined populations 
involving living food animals at farms and/or processed/freshly slaughtered animals at 
abattoirs/markets. In order to be included, studies must have also performed antibiotic 
susceptibility testing with antibiotics belonging to beta-lactam/aminoglycoside, tetracycline, 
and fluoroquinolone classes of antibiotics via disk diffusion, agar dilution, broth micro-dilution 
or E-test methods, and results interpreted according to appropriate guidelines (Antibiogram 
Committee of the French Society of Microbiology: CA-SFM; European Committee on 
Antimicrobial Susceptibility: EUCAST; Clinical Laboratory Standards Institute: CLSI 
formerly known as National Committee on Clinical Laboratory Standards: NCCLS). Multi-site 
and intercontinental studies involving ABR in food animals in African countries were also 
considered. 
3.2.5. Framework for literature screening and data extraction 
EndNote (version X7, Thomson Reuters) was used for literature management and relevant data 
from included papers were extracted as outlined in Table 2. The data were abstracted and 
analysed using a framework onto an Excel® (Microsoft® Office Excel 2013) spreadsheet, 
including for each study, first author details, country of study, year of publication, aims, study 
population (e.g. pigs, poultry, cattle, sheep, goat, human), type of sample (e.g. nasal swabs, 
rectal swabs, faecal samples, meat products), sample size, clinical status (e.g. apparently 
healthy, sick and dead), study site (viz. slaughterhouse, farm, market), type of study (e.g. single, 
multisite, and international study), bacteria of interest (e.g. S. aureus, Salmonella spp., 
Campylobacter spp., E. coli., Enterococcus spp.), antibiotics tested, antimicrobial 
susceptibility testing (AST) methods (disk diffusion, micro-broth dilution, agar dilution, E-test 
and automated methods), guidelines of interpretation  of AST (e.g. CA-SFM, EUCAST, CLSI, 
NCCLS), ABR/MDR prevalence and results. 
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3.2.6. Quality assessment 
Various types of observational studies addressing prevalence were considered in this 
systematic review. There are numerous reporting measures assessing the study quality in 
systematic reviews and meta-analyses, but these are generally limited to specific type of studies 
such as randomized-controlled trials, with no standard method for conducting quality 
assessment of prevalence data studies. Therefore, pre-existing scales could not be used to assess 
study quality. The modified critical appraisal tool (high-quality items rating scale) developed 
by Munn et al. (2014) was used to assess the quality of all included studies (19): (1) Was the 
basic data including study period, sample type, bacteria of interest and study site provided?  (2) 
Were the study participants recruited in an appropriate way? (3) Was the sample size 
representative of the target population? (4) Were the study subjects and setting described in 
detail? (5) Was the data analysis conducted with sufficient coverage of the identified bacteria? 
(6) Were all important confounding factors/ subgroups/differences identified and accounted 
for? (7) Were objectives, standard criteria used to measure the condition? (8) Was the condition 
measured reliably?  
Each item was answered with either a yes, no or unclear, and scored on a three-point scale, 
with 2 indicating high quality, 1 indicating moderate quality and 0 low quality. Summing up 
the scores of each item provided the overall score of the study, with a highest being 16. A total 
score ≥12 was regarded as high quality (low-risk of bias), between 6-12 as moderate quality 
(medium-risk of bias) and <6 as low quality (high-risk of bias). Only high-quality studies were 
included in the study. The quality assessment was undertaken individually by the authors. 
3.2.7. Statistical analysis 
Microsoft Excel® (2013 for Windows) was used to analyse the data following an initial 
extraction. Meta-analyses were performed for outcomes of which there were four or more 
studies that could be combined. Analyses were conducted across animal populations for the 
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two selected endpoints (resistance and multi-drug resistance). The rates of antibiotic-resistant 
and multi-drug resistant bacteria among included studies were calculated as follows: 
  𝐵𝑎𝑐𝑡𝑒𝑟𝑖𝑎𝑙 𝐴𝐵𝑅 𝑟𝑎𝑡𝑒 (%) =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑟𝑎𝑖𝑛𝑠 𝑐𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑡
 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑟𝑎𝑖𝑛𝑠 𝑖𝑠𝑜𝑙𝑎𝑡𝑒𝑑 𝑎𝑛𝑑 𝑠𝑐𝑟𝑒𝑒𝑛𝑒𝑑 𝑓𝑜𝑟 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒
  
 
       𝐵𝑎𝑐𝑡𝑒𝑟𝑖𝑎𝑙 𝑀𝐷𝑅 𝑟𝑎𝑡𝑒 (%) =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑟𝑎𝑖𝑛𝑠 𝑐𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝑀𝑢𝑙𝑡𝑖−𝑑𝑟𝑢𝑔 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑡
 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑟𝑎𝑖𝑛𝑠 𝑐𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑡
   
 
Meta-analyses of rates were undertaken to determine the overall prevalence of antibiotic-
resistant and multi-drug resistant bacteria among food animals and exposed workers. Subgroup 
analyses were conducted for population-, sample-, settings-, organism-, and country-defined 
subgroups.  
Forest plots of pooled event rates for the primary and secondary outcomes, with 95% 
confidence intervals, were generated using the Comprehensive Meta-analysis (CMA) software 
(Biostat, Inc., New Jersey, USA) version 3 for Windows. Studies were weighted in favor of 
those with more precise results (narrower confidence intervals) and results are presented as 
event rates. Data were pooled, and meta-analyses performed using the random-effects model 
to provide a more conservative estimate of resistance, allowing for any heterogeneity between 
studies. This method was used to assess the extent of bacterial resistance of the entire relevant 
population, not only the population in the included studies. The I² statistic with cut-off values 
of 25 % (low), 50% (moderate) and 75% (high) was used to assess heterogeneity between 
studies and the chi square test with p-value <0.05 was used to define a significant degree of 
heterogeneity within studies. Publication bias was assessed and visualized by a funnel plot and 
Egger’s tests for small study effects. 
3.3. Results 
Figure 1 outlines the work-flow of the study selection process with reason of exclusion. The 
systematic search from the four electronic databases identified 852 articles. After duplicates 
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were removed, 463 papers were screened for potential inclusion based on their titles and 
abstracts, with 124 full-text articles being entirely assessed. Two articles were added following 
hand-searching and according to the predefined inclusion and exclusion criteria, yielding a 
final number of 68 studies being eligible for the quality assessment. Of these 68 studies, 17 
were rated as good quality (low risk of bias), 47 were of moderate quality (medium risk of bias) 
and 4 were of poor quality (high risk of bias). Only good quality studies were finally included 
in the qualitative and quantitative synthesis. 
3.3.1. Description and characteristics of included studies  
Most of the data analysed were obtained from single centre studies conducted mainly in Nigeria 
(n=6) (Table 2 and Figure 2). The majority of studies (n=12) reported ABR only in food 
animals while two studies investigated ABR concomitantly in food animals, food products and 
exposed workers (32, 33). Similarly, three studies reported ABR conjointly in food animals 
and food products (34-37). E. coli (n=8), Salmonella spp. (n=6) and Campylobacter spp. (n=2) 
were the main antibiotic-resistant bacteria investigated and reported (Table 2 and Figure 2). 
3.3.2. Assessment of antibiotic resistance of bacterial species 
All papers (100%) included antibiotic susceptibility testing of the identified bacterial species. 
Overall, E. coli isolates were screened with 16 different antibiotics across all respective studies 
using disk diffusion (75%; 6/8) and broth micro-dilution (25%; 2/8). Similarly, 19 antibiotics 
were tested against Salmonella spp. isolates with disk diffusion (50%; 3/6) and broth 
microdilution (33.3%; 2/6) being the main AST methods (Table 3). The use of standardized 
guidelines was reported in all 17 studies. Susceptibility testing was performed most frequently 
to ampicillin (75%) followed by tetracycline, gentamicin, trimethoprim-sulfamethoxazole, 
streptomycin, ciprofloxacin, nalidixic acid, chloramphenicol and cefuroxime in E. coli (Table 
3). Regarding Salmonella spp. the order was as follows, streptomycin, gentamicin, 
ciprofloxacin, tetracycline, chloramphenicol, ampicillin, nalidixic acid, sulphonamides, 
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trimethoprim-sulfamethoxazole. The overall estimated effects for Campylobacter spp., S. 
aureus and Enterococcus spp. were not calculated due to insufficient reports. 
3.3.3. Primary analyses 
Figures 3A and 4A represent forest plots of untransformed event rate estimates of ABR and 
MDR in selected studies. Pooled estimates generated 86% (95%CI, 76.3-92.20%, p=0.000) of 
ABR and 73% (95%CI; 58.3-83.9%, p=0.003) of MDR. Subgroup analyses were performed 
per population, bacteria, setting, sample and country to allow more specific results.     
3.3.4. Subgroup analyses 
a. Population 
Figures 3B and 4B show forest plots of ABR and MDR per population with 95% CIs. The 
prevalence of ABR was very high in pigs with a prevalence of 93.6% (95%CIs; 77.7-98.4%; 
p<0.001). The prevalence of ABR was 78.2% (95%CIs; 44.1-94.3%; p=0.098) in cattle and 
73.1% (95%CIs; 48.8-88.6%; p=0.062) in poultry. Despite the highest level of ABR being in 
pigs (93.6%; 95%CIs; 77.7-98.4%; p<0.001), MDR was assessed to be largely lower in this 
population [51.1% (95%CIs; 23.3-78.3%; p=0.942)] although it was not statistically 
significant. Conversely, overall prevalence of MDR was elevated in cattle and poultry, with 
74.3% (95%CIs; 43.4-91.6%; p=0.117) and 84.3% (95%CIs; 56.0-95.8%; p=0.022) prevalence 
respectively. Pooled estimates for goats and sheep were not calculated due to insufficient data 
(only 2 reports). The I² values of the logit event estimates in cattle, poultry and pigs were 
95.53%, 95.57% and 96.84% respectively (p=0.000). 
b. Bacterial species  
E. coli was the principal bacterium of interest (8 out of 17 studies) and was most frequently 
investigated individually with no other bacterial species in different populations. Significant 
levels of ABR [86.50% (95%CIs; 73.20-93.8%; p=0.000)] and MDR [77.50% (95%CIs; 58.90-
89.2%; p=0.006)] were identified in E. coli. Similarly, rate of ABR was high in Salmonella 
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spp. [80.9% (95%CIs; 54-93.8%; p=0.028)], whereas MDR was estimated at 34.6% (95%CIs; 
19.80-53.20%; p=0.102) (Figures 3C and 4C). 
c. Setting 
Pooled estimates were conducted for isolates collected from farms and abattoirs. Overall 
prevalence of ABR was higher in farms [88.6%, (95%CIs; 74.4-95.4%; p=0.000)] than 
abattoirs [79.3%, (95%CIs;52.4-93.0; p=0.032)]. Similarly, MDR prevalence was higher in 
farms [86.6% (95%CIs; 69.1-94.9%; p=0.001)] than in abattoirs [52.4% (95%CIs; 23.2-79.9%; 
p=0.886%)] (Supplementary Figures 1A and 2A). 
d. Sample 
Supplementary figures 1B and 2B depict forest plot of ABR and MDR analysed per sample. 
Faecal samples were the main isolation site with elevated rates of ABR (96.1%; 95%CIs, 89.2-
98.6%, p=0.000) and MDR (69.5%; 95%CIs, 49.6-84%, p=0.054). Pooled estimates for 
carcasses were not calculated due to insufficient reports. 
e. Country 
Subgroup analyses per country provided a 95.9% (95%CIs; 78.1-99.3%; p=0.001) prevalence 
of ABR in Nigeria (Supplementary figure 1C), while the level of MDR was 61.9% (95%CIs; 
35.4-82.80%; p=0.552) (Supplementary figure 2C). Prevalence in other countries could not be 
ascertained as only respectively one report was available for these countries. 
3.4. Discussion 
Antimicrobial resistance is one of the greatest public health challenges facing the world. The 
situation has become particularly worrying as a result of the escalating global emergence of 
multi-drug resistant bacteria in the food chain, (6, 26). This systematic review and meta-
analysis was undertaken to analyse the published literature reporting prevalence of ABR in 
food animals in Africa. Out of the 852 records found through databases searching, 20 records 
describing 17 different studies were included in the qualitative and quantitative analysis. The 
study proved that antibiotic-resistant foodborne pathogens are under-investigated on this 
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continent with reports from only 12 of the 54 African countries. The overall prevalence of ABR 
and MDR was 86% and 73%, respectively. These results could be attributed to agricultural 
practices being over-reliant on antibiotic use in Africa (4, 5, 27). This is consistent with a recent 
modelling study which suggested that a shift on agricultural practices from small to industrial 
scale in developing countries will lead to up to a third of the global increase in antibiotic 
consumption in food animals by 2030 (28).  
At the animal species level, pigs and poultry were the leading population colonized or infected 
by antibiotic-resistant bacteria and multi-drug resistant bacteria in our study. The high 
prevalence of multi-drug resistant bacteria observed among poultry isolates, reflects the 
relatively large consumption of various antibiotics for their breeding, whereas the high rate of 
single resistance in pigs suggests that few classes of antibiotics are used to treat or prevent 
infections. Our findings are in accordance with that reported elsewhere in other developing 
countries such as Thailand and Vietnam (29-31). In Denmark, the first country to have 
implemented a surveillance program of ABR, as well as in the rest of the European Union 
(EU), the prevalence of antibiotic-resistant and multi-drug resistant bacteria in food animals 
was relatively lower (range: 4-65%) than in our study (26, 32-35). Differences in the level of 
resistance could be associated with long-term surveillance programs, infection prevention and 
control and biosecurity measures, antibiotic use monitoring and a ban on antimicrobials as 
growth-promoters for many years in food animals in these high-income European countries. It 
is probable that such measures and policies would also be appropriate to contain the emergence 
and spread of ABR in food animals in Africa.  
A sound analysis and interpretation of our findings raised some fundamental questions: (i) As 
antibiotic-resistant and multi-drug resistant bacteria have been isolated from healthy and sick 
animals across the continent, what are the genetic elements (resistance and virulence genes) 
and clonal relatedness of these bacteria within and between both populations as well as within 
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and between countries? (ii) Are healthy animals becoming clinically ill following the 
asymptomatic carriage of antibiotic-resistant bacteria? (iii) What are the global health, societal 
and economic implications if these animal-originating strains succeed in spreading and 
undergoing host-adaptive micro-evolutionary changes that could lead to the emergence of new 
and more resistant/virulent strains in the human population? There was unfortunately limited 
data to answer these questions, thereby highlighting areas for future research.   
Subgroup analysis per bacteria displayed high prevalence of ABR and MDR in Salmonella spp.  
A meta-analytical study carried out in Ethiopia, revealed a diverse prevalence of Salmonella 
spp., these being 7.07% in cattle, 8.41% in sheep, 9.01% in goats and 43.81% in pigs with 
antimicrobial susceptibility testing data not reported (36). Our results are also higher than that 
described in the Netherlands where 12 and 43% of ESBL-producing and fluoroquinolone 
resistant Salmonella spp. were observed in poultry respectively (37). This finding could be 
correlated to poor farming/slaughterhouse practices and sub-optimal hygiene measures.  
The high prevalence of ABR and MDR in E. coli reported in our study is of further great 
concern as the involved antibiotic resistance genes (ARGs) may be carried on mobile genetic 
elements (MGEs). ABR and MDR in E. coli could be responsible of serious infections in 
humans on this continent, and serve as reservoirs of ARGs that could potentially be 
disseminated to other commensal and pathogenic bacteria such as Salmonella spp. which, in 
turn, may spread via the food chain (2, 4, 6). This therefore confirms that monitoring ABR in 
indicator bacteria such as E. coli in food animals and products thereof, is imperative to 
understand the evolution and transmission dynamics of antibiotic-resistant bacteria and ARGs 
in the food chain (26, 35, 38). Despite the fact that the nature and extent of antibiotic use in 
food animals were not ascertained, the high prevalence of ABR and MDR observed among E. 
coli and Salmonella spp. isolates is indicative of widespread use of antibiotics in farming 
practices both for prevention and treatment of infectious diseases in food animals in Africa.  
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Antibiotic-resistant and multi-drug resistant bacteria were highly prevalent in food animals at 
farms and abattoirs. Multi-drug resistant bacteria detected in food animals at farms (86.6%; 
95%CIs, 69.1-94.9%, p=0.001) were directly representative of the antimicrobial use in these 
settings, whereas those detected at abattoirs (52.4%; 95%CIs, 23.2-79.9%, p=0.886) reflected 
bacteria surviving the processing stage, and therefore able to reach the consumer. This is a 
grave public health threat, as given the globalization of trade in food animals and food products 
as well as international travels, there are no geographic borders to contain the global 
dissemination of antibiotic-resistant and multi-drug resistant bacteria emerging in Africa.  
A 95.9% and 61.9% prevalence of ABR and MDR were respectively described in Nigeria. 
However, this data was not comparable with other African countries due to insufficient reports. 
These findings should in no way implicate Nigeria as a country with a high prevalence of ABR, 
but rather that ABR in the food chain has been recognized as serious public health concern in 
this country. Our results suggest that more high-quality studies are needed on this continent, 
that a minimum package of criteria for monitoring systems needs to be established and 
implemented, and collaboration of various sectors and disciplines has to be reinforced as 
advocated by the WHO’s Advisory Group on Integrated Surveillance of Antimicrobial 
Resistance (38).  
Our study should be interpreted considering certain limitations. Information about antibiotic 
consumption in food animals in included African countries was not available due to the scarcity 
of data in these nations. The resistance to specific antimicrobials, particularly those regarded 
as ‘critically important’ in animal and human health and correlation with resistance genes and 
virulence factors could not be ascertained in this study, reflecting the limited laboratory 
capacity in Africa. In addition, it is probable that there is publication bias due to the poor quality 
of studies and lack of reporting with only 17 published reports from 12 out of 54 countries 
meeting our strict inclusion criteria, with those not included failing to report on ABR (Figure 
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5). A high level of heterogeneity associated with a number of factors including origin of 
animals, farming and slaughterhouse practices, study design and exposure to environmental 
aspects such as stress, was also observed. Whilst the inclusion criteria and subgroup analyses 
used in this study helped in reducing heterogeneity, we could not confidently assume that 
studies were fully comparable. It is further important to note that effects of all presumptive 
factors such as Salmonella and Campylobacter resistance epidemiology per serotype and 
species, could not be analysed due to scarcity of data and limited number of studies in some 
subgroups. 
Conclusion 
To the best of our knowledge, this is the first systematic review and meta-analysis of ABR in 
food animals in Africa. Given the findings of the review, it seems clear that ABR is 
substantively prevalent and poses a serious threat for food safety and security on this continent. 
Areas for future research concerning antibiotic-resistant and multi-drug resistant pathogens in 
food animals as etiological agents of infectious diseases in humans were identified. Data 
generated here yielded some interesting findings on the burden of ABR, that could be useful in 
developing measures to contain this threat from farm-to-plate in Africa. We therefore strongly 
recommend that the One Health approach and recommendations advocated by the WHO, OIE 
and FAO, be followed to restrict the use of antibiotics and thus ABR in animal and human 
health. In addition, sound sampling and laboratory analyses schemes, cooperation and good 
communication between sectors (agriculture, veterinary and public health sectors), qualitative 
and quantitative risk assessment for emerging and potential hazards, and sustainable political 
will and financial support across the food chain are required. 
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Table 1. Characteristics of eligible studies 
N: Sample size; NR: Not reported; N/A: Not applicable; +: positive result; -: negative result; R: resistance; MDR: multidrug resistance; 








Type of sample (N) Study site (N) Bacteria (N) R MDR 
Detection of genes 
References 
ABR Virulence 
STUDIES CONDUCTED ONLY IN FOOD ANIMALS 
Algeria Poultry (300) NR 
Dropping (100), caeca (100), 





+ + N/A N/A (51) 
Cameroon Poultry (150) NR Carcasses (150) Abattoir (8) 
Salmonella spp. 
(103) 






Carcasses (90), feces (95), 
cloacal swab (48) pharyngeal 
swab (12) 




Healthy Fecal samples (200) Abattoirs (NR) E. coli (162) + + + N/A (55) 
Nigeria Poultry (400) 
Healthy 
and sick 
Cloacal swabs (201), tracheal 
swabs (196), internal organs 
(903) 
Farms (100) 
E. coli (805) 
S. aureus (660) 
+ NR + N/A (56) 
Nigeria Poultry (525) NR 
Internal organs (235), feces 




+ + N/A N/A (57) 
Nigeria Pig (306) NR Fecal samples (306) Farms (31) 
Salmonella spp. 
(229) 
+ + + N/A (58) 
South 
Africa 
Pig (400) NR Fecal samples (400) Farms (2) 
Enterococcus 
spp. (320) 
+ + N/A + (59) 
Tunisia Poultry (136) Healthy Fecal samples (136) Farms (36) E. coli (67) + + + N/A (60) 
Uganda Pig (465) 
Sick and 
healthy 
Fecal samples (465) Farms (93) 
Salmonella spp. 
(53) 
+ + N/A N/A (61) 




NR Cloacal swabs (2 833) Farms (NR) 
Salmonella spp. 
(206) 
+ + N/A N/A (63) 
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Table 1. Characteristics of eligible studies (Continued) 
N: Sample size; NR: Not reported; N/A: Not applicable; +: positive result; -: negative result; R: resistance; MDR: multidrug resistance; 












Type of sample 
(N) 
Study site (N) Bacteria (N) R MDR 
Detection of genes 
References 
ABR Virulence 
STUDIES CONDUCTED IN FOOD ANIMALS, FOOD PRODUCTS AND EXPOSED WORKERS 
Ethiopia 
Cow (195) 




Milk samples (195) 












Animal feces (210) 
Human stool (58) 
Farms (NR) E. coli (178) + + N/A N/A (33) 

















E. coli (154) + + N/A + (37) 
Cattle (800) NR 
Carcasses (800) 
Meats (250) 
Abattoirs (4) E. coli (227) + + N/A N/A (64) 
Senegal Poultry (250) NR Carcasses (250) Abattoirs (80) 
Campylobacter spp. 
(205) 
+ NR + N/A (34-36) 
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jejuni and coli 
Disk 
diffusion 

























NCCLS E. coli 
Disk 
diffusion 




CLSI E. coli 
Disk 
diffusion 




EUCAST E. coli 
Disk 
diffusion 
162 100 NR 100       NR NR NR    55 55  NR NR  NR  
Ojo et al. 
2010 
(37) 
CLSI E. coli 
Broth 
microdilution 
154 96.2 69.5 82.5        50.3   24  37.7 22.1 25.3 75.3 42.9    
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AST: Antimicrobial Susceptibility Testing; NR: Not Reported; NA: Not Applicable; CA-SFM: Antibiogram Committee of the French Society of Microbiology; EUCAST: 
European Committee on Antimicrobial Susceptibility; CLSI: Clinical and Laboratory Standards Institute; NCCLS: National Committee on Clinical Laboratory Standards 
Antibiotic resistance rates (%): 
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Figure 2. Graphical representation of antibiotic resistant bacteria reported in food 
animals in Africa. Each bacterium is annotated with a coloured circle. The number of studies 
carried out in each country is also indicated. Map was created using ArcGIS® and ArcMap 

























    
                       
Figure 3. Meta-analyses of overall rate and sub-group analyses of bacterial resistance. Each box represents the value of each included study while the 
diamond represents the overall and summary effect for each sub-group. The line in the middle is the line of null effect, the right-hand side of the line is in favour 
of resistance whereas the left is in favour of susceptibility. 3A Pooled random-effects estimate of overall (95% CI) bacterial resistance in selected studies; 3B Sub-





















               
                       
Figure 4. Meta-analyses of overall rate and sub-group analyses of bacterial multi-drug resistance. Each box represents the value of each included study 
while the diamond represents the overall and summary effect for each sub-group. The line in the middle is the line of null effect, the right-hand side of the line 
is in favour of resistance whereas the left is in favour of susceptibility. 4A Pooled random-effects estimate of overall (95% CI) bacterial resistance in selected studies; 











Figure 5. Bias assessment (Funnel) plot with 95% confidence limits for studies included 












Supplementary Table 1. PRISMA Checklist 




Title 1 Identify the report as a systematic review, meta-analysis, or both. 1 
ABSTRACT  
Structured summary 2 
Provide a structured summary including, as applicable: background; objectives; data 
sources; study eligibility criteria, participants, and interventions; study appraisal and 
synthesis methods; results; limitations; conclusions and implications of key findings; 
systematic review registration number. 
2 
INTRODUCTION  
Rationale 3 Describe the rationale for the review in the context of what is already known. 3-5 
Objectives 4 
Provide an explicit statement of questions being addressed with reference to participants, 
interventions, comparisons, outcomes, and study design (PICOS). 
5 
METHODS  
Protocol and registration 5 
Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, 
if available, provide registration information including registration number. 
NA 
Eligibility criteria 6 
Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics 
(e.g., years considered, language, publication status) used as criteria for eligibility, giving 
rationale. 
7, Suppl Table 3 
Information sources 7 
Describe all information sources (e.g., databases with dates of coverage, contact with study 
authors to identify additional studies) in the search and date last searched. 
7 
Search 8 
Present full electronic search strategy for at least one database, including any limits used, 
such that it could be repeated. 
6, Suppl Table 2 
Study selection 9 
State the process for selecting studies (i.e., screening, eligibility, included in systematic 
review, and, if applicable, included in the meta-analysis). 
6-8, Figure 1. 
Data collection process 10 
Describe method of data extraction from reports (e.g., piloted forms, independently, in 




Data items 11 
List and define all variables for which data were sought (e.g., PICOS, funding sources) and 
any assumptions and simplifications made. 
5-8, Suppl Table 
2 
Risk of bias in individual studies 12 
Describe methods used for assessing risk of bias of individual studies (including 
specification of whether this was done at the study or outcome level), and how this 
information is to be used in any data synthesis. 
8-9 
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 9-10 
Synthesis of results 14 
Describe the methods of handling data and combining results of studies, if done, including 
measures of consistency (e.g., I2) for each meta-analysis. 
9-10 
Risk of bias across studies 15 
Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., 
publication bias, selective reporting within studies). 
Figure. 5 
Additional analyses 16 
Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-
regression), if done, indicating which were pre-specified. 
9-10 
RESULTS  
Study selection 17 
Give numbers of studies screened, assessed for eligibility, and included in the review, with 
reasons for exclusions at each stage, ideally with a flow diagram. 
10-11, Fig 1. 
Study characteristics 18 
For each study, present characteristics for which data were extracted (e.g., study size, 
PICOS, follow-up period) and provide the citations. 
10-11, Table 1 
Risk of bias within studies 19 
Present data on risk of bias of each study and, if available, any outcome level assessment 
(see item 12). 
NA 
Results of individual studies 20 
For all outcomes considered (benefits or harms), present, for each study: (a) simple 
summary data for each intervention group (b) effect estimates and confidence intervals, 
ideally with a forest plot. 
11-13, Figures 
3-4;   
Synthesis of results 21 




Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). Figure 5 
Additional analysis 23 
Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-






Summary of evidence 24 
Summarize the main findings including the strength of evidence for each main outcome; 
consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). 
13-19 
Limitations 25 
Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., 
incomplete retrieval of identified research, reporting bias). 
18-19 
Conclusions 26 
Provide a general interpretation of the results in the context of other evidence, and 




Describe sources of funding for the systematic review and other support (e.g., supply of 










































         
Supplementary figure 1. Subgroup analyses of bacterial antibiotic resistance. 1A Subgroup analysis per settings; 1B Subgroup analysis per sample; 1C 



























          
                                                                      
Supplementary figure 2. Subgroup analyses of bacterial multi-drug resistance. 2A Subgroup analysis per settings; 2B Subgroup analysis per sample; 2C 
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Emergence and Spread of Extended Spectrum Beta-Lactamase 
(ESBL)-Producing Enterobacteriaceae in Pigs and Exposed Workers: 





- Luria Leslie Founou, as the principal investigator, co-conceptualized the study, undertook 
sample collection, laboratory and statistical analyses, prepared tables and figures, and 
drafted the manuscript. 
- Raspail Carrel Founou undertook sample collection, laboratory analyses, contributed to 
data analysis and vetting of the results, and reviewed the manuscript. 
- Noyise Ntshobeni participated in the genomic extraction and fingerprinting analysis. 
- Usha Govinden contributed materials and reagents for sample collection and primary 
laboratory analyses, and took part in the design of the study. 
- Linda Antoinette Bester contributed materials and reagents for sample collection and 
primary laboratory analyses, and took part in the design of the study. 
- Hafizah Yousuf Chenia contributed materials and reagents for and vetting of genomic 
fingerprinting results. 
- Cyrille Finyom Djoko contributed materials, equipment and reagents, took part in the 
design of the study, coordinated the field implementation in Cameroon and reviewed the 
manuscript. 
- Sabiha Yusuf Essack, as principal supervisor, co-conceptualized the study, contributed to 
vetting of the results and undertook critical revision of the manuscript.  
Objectives met: This original research article reports and compare the prevalence, risk factors 
as well as clonal relatedness of ESBL-PE circulating in Cameroonian and South African 
slaughterhouses and meets objectives Three, Four, Five, Six, Seven, Nine and Ten. 
 
 
                                                 
3 This paper has been submitted to PloS One and is currently under review. 
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Running title: Emergence and spread of ESBL-producing Enterobacteriaceae in the food 
chain  








Background: Extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) 
represent a significant public health concern globally and are recognized by the World Health 
Organization as pathogens of critical priority. However, the prevalence of ESBL-PE in food 
animals and humans across the farm-to-plate continuum is yet to be elucidated in Sub-Saharan 
countries including Cameroon and South Africa. This study determined the risk factors, 
carriage, antimicrobial resistance profiles and genetic relatedness of extended spectrum beta-
lactamase producing Enterobacteriaceae (ESBL-PE) among pigs and exposed workers in 
Cameroon and South Africa. 
Methods: The study was carried out from March to October 2016. ESBL-PE from pooled 
samples of 432 pigs and nasal and hand swabs of 82 humans were confirmed with VITEK 2 
system. Genomic fingerprinting was performed by ERIC-PCR. Univariate and multivariate 
logistic regression analyses were performed to identify risk factors for ESBL-PE carriage in 
humans from a questionnaire survey amongst slaughterhouse workers. 
Results: ESBL-PE prevalence in animal samples from Cameroon were higher than for South 
Africa and ESBL-PE carriage was observed in Cameroonian workers only. Nasal ESBL-PE 
colonization was statistically significantly associated with hand ESBL-PE (21.95% vs 91.67%; 
p=0.000; OR=39.11; 95% CI 2.02-755.72; p=0.015). Low level of education, insufficient 
monthly income, previous hospitalization, recent antibiotic use, inadequate handwashing, lack 
of training and contact with poultry were the risk factors identified. 
Conclusion: The study highlights the threat posed by ESBL-PE in the food chain and 
















Antibiotic resistance (ABR) is a global public health concern, with grave health and socio-
economic implications (1, 2). It is a natural evolutionary process emerging wherever antibiotics 
are used including in hospitals, communities, veterinary health, agriculture, aquaculture, and 
the environment. ABR is exacerbated by the fact that very few new antibiotics have lately been 
introduced by pharmaceutical industries. ABR can occur in saprophytic, commensal and 
pathogenic bacteria present in (food) animals, humans, and the environment (1, 2). Food 
animals are considered important reservoirs of antibiotic-resistant bacteria (ARB) that spread 
directly and indirectly in the farm-to-plate continuum (1, 2, 3). Direct contact occurs due to 
exposure of humans to animals and their biological substances such as urine, blood, feces, 
saliva, milk, and semen, and this enhances the rapid and easy dissemination of ARB from 
person-to-person (1, 2, 3). Whilst this transmission mode did not originally appear as a danger 
at population-health level, it is now widely recognized that exposed workers and their families 
provide a likely route for the entry of ARB and antibiotic resistance genes (ARGs) into the 
community and health care settings, where potential for subsequent genetic exchanges and 
emergence of resistance mechanisms is high (3, 4). Humans might also be indirectly exposed 
to ARB and ARGs by contact with or consumption of contaminated food products such as 
meat, eggs, milk and other dairy products. Farmers, abattoir workers, veterinarians and food 
handlers as well as consumers are thus at great risk of acquiring ARB and ARGs if these emerge 
at any step in the farm-to-plate continuum (1, 3). 
The family Enterobacteriaceae is a heterogeneous group of rod-shaped, Gram-negative 
bacteria, fermenting glucose, usually motile and facultative anaerobes, with the majority of 
genera being natural residents of gastrointestinal tract of animals, humans and some of these 
bacteria can be found in the environment (1, 5, 6). They are causative agents of several clinical 
diseases, ranging from intestinal infections such as typhoid fever and dysentery, to extra-
intestinal infections such as urinary tract infections, pneumonia, peritonitis, septicaemia, 
wound infections and meningitis, thereby constituting amongst the most clinically important 
group of bacteria in human and animal health (1, 7). The extensive use of beta-lactam 
antibiotics, especially third and fourth generation cephalosporins, has led to the emergence of 
extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE), that are able to 
inactivate beta-lactam antibiotics by hydrolysis and opening of the beta-lactam ring. ESBL-PE 
are resistant to the majority of beta-lactam antibiotics with a few exceptions of carbapenems, 
cephamycins and beta-lactamase inhibitors that are hydrolysed by other enzymes such as Amp-
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C enzymes, carbapenemases and inhibitor-resistant enzymes, respectively. They can also 
exhibit additional resistance to several classes of antibiotics, including aminoglycosides, 
fluoroquinolones, potentiated sulfonamides, cyclins and phenicols, which lead to multi-drug 
resistance (MDR) and limit effective therapeutic options for treatment of infectious diseases 
(8).  
Several studies have detected ESBL-PE in food animals, especially pigs, poultry and cattle, 
and food products throughout the world and their transmission from livestock to humans in the 
farm-to-plate continuum has been evidenced (5, 6, 8-10). ESBL-PE can easily contaminate 
humans, food animals and products during an assortment of procedures occurring in the farm-
to-plate continuum, including farming (directly via person-to-person contact and indirectly via 
food, water, soil, air), slaughtering processes (stunning, cutting, scalding, evisceration), 
storage, food transportation and consumption, with increased transmission risks to the global 
population, as there are no geographic boundaries to contain their worldwide dissemination (3, 
8, 9). ESBL-PE thus represent a significant public health concern globally and have recently 
been classified by the World Health Organization as pathogens of critical priority (11).  
However, the prevalence of ESBL-PE in food animals and humans across the farm to fork 
continuum is yet to be elucidated in Sub-Saharan countries including Cameroon and South 
Africa. It is therefore imperative to understand the epidemiology and determine the burden of 
ESBL-PE in food animals in order to highlight the threat posed by these resistant bacteria and 
provide evidence for decision-makers to implement effective prevention and containment 
measures of ABR in Cameroon and South Africa. The objectives of this study were therefore 
to determine the carriage, antimicrobial resistance profiles and genetic relatedness of ESBL-
PE among pigs and exposed workers, and delineate risk factors of ESBL-PE carriage in humans 
in Cameroon and South Africa.  
4.2.Materials and methods 
4.2.1. Study design and study sites  
A cross-sectional, multicentre study was conducted between March and October, 2016 in three 
slaughterhouses/markets in Cameroon and two abattoirs in South Africa, that were encoded for 
ethical reasons as SH001, SH002, SH003 and SH004 and SH005, respectively. All 
slaughterhouses were visited at different time points to allow better representativeness of the 
pig population.  
In Cameroon, samples were randomly taken at the two biggest pig abattoirs (SH001 and 
SH002) of Yaoundé, where more than 80% of pigs are slaughtered and with annual productivity 
scale ranging from 25 000 to 45 000 pigs (12). Samples from an auxiliary abattoir (SH003) 
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were additionally collected to ensure a geographically representative distribution since animals 
originating from surrounding farms of Yaoundé are typically underrepresented in these 
slaughterhouses. These slaughterhouse/markets were located in three geographically distinct 
districts of Yaoundé. In South Africa, samples were taken at two of the biggest and most 
productive abattoirs of the province of KwaZulu-Natal (SH004 and SH005), with annual 
productivity ranging from 120 000 to 150 000 pigs.  
4.2.2. Ethical considerations 
Ethical approvals from the Biomedical Research Ethics Committee (Ref. BE365/15) and 
Animal Research Ethics Committee (Ref. AREC/091/015D) of the University of KwaZulu-
Natal as well as from the National Ethics Committee for Research in Human Health of 
Cameroon (Ref. 2016/01/684/CE/CNERSH/SP) were obtained prior the implementation of 
the study. Ministerial approvals from the Cameroonian Ministry of Livestock, Fisheries and 
Animal Industries (Ref. 061/L/MINEPIA/SG/DREPIA/CE) and Ministry of Scientific 
Research and Innovation (Ref. 015/MINRESI/B00/C00/C10/C14) were also obtained. 
4.2.3. Sampling procedure and questionnaire 
a. Procedures for animal data   
A randomized sampling method of apparently healthy and freshly slaughtered/stunned pigs 
was undertaken in both countries. Nasal (inner cavity of both anterior nares) and rectal swabs 
of pigs were collected using Amies swabs without charcoal (Copan Italia Spa, Brescia, Italia). 
Overall, 864 swabs (432 nasal and 432 rectal) were collected from 432 pigs in Cameroon 
(n=216) and South Africa (n=216), with the number of specimens from each slaughterhouse 
(SH001, n=129; SH002, n=57; SH003, n=30; SH004, n=120; SH005, n=96) being 
proportionally calculated to be representative of the number of pigs slaughtered annually per 
site.  
b. Procedures for human subjects 
All abattoir workers older than 21 years old and willing to participate were included in the 
study after oral and written informed consent. Upon this step, participants were asked to 
complete a questionnaire addressing socio-demographic and clinical information, as well as 
other potential risk factors associated with ESBL-PE colonization and dissemination. Both 
anterior nares and hands (between fingers for each right and left hand) were collected with 
Amies media and all samples were processed within 4 h after collection. 
4.2.4. Laboratory analysis 
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For microbiological analysis, three individual pig samples were pooled per slaughterhouse and 
according to the gender, specimen type and area of breeding to yield 144 nasal and 144 rectal 
pools representing 432 original nasal and rectal samples respectively collected from 432 pigs. 
A total of 288 swabs from the 144 nasal and 144 rectal pools constituted the final pig sample. 
Pooled samples of pigs and human swabs were streaked onto an in-house screening 
MacConkey agar supplemented with 2 mg/L cefotaxime (MCA+CTX) and incubated for 18-
24 h at 37°C for ESBL-PE screening. Presumptive ESBL-PE were phenotypically confirmed 
with Vitek® 2 System (BioMérieux, Marcy l’Etoile, France). 
a. ESBL detection, species identification and antimicrobial susceptibility testing 
Each colony growing on MCA+CTX and with a unique morphotype was screened for the 
production of ESBLs through the standard double disk synergy test (DDST), using cefotaxime 
and ceftazidime, alone and in association with clavulanic acid as recommended by the Clinical 
Laboratory and Standards Institute (CLSI). An increase in size of the inhibition zone of more 
than 5 mm in the presence of clavulanic acid was regarded as positive for ESBL production 
(13). Upon this two-step screening, a representative subset of isolates, underwent phenotypic 
identification via Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France).  
Using an 18-24 h fresh culture, 1 to 2 colonies were mixed with 3.70 ml of sterile saline 
solution, resulting into a 0.5 turbidity on the McFarland scale. The minimum inhibitory 
concentrations (MIC) of ampicillin, amoxicillin + clavulanic acid, cefuroxime, cefuroxime 
acetyl, cefoxitin, cefotaxime, ceftazidime, cefepime, ertapenem, imipenem, meropenem, 
gentamicin, amikacin, ciprofloxacin, tigecycline, nitrofurantoin, piperacillin/tazobactam, 
colistin and trimethoprim-sulfamethoxazole, were determined by broth microdilution method 
using Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France) and Vitek® 2 Gram Negative 
Susceptibility card (AST-N255) (BioMérieux, Marcy l’Etoile, France). The results were 
interpreted according to the CLSI guidelines (13) with the exception of colistin, amoxicillin + 
clavulanic acid, piperacillin/tazobactam and amikacin that were based on EUCAST 
breakpoints (14) with E. coli ATCC 25922 being used as the control.  
b. Genomic Extraction 
Genomic DNA was extracted from a subset of ESBL-PE strains selected on the basis of their 
antimicrobial resistance profiles. Samples were cultured in 3 ml of Tryptone soya broth with 
moderate shaking for 18 h at 37oC in normal atmosphere. After incubation 1.5 ml of broth was 
centrifuged at 12,000 g for 10 min and the pellet was prepared for genetic analysis using the 
Thermo Scientific® GeneJet Genomic DNA purification kit (Thermo Fisher Scientific, South 
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Africa) according to the manufacturer’s instructions. DNA templates were stored at -20°C until 
used.  
c. Genotypic relatedness determination of ESBL-producing Escherichia coli strains 
Genomic DNA was extracted using the Thermo Scientific® GeneJet Genomic DNA 
purification kit (Thermo Fisher Scientific, South Africa) according to the manufacturer’s 
instructions. ERIC-PCR was performed with primers ERIC 1 5’-ATG TAA GCT CCT GGG 
GAT TCA C-3’ and ERIC2 5’-AAG TAA GTG ACT GGG GTG AGC G-3’ (8). Reactions 
were carried out in a 10 µl final solution containing 0.1 µl of each primer (100 μM), 5 µl 
DreamTaq Green Polymerase Master Mix 2× (Thermo Fisher Scientific, South Africa), 2.8 µl 
nuclease free water and 2 µl DNA template and run in an Applied Biosystems 2720 
programmable thermal cycler (Thermo Fisher Scientific, South Africa) with the following 
protocol: initial denaturation at 94°C for 3 min, 30 cycles consisting of a denaturation step at 
94°C for 30 s, annealing at 50°C for 1 min, extension at 65°C for 8 min, a final extension step 
at 65°C for 16 min and final storage at 4°C. ERIC profiles were digitized for analysis using 
Bionumerics software (version 7.6, Applied Maths, TX, USA). The similarity between each 
strain was determined from the homology matrix using Dice coefficient and dendrograms 
constructed using the algorithm Unweighted Pair-Group Method (UPGMA).  
d. Data analysis 
Data was coded and entered into Excel spreadsheet (Microsoft Office 2016) and Epi Info 
(version 7.2, CDC, Atlanta, GA, USA), and analysed STATA (version 14.0, STATA 
Corporation, TX, USA). A data set was created for individual human results and, aggregated 
animal and abattoir data. Abattoirs were classified as ESBL-positive if an ESBL-PE was 
detected from at least one pooled sample (nasal or rectal). Likewise, each human was 
categorized as carrier or non-carrier, with carrier being defined as having ESBL-PE in at least 
one site (nose or hand). 
4.3.Results 
4.3.1. Demographic characteristics  
Altogether, 114 people were contacted in the five selected abattoirs and 83 (73%) workers 
agreed to participate in the study. Seventy-six filled out the questionnaire and provided both 
nasal and hand swabs, six provided questionnaire and hand swabs only, while one withdrew 
before the sampling step. The response rate was higher in Cameroon (71%) than in South Africa 
(59%), with the most common reason for non-participation being lack of time or interest and 
fear of the sampling procedure and of the results.  
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Table 4.1. describes nasal and hand ESBL-PE carriage of exposed workers in relation to 
individual, clinical and abattoir-related characteristics. Unlike in South Africa where no human 
was colonized by ESBL-PE, the prevalence of ESBL-PE carriage in Cameroonian workers was 
significantly high (67.92%; p=0.000). People with a lower educational level (p=0.048), 
monthly income (p=0.007) and not having received training (p=0.000) were more prone to be 
colonized by ESBL-PE. 
Table 4.1. Nasal and hand ESBL-E carriage of exposed workers in relation to individual, 
clinical and abattoir-related characteristics4.  
Variables 















Cameroon 53 (69) 67.92 
0.000 
53 (64) 79 
0.000 
South Africa 24 (31) 0 30 (36) 0 
Gender 
Female 9 (12) 44.44 
0.883 
12 (12) 41.67 
0.503 
Male 68 (88) 47.06 71 (88) 52.11 
Age 
[21-30] 31 (40) 41.94 
0.084 
32 (39) 46.88 
0.063 
[31-40] 26 (34) 50 28 (34) 42.86 
[41-50] 13 (17) 38.46 14 (17) 71.43 
[51-60] 5 (6) 100 6 (7) 83.33 
Above 60 2 (3) 0 3 (3) 0 
Educational level 
Never been to school 4 (5) 50 
0.048 
5 (6) 40 
0.032 
Primary school not completed 6 (8) 50 7 (8) 42.86 
Primary school 34 (44) 64.71 35 (42) 71.43 
Secondary school 27 (35) 25.93 27 (33) 37.04 
High school/university 6 (8) 33.33 8 (10) 25 
Average monthly income (US $) 
Below 55 8 (10) 62.50 
0.007 
8 (14) 62.5 
0.004 
55-110 14 (19) 78.57 14 (29) 85.71 
110-165 12 (16) 66.67 12 (17) 58.33 
165-220 10 (13) 40 10 (17) 70 
220-275 20 (27) 20 24 (10) 25 
Above 275 11 (15) 27.27 13 (12) 30.77 
Relative working at hospital or with animals 
Yes 42 (55) 64.29 
0.001 
44 (53) 68.18 
0.001 
No 35 (45) 25.71 39 (47) 30.77 
Clinical factors 
Previous hospitalization (within the year of sampling) 
Yes 21 (27) 39.29 0.032 21 (25) 71.43 0.027 
                                                 
4Six out of the 84 enrolled workers refused the nasal sampling, one withdrew prior to the sample collection, for 
a total of 77 nasal and 83 hand samples collected. Few questions were not answered by workers while other 
could not recall the exact information leading to missing information that were not considered in the analysis.  
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No 56 (73) 66.67 62 (75) 43.55 
Nasal problem 
Yes 11 (14) 36.36 
0.456 
11 (13) 45.45 
0.714 
No 66 (86) 48.48 72 (87) 51.39 
Skin problem 
Yes 14 (18) 28.57 
0.132 
14 (17) 35.71 
0.222 
No 63 (82) 50.76 69 (83) 53.62 
Recent antibiotic use (month prior the sampling) 
Yes 38 (49) 55.26 
0.140 
38 (64) 71.05 
0.001 
No 39 (51) 38.46 45 (36) 33.33 
Abattoir-related factors 
Proximity of abattoir with house 
Yes 32 (42) 40.63 
0.363 
14 (33) 17 
0.184 
No 45 (58) 51.11 28 (67) 34 
Abattoir 
SH001 21 (27) 76.19 
0.000 
21 (25) 85.71 
0.000 
SH002 19 (25) 36.84 19 (23) 63.16 
SH003 13 (17) 100 13 (16) 92.31 
SH004 4 (5) 0 10 (12) 0 
SH005 20 (26) 0 20 (24) 0 
Principal activity or working area 
Slaughterer 34 (44) 58.82 
0.012 
34 (41) 58.82 
0.000 
Transport of pig/pork 5 (7) 80 5 (6) 80 
Wholesaler 7 (9) 28.57 7 (8) 85.71 
Butcher 5 (7) 80 5 (6) 80 
Retailer of viscera* 7 (9) 71.43 7 (8) 85.71 
Retailer of grilled pork# 1 (1) 0 1 (1) 100 
Scalding of pigs 3 (4) 0 3 (4) 0 
Evisceration 8 (10) 0 14 (17) 0 
Transport of viscera/blood 1 (1) 0 1 (1) 0 
Veterinarian 5 (7) 20 5 (6) 20 
Meat inspector 1 (1) 0 1 (1) 0 
Training to practice profession 
Yes 28 (36) 3.57 
0.000 
34 (41) 2.94 
0.000 
No 49 (64) 71.43 49 (59) 83.67 
Year in profession 
[0-4] 31 (43) 35.48 
0.356 
31 (39) 38.71 
0.357 
[5-9] 6 (8) 66.67 8 (10) 50 
[10-14] 22 (30) 50 24 (30) 58.33 
Above 15 14 (19) 57.14 16 (20) 62.50 
Intensity of pig’s contact 
Always 35 (45) 51.43 
0.348 
35 (42) 57.14 
0.136 Almost always 32 (42) 37.50 38 (46) 39.47 
Sometimes 10 (13) 60 10 (12) 70 
Contact with other animals 
Yes 38 (50) 60.53 
0.046 
39 (48) 69.23 
0.004 
No 38 (50) 34.21 42 (52) 35.71 
Intensity of contact with other animals 
Always 8 (21) 87.50 
0.025 
8 (20) 100 
0.006 
Almost always 9 (24) 22.22 10 (26) 30 
Sometimes 17 (45) 58.82 17 (44) 70.59 
Rarely 4 (10) 100 4 (10) 100 
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 *retailer of viscera: street-vendor purchasing pig’s viscera from the abattoir, undertaking manual 
cleaning and sells ready-to-eat meal; #retailer of grilled pork: street-vendor purchasing pork at the 
abattoir and sells ready-to-eat grilled pork.  
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4.3.2. Risk factors of ESBL-PE carriage in humans 
Table 4.2 (univariate and multivariate logistic regression) shows the association between 
ESBL-PE carriage in humans and the main potential risk factors. Previous hospitalization, 
recent antibiotic use, inadequate handwashing, occupation of relatives and year in the 
employment, were identified through univariate logistic regression as the main risk factors for 
nasal and hand ESBL-PE carriage. In contrast, the level of education, average monthly income, 
training, convenient handwashing and wearing of protective working clothes significantly 

























Table 4.2. Predictors of nasal and hand ESBL-PE carriage among exposed workers. Univariate and multivariate analysis (logistic 
regression)  
a: Family members working at hospital, with food animals or crop production, b: Exposure within 12 months prior the date of sampling; c: Within one month prior the date of sampling 
 
Variables 
Univariate Analysis Multivariate Analysis 
Nasal carriage of ESBL-PE Hand carriage of ESBL-PE Nasal carriage of ESBL-PE Hand carriage of ESBL-PE 
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Abattoir 0.43 (0.22-0.85) 0.014 0.28 (0.15-0.55) 0.000 2.54 (0.47-17.75) 0.254 1.75 (0.19-15.54) 0.615 
Hand ESBL-PE carriage (Yes or No) 39.11 (2.02-755.73) 0.015 …  …  …  
Nasal ESBL-PE carriage (Yes or No) …  39.11 (2.02-755.72) 0.015 …  …  
Gender 1.11 (0.10-12.39) 0.932 1.52 (0.20-11.38) 0.682 8.74 (1.03-74.16) 0.047 27.94 (1.68-463.05) 0.020 
Educational level 0.61 (0.39-0.94) 0.024 0.72 (0.56-0.91) 0.006 …  …  
Monthly Income 0.57 (0.36-0.89) 0.014 0.60 (0.36-0.99) 0.045 0.58 (0.35-0.97) 0.039 0.76 (0.44-1.31) 0.324 
Training 0.01 (0.0003-0.79) 0.038 0.006 (0.0005-0.0658) 0.000 0.004 (0.00009-0.22) 0.006 0.0008 (0.000008-0.09) 0.003 
Principal Activities 0.63 (0.50-0.78) 0.000 0.63 (0.46-0.87) 0.004 …  …  
Occupation of relative a 5.2 (1.46-18.56) 0.011 4.82 (0.64-36.56) 0.128 5.62 (1.02-30.82) 0.047 3.58 (0.57-22.43) 0.172 
Year in Profession 1.40 (0.66-2.97) 0.387 1.35 (0.68-2.69) 0.398 …  …  
Age 1.09 (0.80-1.48) 0.595 1.07 (0.61-1.89) 0.817 …  …  
Recent hospitalization b 3.09 (1.26-7.59) 0.014 3.24 (1.18-8.86) 0.022 1.28 (0.24-6.87) 0.769 0.57 (0.08-4.12) 0.576 
Recent antibiotic use c 1.97 (0.40-9.73) 0.402 4.91 (1.20-20.03) 0.027 …  …  
Skin problem 0.39 (0.17-0.89) 0.025 0.48 (0.21-1.08) 0.076 …  …  
Nasal problem 0.61 (0.29-1.28) 0.192 0.79 (0.34-1.82) 0.578 …  …  
Proximity of abattoir with house 0.65 (0.20-2.15) 0.485 0.53 (0.25-1.12) 0.097 …  …  
Protective working clothes 0.04 (0.002-0.812) 0.036 0.022 (0.002-0.258) 0.002 …  …  
Inadequate Handwashing 4.71 (2.28-9.70) 0.000 3.9 (1.01-15.01) 0.048 …  …  
Convenient handwashing 0.08 (0.017-0.41) 0.002 0.04 (0.013-0.145) 0.000 …  …  
Intensity of contact with pigs 0.97 (0.50-1.87) 0.920 0.96 (0.40-2.31) 0.934 …  …  
Contact with other animals 2.95 (0.87-10.04) 0.084 4.05 (1.42-11.53) 0.009 …  …  
Intensity of contact with other animals 1.09 (0.42-2.83) 0.854 1.03 (0.52-2.06) 0.927 …  …  
Contact with poultry 5.83 (1.58-21.48) 0.008 8.41 (2.27-31.11) 0.001 9.93 (1.37-71.63) 0.023 24.22 (1.28-457.35) 0.034 
Pig contamination Nasal ESBL (yes or No) 1.04 (0.93-1.16) 0.509 1.06 (0.95-1.17) 0.313 1.36 (0.84-2.21) 0.216 1.22 (0.58-2.56) 0.597 
Pig contamination Rectal ESBL (yes or No) 1.03 (0.93-1.15) 0.585 1.05 (0.96-1.16) 0.273 0.82 (0.53-1.25) 0.353 0.91 (0.46-1.79) 0.778 
Sow 1.04 (0.87-1.24) 0.697 1.05 (0.88-1.25) 0.565 …  …  
Boar 0.84 (0.66-1.07) 0.151 0.80 (0.66-0.96) 0.019 …  …  
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Nasal ESBL-PE colonization was highly statistically associated with hands contamination of 
ESBL-PE (21.95% vs 91.67%; p=0.000) with an odds ratio (OR) of 39.11 (95% CI 2.02-
755.72; p=0.015). The univariate analysis further reveals that nasal and hand ESBL-PE carriage 
were however not associated with rectal (OR=1.03, 95% CI 0.93-1.15; p=0.585; vs. OR=1.05, 
95% CI 0.96-1.16; p=0.273) and nasal ESBL-PE contamination (OR=1.04, 95% CI 0.93-1.16; 
p=0.509 vs. OR=1.05, 95% CI 0.95-1.17; p=0.313) in pigs, although without statistical 
significance. In contrast, nasal and hand ESBL-PE carriage in humans were associated with 
contact with other animals, especially poultry with high statistical significance for both sample 
types (OR=5.83, 95% CI 1.58-21.48, p=0.008; vs OR=8.41, 95% CI 2.27-31.11, p=0.001; 
Table 4.2). 
4.3.3. ESBL-PE status in humans  
Out of the 53 workers sampled in Cameroon 42 (79%) and 36 (68%) were colonized by hand 
and nasal ESBL-PE, respectively. Multiple colonies (up to eight) were isolated from majority 
of workers, with a total of 109 and 83 presumptive ESBL-PE being detected from hand and 
nasal swabs, respectively. Due to the large number of isolates a selection based on statistical 
analysis allowed the selection of a subset of 82 non-duplicate (hand=48, nasal=34) ESBL-PE 
isolates representative of the main population for phenotypic analysis. All of these 82 (100%) 
presumptive human ESBL-PE isolates selected were confirmed via Vitek® 2 System 
(BioMérieuX, Marcy l’Etoile, France) as Enterobacteriaceae and antimicrobial susceptibility 
testing (with double disc synergy and VITEK 2 system) revealed that 78/82 (95%) were ESBL-
PE. The main species identified were E. coli, K. pneumoniae and Enterobacter spp. (S1 Table). 
In contrast, in South Africa, Enterobacteriaceae was not isolated from slaughterhouse workers 
(S1 Table).  
4.3.4. Epidemiological background of ESBL-PE in pigs 
From the five abattoirs, 144 pooled nasal samples (three nasal swabs each, proportionally to 
abattoir productivity, 72 per country) and 144 pooled rectal samples (three rectal swabs each, 
proportionally to abattoir productivity, 72 per country) taken from 432 pigs were analysed. 
Overall, ESBL-PE were isolated from 75% (108/144, p=0.000) and 71% (102/144, p=0.000) 
of the pooled nasal and rectal samples respectively (Table 3), with multiple colonies (up to ten) 
isolated from the majority of ESBL-positive pooled samples in both countries. Nasal ESBL-
PE colonization in pigs was highly statistically associated with rectal ESBL-PE positivity 
(OR=15.95; 95%CI 6.06-36.85; p=0.000). When comparing the results at country-level, a 
maximum level of ESBL-PE (100%) was detected in both type of pooled samples in Cameroon, 
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whereas 42% (30/72; p=0.011) and 50 % (36/72; p=0.284) ESBL-PE were respectively isolated 
in rectal and nasal pooled samples in South Africa (Table 3).  
Table 4.3. Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) in 
pooled nasal and rectal samples  
Characteristics 




















Cameroon 72 (50) 72 (100) 
0.000 
72 (50) 72 (100) 
0.000 
South Africa 72 (50) 36 (50) 72 (50) 30 (41.67) 
Abattoir 
SH001 43 (30) 43 (100) 
0.000 
43 (30) 43 (100) 
0.000 
SH002 19 (13) 19 (100) 19 (13) 19 (100) 
SH003 10 (7) 10 (100) 10 (7) 10 (100) 
SH004 40 (28) 19 (47.50) 40 (28) 9 (22.50) 
SH005 32 (22) 17 (53.13) 32 (22) 21 (65.63) 
Gender 
Sow 79 (55) 64 (81.01) 
0.066 
79 (55) 59 (74.68) 
0.262 
Boar 65 (45) 44 (67.69) 65 (45) 43 (66.15) 
Time point 
First 42 (29) 31 (73.81) 
0.149 
42 (29) 34 (80.95) 
0.050 Second 54 (38) 45 (83.33) 54 (38) 40 (74.07) 
Third 48 (33) 32 (66.67) 48 (33) 28 (58.33) 
 
4.3.5. Prevalence of ESBL-PE based on the time point 
Figs 1A and 1B illustrate the rectal and nasal ESBL-PE colonization in pigs per abattoir and at 
each time point, respectively. Overall, in South Africa, the prevalence of rectal ESBL-PE 
decreased from 65 to 23% from the first to the third time point with high statistical significance 
(p=0.011). At abattoir level, maximum prevalence of 100 and 90% rectal ESBL-PE were 
recorded in SH005 during the first and second time point (p=0.000), respectively; whereas less 
than 40% prevalence was detected in SH004 at all time points (p=0.051) (Fig 1). ESBL-PE 
positivity associated with nasal colonization was more diverse along time points in the country, 
with the highest prevalence being 61% at the second point of collection. In contrast with South 
Africa, 100% ESBL-PE carriage was detected at all time-points and for both type of pooled 
samples in Cameroon. 
Fig 1. Overall prevalence of ESBL-PE positivity in pigs per abattoir and time point. A. 
Prevalence of nasal ESBL-PE positivity; B. Prevalence of rectal ESBL-PE positivity 
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4.3.6. ESBL-PE status in pooled samples 
In total, 262 and 258 ESBL-PE were detected from nasal and rectal pooled samples respectively 
in Cameroon. Due to the large number of isolates, post-stratification allowed the selection of a 
subset of 162 non-duplicate (nasal=79 and rectal=83) ESBL-PE strains representative of the 
main population and slaughterhouse for phenotypic analyses. Out of these, 138 (85%) were 
identified as Enterobacteriaceae with 137 (99%) being phenotypically confirmed as ESBL-
PE. The main species identified were E. coli (61%), Klebsiella pneumoniae (25%), 
Enterobacter spp. (6%), Shigella sonnei (3%) and Citrobacter freundii (3%) (S2 Table). In 
South Africa, a total of 159 presumptive ESBL-PE (81 nasal and 78 rectal) strains underwent 
phenotypic characterization, with E. coli (24%) being the only Enterobacteriaceae species 
isolated in both types of pooled samples in South Africa. Bordetella bronchoseptica (23%), 
Acinetobacter baummanii (3%), Aeromonas salmonicida (3%), Pseudomonas aeruginosa (3%) 
and Myroides spp. (1%), were the other bacterial species identified (S2 Table). 
4.3.7. Antimicrobial resistance patterns in humans 
Overall, ESBL-PE were not detected in humans in South Africa, but strains isolated from those 
in Cameroonian abattoirs, expressed high resistance to ampicillin (77%), trimethoprim-
sulfamethoxazole (50%), cefuroxime (43%), cefuroxime-acetyl (43%), cefotaxime (32%), 
ceftazidime (18%) and amoxicillin-clavulanic acid (18%) (Table 4.4). One strain isolated from 
hand was resistant to colistin (4 µg/ml) although not being multi-drug resistant. No resistance 
















Table 4.4. Resistance to antibiotics of extended-spectrum beta-lactamase-producing 
Enterobacteriaceae (ESBL-PE) isolated from pigs and humans 
 
Table 4.5. presents the resistance patterns detected in ESBL-PE in humans. 
AMP.TMP/SXT.CXM.CXM-A.CTX (34%) and AMP.AMC.TZP.CXM.CXM-
A.CTX.CAZ.TMP/SXT (7%) were the main resistance patterns in hand and nasal ESBL-E. 
coli respectively, in humans in Cameroon. Seven percent of hand ESBL-K. pneumoniae 
expressed the AMP.AMC.CXM.CXM-A.CTX.TMP/SXT.GM.FT, AMP.AMC.CXM.CXM-
A.CTX.CAZ.AN.GM.CIP and AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ profiles, that were 
resistant to four, three and two classes of antibiotics respectively (Table 4.5). The same analysis 
could not be performed with South African samples as there were no ESBL-PE detected in 






Cameroon South Africa 


















Ampicillin ≥32 126 (95) ≤2 ̶ ≥32 32(73) ≥32 38 (100) 
Amoxicillin-clavulanate 4 ̶ ≥32 54(40) ≤2 ̶ ≥32 8(18) 8 ̶ 16 2(5) 
Piperacillin-tazobactam ≤ 4 ̶ ≥128 24(18) ≤4 ̶ 64 2(5) ≤4 0 
Cefuroxime 4 ̶ ≥64 124(93) ≤1 ̶ ≥64 19(43) ≥64 38(100) 
Cefuroxime-acetyl 4 ̶ ≥64 125(93) ≤1 ̶ ≥64 19(43) ≥64 38(100) 
Cefoxitin ≤4 ̶ ≥64 10(7) ≤4 ̶ ≥64 3(7) ≤4 0 
Cefotaxime ≤1 ̶ ≥64 118(88) ≤1 ̶ ≥64 14(32) 4 ̶ ≥64 38(100) 
Ceftazidime ≤1 ̶ ≥64 93(69) ≤1 ̶ ≥64 8(18) ≤1 ̶ 4 1(3) 
Cefepime ≤0.5 ̶ ≥64 6(4) ≤1 ̶ ≥64 2(5) ≤1 ̶ 4 1(3) 
Meropenem ≤0.25 0 ≤0.25 0 ≤0.25 0 
Imipenem ≤0.25 0 ≤0.25 0 ≤0.25 0 
Ertapenem ≤0.5 0 ≤0.5 0 ≤0.5 0 
Amikacin ≤2 ̶ 16 11(8) ≤2 ̶ 16 1(2) ≤2 ̶ 16 1(3) 
Gentamicin ≤1 ̶ ≥16 43(32) ≤1 ̶ ≥16 3(7) ≤1 ̶ ≥16 7(18) 
Ciprofloxacin ≤0.25 ̶ ≥4 33(25) ≤0.25 ̶ ≥4 2(5) ≤0.25 0 
Tigecycline ≤0.5 ̶ 2 0 ≤0.5 ̶ 1 0 ≤0.5 ̶ 1 0 
Nitrofurantoin ≤16 ̶ 64 0 ≤16 ̶ 128 1(2) ≤16 ̶ 64 0 
Colistin ≤0.5 0 ≤0.5 ̶ 4 1(2) ≤0.5 ̶ 8 1(3) 
Trimethoprim-sulfamethoxazole ≤20 ̶ ≥320 119 (89) ≤20 ̶ ≥320 22(50) ≤20 ̶ ≥320 36(95) 
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Table 4.5. Antimicrobial resistance profiles of extended-spectrum beta-lactamase-
producing Enterobacteriaceae (ESBL-PE) strains isolated from humans 







AMP.AMC.TZP.CXM.CXM-A.CTX.CAZ.TMP/SXT 1 (50) 0 
AMP.CXM.CXM-A.CAZ.CS 0 1(8) 
AMP.TMP/SXT.CXM.CXM-A.CTX 0 4(31) 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.GM.CIP.FEP 0 1(8) 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.TZP 0 1(8) 
AMP.TMP/SXT.CXM.CXM-A.CTX 0 1(8) 
AMP.CXM.CXM-A.CTX.FEP.TMP/SXT 0 1(8) 
E. dissolvens AMP.AMC.CXM.CXM-A.FOX.CTX.TMP/SXT 1 (50) 0 
S. sonnei AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 0 1(8) 
K. pneumoniae 
AMP.AMC.CXM.CXM-A.CTX.TMP/SXT.GM.FT 0 1(8) 
AMP.AMC.CXM.CXM-A.CTX.CAZ.AN.GM.CIP 0 1(8) 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 0 1(8) 
Grand Total 2 (100) 13 (100) 
AMP: Ampicillin; AMC: Amoxicillin-clavulanate; TZP: Piperacillin-tazobactam; CXM: Cefuroxime; 
CXM-A: Cefuroxime-Acetyl; CTX: Cefotaxime; CAZ: Ceftazidime; TMP/SXT: Trimethoprim-
Sulfamethoxazole; FOX: Cefoxitin; GN: Gentamicin; CIP: Ciprofloxacin; FEP: Cefepime; CS: 
Colistin 
4.3.8. Antimicrobial resistance patterns in pigs 
Table 4.6. presents the antimicrobial resistance profiles in ESBL-PE isolated from animals in 
both Cameroon and South Africa. ESBL-PE isolated from pigs in Cameroon, exhibited high 
resistance to ampicillin (95%), cefuroxime (93%), cefuroxime-acetyl (93%), cefotaxime 
(88%), ceftazidime (69%) and trimethoprim-sulfamethoxazole (89%) (Table 4.4). No ESBL-
PE showed resistance to ertapenem, meropenem, imipenem and only few isolates expressed 
resistance to cefoxitin, cefepime, gentamicin, amikacin and ciprofloxacin (Table 4.4). 
Similarly, 100% resistance to ampicillin, cefuroxime, cefuroxime-acetyl, and cefotaxime, and 
95% resistance to trimethoprim-sulfamethoxazole were observed in ESBL-PE isolated from 
117 
 
pigs in South Africa. One strain expressed high resistance to colistin (8 µg/ml) and to nine 
other antibiotics, whereas none was resistant to imipenem, ertapenem, meropenem and 






Table 4.6. Antimicrobial resistance profiles of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) isolated from 
pigs 















AMP.TMP/SXT.CXM.CXM-A.CTX 5 2 3(5) 2(4) 0 29(94) 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 6 2 7(12) 1(20) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.FEP 7 2 2(3) 2(4) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.GM.CIP 8 4 1(2) 2(4) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.CIP 7 3 1(2) 0 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC 8 3 1(2) 3(5) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.GM.CIP 9 4 2(3) 3(5) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.TZP 8 2 5(8) 5(9) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.TZP.FOX.FEP.GM.CIP 12 4 1(2) 0 0 0 
AMP.CXM.CXM-A.CTX.CAZ 5 1 0 2(4) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.FEP.GM. 8 3 0 1(2) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CIP 6 3 0 1(2) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.CIP.AMC 8 3 0 5(9) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.GM 6 3 0 1(2) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.CIP.AMC.TZP 9 3 0 1(2) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.CIP.GM.TZP.FEP 10 4 0 1(2) 0 0 
AMP.CXM.CXM-A.CTX 4 1 0 0 0 2(6) 
AMP.CXM.CXM-A.CTX.TMP/SXT.CAZ.FEP.AK.GM.CS 10 4 0 0 1(14) 0 
AMP.CXM.CXM-A.CTX.TMP/SXT.GM 6 3 0 0 1(14) 0 
AMP.CXM.CXM-A.CTX.TMP/SXT.GM.AMC 7 3 0 0 5(71) 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.CIP.GM.AMC.TZP 10 4 0 2(4) 0 0 
K. pneumoniae 
AMP.TMP/SXT.CXM.CXM-A.CTX.GM 6 3 2(3) 1(2) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AK.GM.CIP.AMC 10 4 0 6(11) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CAZ.AMC.TZP 7 2 0 1(2) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.GM.AMC.TZP 9 3 4(7) 2(4) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.TZP.AK.GM.CIP 11 4 0 3(5) 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX 5 2 1(2) 0 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 6 2 4(7) 0 0 0 
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AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.GM 7 3 8(14) 0 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.GM.AMC.TZP 9 3 4(7) 0 0 0 
K. ozanae AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AK.GM.CIP.AMC 10 4 1(2) 0 0 0 
Enterobacter cloacae AMP.AMC.CXM.CXM-A.FOX.CTX.TMP/SXT 7 2 4(7) 0 0 0 
C. freundii AMP.AMC.CXM.CXM-A.FOX.CTX.TMP/SXT 7 2 3(5) 0 0 0 
S. sonnei 
AMP.CTX.CAZ.TMP/SXT 4 2 1(2) 0 0 0 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 6 2 4(7) 0 0 0 
AMP: Ampicillin; AMC: Amoxicillin-clavulanate; AK: Amikacin; CXM: Cefuroxime; CXM-A: Cefuroxime-acetyl; CTX: Cefotaxime; CAZ: Ceftazidime; 






The majority of rectal ESBL-producing E. coli isolated from pigs in South Africa showed the 
resistance profile AMP.TMP/SXT.CXM.CXM-A.CTX (94%) while the pattern 
AMP.CXM.CXM-A.CTX.TMP/SXT.GM.AMC (71%) was more prevalent in nasal ESBL- 
producing E. coli with resistance to two and five classes of antibiotics, respectively. In 
Cameroonian pigs, AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ (20%), 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.TZP (9%) and 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.CIP.AMC (9%) were the main resistance profiles 
detected in rectal ESBL-producing E. coli, while AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 
(12%) and AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC.TZP (8%) were most prevalent in 
nasal ESBL-E. coli (Table 4.6). ESBL-producing K. pneumoniae were not detected in South 
Africa but in Cameroon, the main resistance profiles were AMP.TMP/SXT.CXM.CXM-
A.CTX.CAZ.AK.GM.CIP.AMC (11%) and AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.GM 
(14%) in rectal and nasal pooled samples, respectively (Table 4.6). 
4.3.9. Genotypic relatedness 
In total, 93 ESBL-producing E. coli strains showing the most representative resistance profiles 
and originating from both pigs and humans of Cameroon and South Africa were subjected to 
genotyping by ERIC-PCR to determine their clonal relationships. ERIC-PCR allowed the 
differentiation of the 93 E. coli into 14 clusters named alphabetically from A-N (Table 4.7 and 
Fig 2). A batch of isolates in cluster M (PR210, PR212E*, PR209E2, PR246B1C and PN254E), 
collected from pigs of abattoir SH004 and SH005 in South Africa was considered to be closely 
related. Moreover, great interest was observed in cluster I, where one pair of animal strains, 
PR085E3 and PR209E1 isolated in abattoirs SH002 and SH004 in Cameroon and South Africa, 
respectively, showed 100% similarity, and were closely related with a human strain 
(HN503E2II) detected in abattoir SH001 in Cameroon (Fig 2). 
 
Fig 2. Genotypic relationship of ESBL-E. coli strains (n=93) isolated from pigs and 
humans in Cameroon and South Africa. Dendrogram established by the biostatistical 
analysis software Bionumerics using the Dice similarity coefficient and UPGMA method on 






Table 4.7. Prevalence and distribution of extended-spectrum beta-lactamase producing-E. coli clusters per abattoir 






SH001 SH002 SH003 SH004 SH005 
A AMP.TMP/SXT.CXM.CXM-A.CTX 5 5 (5) 0 0 0 0 5 
B 
AMP.TMP/SXT.CXM.CXM-A.CTX 1 












4 (4) 1 1 0 0 2 AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 1 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.FEP 1 
F AMP.TMP/SXT.CXM.CXM-A.CTX 4 4 (4) 0 0 0 0 4 
G 
AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ 2 

























































3 (3) 3 0 0 0 0 AMP.TMP/SXT.CXM.CXM-A.CTX.CAZ.AMC 1 
AMP.CXM.CXM-A.CTX.CAZ.FEP.GEN.TMP/SXT 1 
Grand Total 93 93 (100) 48 8 6 5 26 
123 
 
AMP: Ampicillin; AMC: Amoxicillin-clavulanate; AK: Amikacin; CXM: Cefuroxime; CXM-A: Cefuroxime-acetyl; CTX: Cefotaxime; CAZ: Ceftazidime; 






Enterobacteriaceae and especially ESBL-PE, were recently recognized as critical priority 
ARB by the WHO (3) and their emergence at the animal-human-environment interface leads 
to serious and multifaceted public health concern globally. In this study, the carriage, risk 
factors, antimicrobial resistance patterns and genetic relatedness of ESBL-PE isolated from 
healthy pigs and exposed workers in Cameroon and South Africa were determined. 
The overall prevalence of ESBL-PE carriage in humans was 50% in hand and 45.75% nasal 
samples. Similar findings were reported by Magoue et al. (2013) in Cameroon, where the 
prevalence of ESBL-PE faecal carriage was 45% in outpatients in the region of Adamaoua (9). 
They are however higher than that reported by Dohmen et al. (2015) where a 27% prevalence 
of ESBL-PE carriage in faecal samples of people with daily exposure to pigs in Netherlands 
was described (10).  
Our results are in contrast to a study of Fisher et al. (2016), where none of the 66.7% 
Enterobacteriaceae detected in the nares of participants were ESBL producers and where the 
authors concluded that nares were a negligible reservoir for colonization of ESBL-PE in pig’s 
exposed workers (11). Our finding shows that the prevalence of ESBL-PE carriage in nasal 
samples substantially increased (8.33 vs 91.67%; p<0.001) and was significantly associated 
with their carriage on hand (OR 39.11; 95% CI 2.02-755.72; p=0.015). In addition, nasal 
ESBL-PE carriage was associated with inappropriate handwashing with high statistical 
significance (OR 4.71; 95% CI 2.28-9.70; p<0.001). This suggests, that nares might likely 
become reservoir of ESBL-PE when limited hygienic conditions prevail and biosecurity 
measures are not adequately implemented. It further reveals that, as with the transmission of 
nosocomial infections in hospital settings, hands constitute important vectors of ABR 
transmission in the food production industry and may not only drive the transfer from person-
to-person but also the contamination of food products intended for the end consumer. Nasal 
ESBL-PE carriage reported in our study could also be attributed to airborne contamination as 
recently reported by Dohmen et al. (2017) who revealed that human CTX-M-gr1 carriage was 
statistically associated with presence of CTX-M-gr1 in dust (OR=3.5, 95% CI=0.6–20.9) and 
that inhalation of air might constitute another transmission route of ESBL-PE in the food chain 
(12).  
The difference in the prevalence of ESBL-PE carriage in humans in both countries could be 
explained by the fact that South Africa not only has existing abattoir regulations in place, but 
also that implementation of Hazard Analysis Critical Control Points (HACCP) plans and 
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compliance with international food safety standard ISO 22000 were stringent in both abattoirs. 
In Cameroon, slaughterhouse/markets were principally low-grade, lacking in basic amenities, 
with sub-optimal hygienic conditions and minimal or non-existent biosecurity measures. The 
Food and Agriculture Organization for the United Nations (FAO) report on abattoir facilities 
in Central African countries including Cameroon, already underlined the gaps in term of 
biosecurity measures in these settings (13). Our findings, therefore, reinforce the importance 
of and the need to implement strict biosecurity procedures as when effective prevention and 
containment measures are implemented, the risk of ABR dissemination is reduced. 
The overall prevalence of ESBL-PE in pigs was 71% and 75% in rectal and nasal pooled 
samples, respectively. The results are consistent with that reported by Le et al. (2015) in food 
animals and products in Vietnam where a 68.4% prevalence of ESBL-producing E. coli was 
described (14). They are however lower than that reported in pig farms in Germany, where 
88.2% of ESBL-producing E. coli was detected (15), and higher than that reported in two other 
studies with prevalence ranging from 8.6 to 63.4% in food animals and products in Netherlands 
(16), and 8.4% in cattle in Switzerland (2).  
The high rate of ESBL-PE carriage detected in both type of pooled samples in Cameroon may 
indicate that ESBL-PE are consistently widespread in food animals in Cameroon, disseminate 
in the farm-to-plate continuum and represent a serious food safety threat in the country. 
Similarly, the ESBL-PE prevalence detected in pigs in South Africa is not surprising, knowing 
that the use of antibiotics as growth promoters is legally approved in the country (17). These 
findings reveal gaps in the current state of knowledge about antibiotic use and ABR in food 
animals, and suggests that the debate about ABR-related consequences in the farm-to-plate 
continuum is neglected in Cameroon and South Africa and should be more seriously considered 
in these countries. Additionally, our study revealed a high frequency (95%) of ESBL-producing 
E. coli, emphasizing the relevance of this indicator bacteria as a serious public health issue.  
ERIC analysis, demonstrated relative association between animal and human strains within and 
across countries. Some strains detected in humans were highly related with those isolated from 
pigs at the same or different slaughterhouse. These results suggest that occurrence of ESBL-
PE in humans may be of animal origin or vice-versa, and that these pathogens may be 
transferred to human via the food chain, allowing their dissemination to the global population. 
Although not providing evidence on the transmission dynamics of the spread of ESBL-PE, our 




Hospitalization, antibiotic use and contact with (food) animals are known risk factors for 
human ESBL-PE carriage (18). Twenty-one workers or their close relatives had been 
hospitalized within a year of the sample collection, leading to a 39.29% and 71.43% prevalence 
of nasal and hand ESBL-PE, respectively (Table 1). Likewise, 55.26% and 71.05% of workers 
who had used antibiotics the month preceding the sampling were colonized by ESBL-PE in 
nasal and hand samples, respectively (Table 1). In this cross-sectional study, duration of ESBL-
PE carriage was not investigated, and no association between human ESBL-PE carriage and 
contact with ESBL-PE carrying pigs was observed for all type of samples, although not 
statistically significant (Table 6). In contrast, a clear association between human ESBL-PE 
carriage and contact with other animals, especially poultry, was observed and with high 
statistical significance (Table 6). This suggest that more research is required on ESBL-PE 
carriage in high risk population and other food animals such as poultry in order to improve our 
knowledge about on the public health significance associated with the likely transmission of 
ESBL-PE through the farm-to-plate continuum. 
4.5. Conclusion  
To the best of our knowledge, this is the first report of ESBL-PE in animals and humans in 
both Cameroon and South Africa taking food safety perspective. The high prevalence of ESBL-
PE found in pigs in both countries as well as in humans in Cameroon highlights the food safety 
issue associated with their presence in the farm-to-plate continuum. It demonstrates the urgent 
need to implement multi-sectorial, multi-faceted and sustainable collaboration and activities 
among all stakeholders involved in this continuum in order to reduce the prevalence and 
contain the dissemination of ESBL-PE and ABR in these countries. 
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Figure 4.1. Overall prevalence of nasal (A) and rectal (B) ESBL-PE carriage in pigs per 



























Figure 4.2. Genotypic relationship of ESBL-E. coli strains (n=93) isolated from pigs and humans in Cameroon and South Africa. Dendrogram established by* 
the biostatistical analysis software Bionumerics using the Dice similarity coefficient and UPGMA method on the basis of the ERIC-PCR profiles obtained with 







S1 Table. Overall prevalence of extended spectrum beta-lactamase (ESBL) producing 










*Acinetobacter baumannii, Pseudomonas aeruginosa, Sphingomonas spp., Pseudomonas fluorescens 
 
 
S2 Table. Overall prevalence of extended spectrum beta-lactamase (ESBL) producing 
bacteria isolated from animals per country and specimen type 
 










Cameroon South Africa 
Hand (%) Nasal (%) Hand (%) Nasal (%) 
E. coli 16 (41) 15 (47) 0 0 
E. dissolvens 2 (5) 1 (3) 0 0 
K. pneumoniae 2 (5) 6 (19) 0 0 
Shigella sonnei 1 (3) 1 (3) 0 0 
Others* 18 (46) 9 (28) 10 (50) 10 (50) 
Total 39 (100) 32 (100) 10 (100) 10 (100) 
Bacteria 
Cameroon South Africa 
Nasal (%) Rectal (%) Nasal (%) Rectal (%) 
Bordetella bronchoseptica 0 0 33 (60) 2 (5) 
C. freundii 3 (3) 0 0 0 
E. coli 29 (32) 42 (63) 10 (18) 17 (42.5) 
Enterobacter cloacae 
dissolvens 
8 (9) 0 0 0 
K. ozanae 1 (1) 0 0 0 
K. pneumoniae 19 (21) 15 (22) 0 0 
S. sonnei 1 (1) 4 (6) 0 0 
Others* 29 (32) 6 (9) 12 (22) 21 (52.5) 




















Article IV. Mannitol-Fermenting Methicillin-Resistant Staphylococci 
(MRS) in Pig Abattoirs in Cameroon and South Africa: A Serious 
















Mannitol-Fermenting Methicillin-Resistant Staphylococci (MRS) in 
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Food animals can be reservoirs of methicillin-resistant staphylococci (MRS) and are involved 
in their zoonotic transmission through the food chain. In Africa, there is a dearth of information 
about the food safety issues associated with their dissemination in the farm-to-plate continuum. 
This study sought to determine and compare the carriage, antimicrobial resistance profiles and 
clonal relatedness of circulating MRS strains among pigs and exposed workers in Cameroon 
and South Africa.  
A total of 288 nasal and rectal pooled samples collected from 432 pigs as well as nasal and 
hand swabs from 82 humans were cultured on mannitol salt agar supplemented with 6 mg/L 
cefoxitin. Presumptive MRS were screened for methicillin resistance using the cefoxitin disc 
test and confirmed with the VITEK 2 system. Selected isolates underwent genomic 
fingerprinting via REP-PCR. Univariate and multivariate logistic regression analyses were 
performed to identify risk factors for MRS carriage in humans from a questionnaire survey 
amongst slaughterhouse workers. 
Overall, 75% and 70% of nasal and rectal pooled samples were respectively positive for MRS. 
The MRS prevalence in all pooled pig samples from Cameroon was higher than that of South 
Africa. MRS prevalence of carriage (nasal and hand) was higher in Cameroonian exposed 
workers compared to those from South Africa, with high statistical significance. Nasal MRS 
colonization was highly statistically associated with hand MRS (31.58% vs 86.21%; p=0.000; 
OR=13.54; 95% CI 3.99-45.95; p=0.015). Recent antibiotic use, previous hospitalization, 
occupation of relatives, years in the employment and contact with poultry were the main risk 
factors identified in the emergence and spread of MRS. 
MRS are emerging as serious foodborne pathogens and present a food safety threat. There is 
an urgent need to implement stringent and effective prevention and containment measures to 
curb antibiotic resistance in the farm-to-plate continuum in Cameroon and South Africa. 
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The family of Staphylococcaceae encompasses 51 species and 27 sub-species of ubiquitous 
bacteria occurring in grapelike clusters of Gram-positive cocci. They are grouped into 
coagulase-positive (CoPS) and negative (CoNS) staphylococci due to their ability to produce 
the coagulase enzyme (Kluytmans, 2010; Osman et al., 2016). Staphylococcal species appear 
worldwide as commensal colonizers of skin of animals and humans. Additionally, they are 
found on mucous membrane of the upper respiratory and lower urogenital tracts, and 
transiently in the digestive tract (Kluytmans, 2010).  
S. aureus is the most important human pathogenic specie of this bacterial family and constitutes 
together with S. (pseud)intermedius to be the main pathogenic CoPS in animals. Globally, S. 
aureus asymptomatically colonizes mucous membranes of the respiratory and intestinal tracts 
as well as other body surfaces, but it is also frequently involved in a broad range of diseases 
ranging from mild skin infections to life-threatening invasive infections in humans and animals. 
S. aureus became a worldwide health problem due to the emergence of methicillin resistant S. 
aureus (MRSA) (Njoungang et al., 2015). MRSA was first reported from animals in 1972 
following its isolation in milk from mastitic cows (Kluytmans, 2010). Subsequently, it was 
isolated from various animal species including pets, horses, pigs, poultry, sheep, veal calves 
and dairy cows.  
Although S. aureus is the most important pathogen among all staphylococcal species, CoNS 
have recently gained importance with increasing concerns in human and animal health due to 
the emergence and implications of resistant strains in several human and animal infections 
(Bhargava and Zhang, 2012; Njoungang et al., 2015). More significantly, methicillin-resistant 
CoNS (MRCoNS) have been detected worldwide from food animals including pigs, poultry, 
calves and cows as well as food and food products (Huber et al., 2011). There is a dearth of 
information about MRS in food animals and food products in Africa. This study therefore 
sought to determine and compare the carriage, antimicrobial resistance profiles and clonal 
relatedness of circulating MRS strains among pigs and abattoir workers in Cameroon and South 
Africa, in order to ascertain the food safety threat associated with these bacteria in the farm-to-
plate continuum. 
5.2.Materials and methods 
5.2.1. Study design and site selection  
A cross-sectional, multicentre study was conducted between March and October, 2016 in three 
slaughterhouses/markets in Cameroon and two abattoirs in South Africa, that were encoded for 
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ethical reasons as SH001, SH002, SH003 and SH004 and SH005, respectively. All 
slaughterhouses were visited at different time points to allow better representativeness of the 
pig population.  
In Cameroon, samples were randomly taken at the two biggest pig abattoirs (SH001 and 
SH002) of Yaoundé, where more than 80% of pigs are slaughtered and with annual productivity 
scale ranging from 25 000 to 45 000 pigs. Samples from an auxiliary abattoir (SH003) were 
additionally collected to ensure a geographically representative distribution since animals 
originating from surrounding farms of Yaoundé are typically underrepresented in these 
slaughterhouses. These slaughterhouses/markets were located in three geographically distinct 
districts of Yaoundé. In South Africa, samples were taken at two of the biggest and most 
productive abattoirs of the province of KwaZulu-Natal (SH004 and SH005), with annual 
productivity ranging from 120 000 to 150 000 pigs. 
5.2.2. Ethical considerations 
Ethical approvals were received from the Animal Research Ethics Committee (Ref. 
AREC/091/015D) and Biomedical Research Ethics Committee (Ref. BE365/15) of the 
University of KwaZulu-Natal as well as from the National Ethics Committee for Research in 
Human Health of Cameroon (Ref. 2016/01/684/CE/CNERSH/SP) prior the implementation 
of the study. Ministerial approvals from the Cameroonian Ministry of Scientific Research and 
Innovation (Ref. 015/MINRESI/B00/C00/C10/C14) and Ministry of Livestock, Fisheries and 
Animal Industries (Ref. 061/L/MINEPIA/SG/DREPIA/CE) were also obtained. 
5.2.3. Sampling procedures and questionnaire 
a. Procedure for animal data   
A randomized sampling method of apparently healthy and freshly slaughtered/stunned pigs 
was undertaken in both countries. Nasal (inner cavity of both anterior nares) and rectal swabs 
of pigs were collected using Amies swabs without charcoal (Copan Italia Spa, Brescia, Italia). 
Overall, 864 swabs (432 nasal and 432 rectal) were collected from 432 pigs in Cameroon 
(n=216) and South Africa (n=216), with the number of specimens from each slaughterhouse 
(SH001, n=129; SH002, n=57; SH003, n=30; SH004, n=120; SH005, n=96) being 
proportionally calculated to be representative of the number of pigs slaughtered annually per 
site. 
b. Procedure for human subjects 
Saturation of sampling was applied for human participants, i.e., all abattoir workers including 
slaughterers, transporters, wholesalers, farmers, butchers, veterinarians, food inspectors, older 
than 21 years old and willing to participate were included in the study after oral and written 
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informed consent. Upon this step, participants were asked to complete a questionnaire 
addressing socio-demographic (age, gender, educational level, average monthly income) and 
clinical (recent hospitalization, antibiotic use, medical history related to skin or nasal infection) 
information, as well as other potential risk factors associated with MRS colonization and 
dissemination. Data on abattoir-related factors including years in the employment, intensity of 
contact with pigs or other animals, measures of hygiene implemented, and training were also 
recorded. Information regarding areas of pig breeding were also collected from workers, from 
either abattoir’ leader, supervisor, food safety inspector or veterinarian. Both anterior nares and 
hands (between fingers for each right and left hand) were swabbed with Amies media and all 
samples were processed within 4 h after collection. 
5.2.4. Laboratory analysis 
For microbiological analysis, three individual pig samples were pooled per slaughterhouse and 
according to the gender, sample type and area of breeding. This approach resulted in 144 pooled 
samples representing 432 original nasal and rectal samples respectively collected from 432 
pigs.  
Pooled samples from pigs and human swabs were streaked onto an in-house screening mannitol 
salt agar supplemented with 6 mg/L cefoxitin (MSA+FOX) and incubated for 18-24 h at 37°C 
for MRS screening. When no growth was observed, plates were incubated for another 18-24 h. 
Mannitol fermenting yellow colonies, presumptive of MRS were subsequently subjected to 
Gram staining, catalase and oxidase for phenotypic characterization of the isolates to the genus 
level. 
a. Species identification and antimicrobial susceptibility testing 
Each colony growing on MSA+FOX and with a unique morphotype was screened for 
methicillin resistance using the cefoxitin disk test as recommended by the Clinical Laboratory 
and Standards Institute (CLSI). An inhibition zone below 21 mm was regarded as positive for 
methicillin resistance (CLSI, 2014). Upon this two-step screening, a representative subset of 
isolates, underwent phenotypic identification via Vitek® 2 System (Biomérieux, Marcy 
l’Etoile, France). Using an 18 to 24 h fresh culture, 1 to 2 colonies were mixed with 3.70 ml of 
sterile saline solution, resulting into a 0.5 turbidity on the McFarland scale. Afterward, the 
minimum inhibitory concentrations (MIC) of benzylpenicillin, cefoxitin, oxacillin, 
clindamycin, erythromycin, gentamicin, ciprofloxacin, moxifloxacin, mupirocin, rifampicin, 
fusidic acid, teicoplanin, vancomycin, linezolid, tigecycline, trimethoprim-sulfamethoxazole, 
were determined by the broth micro-dilution method using Vitek® 2 System (BioMérieuX, 
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Marcy l’Etoile, France) and VITEK® 2 Gram Positive Susceptibility card (AST-P603) 
(bioMérieux, Marcy l’Etoile, France). The results were interpreted according to the CLSI 
guidelines (CLSI, 2014) and S. aureus ATCC 29213 was used as the control.  
b. Genomic extraction 
Genomic DNA was extracted from a subset of MRS strains selected on the basis of their 
antimicrobial resistance profiles. Samples were cultured in 3 ml of Tryptone soya broth with 
moderate shaking for 18 h at 37oC in normal atmosphere. After incubation 1.5 ml of broth was 
centrifuged at 12,000 g for 10 min and the pellet was prepared for genetic analysis using the 
Thermo Scientific® GeneJet Genomic DNA purification kit (Thermo Fisher Scientific, South 
Africa) according to the manufacturer’s instructions. DNA templates were stored at -20°C until 
used. 
c. Genotypic relatedness determination of methicillin resistant staphylococci 
i. Repetitive element palindromic-polymerase chain reaction (REP-PCR)  
To establish the link of selected MRS strains from animals and humans within and between 
abattoirs and countries, the REP-PCR was performed with (GTG)5 primer 5’-
GTGGTGGTGGTGGTG-3’ (Švec et al., 2010). REP-PCR reactions were carried out in a 10 
µl final solution containing 0.1 µl of (GTG)5 primer (100 μM), 5 µl DreamTaq Green 
Polymerase Master Mix 2× (Thermo Fisher Scientific, South Africa), 2.9 µl nuclease free water 
and 2 µl DNA template. Reactions were run in a 0.2 ml micro-centrifuge tube using a 
programmable thermal cycler (Bio-Rad, Johannesburg, South Africa) according to the 
following protocol: initial denaturation at 94°C for 7 min, 30 cycles consisting of a denaturation 
step at 94°C for 1 min, primer annealing at 40°C for 1 min, extension at 65°C for 8 min, a final 
extension step at 65°C for 16 min and final storage at 4°C. The amplicons were run on a 1.5% 
(wt/vol) agarose (Merck Diagnostic, Johannesburg, South Africa) gels along with the Quick 
Load® 1-kb DNA ladder (New England Biolabs, USA) in an electric field of 100 V for 1 h. 
Gels were subsequently stained in a solution containing 0.5 mg/ml ethidium bromide (10 
mg/ml) for 15 min. Amplification products were visualized by UV trans-illuminator with 
images captured using a gel documentation system (Syngene, Johannesburg) and recorded for 
further analyses. 
ii. Computer-Assisted DNA Fingerprint Analysis 
DNA profiles were digitized for analysis using Bionumerics software (version 7.6, Applied 
Maths, TX, USA). All DNA fragment sizes within each gel were normalized using the Quick 
Load® 1-kb DNA molecular weight marker as external reference standard. The similarity 
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between each strain was determined from the homology matrix using Dice coefficient. 
Dendrograms were constructed based on the averaged similarity of the matrix using the 
algorithm Unweighted Pair-Group Method (UPGMA) with optimization and band tolerance 
set a 1% (version 7.6, Applied Maths, TX, USA). The cophenetic correlation value was 
calculated for the dendrogram, in order to measure the reliability of generated clusters. Clusters 
were defined based on a similarity cut-off of 80%. 
5.2.5. Data analysis 
Data was coded and entered into Excel spreadsheet (Microsoft Office 2016) and Epi Info 
(version 7.2, CDC, Atlanta, GA, USA), double-checked and verified with the questionnaire 
and analysed using Excel (Microsoft Office 2016) and STATA (version 14.0, STATA 
Corporation, TX, USA). A data set was created for individual human results and, aggregated 
animal and abattoir data. Abattoirs were classified as MRS-positive if an MRS strain was 
detected from at least one pooled sample (nasal or rectal). Prevalence of MRS was compared 
between categories (viz. type of sample, country and abattoir) using the chi square test. A p-
value < 0.05 was considered as statistically significant. The relationship between MRS carriage 
in humans and pigs was calculated with the logistic regression analysis adjusted for clustering 
at abattoir level. Similarly, risk factors for MRS colonization including pig contamination, 
training, principal abattoir activities, previous hospitalization, antibiotic use, occupation of 
relatives and potential confounders such as age, gender, monthly income, educational level, 
and contact with other animals, were ascertained univariately and selected for multivariate 
analysis when the p-value was <0.2. Model fit was checked with the McFadden’s pseudo R2 
statistic (maximum likelihood method) and the final model built included all determinants for 
which the pseudo R2 was the most elevated with p<0.05 for each dependent variable.  
5.3.Results 
5.3.1. Participant characteristics 
Out of 114 people contacted in the five abattoirs, 84 were enrolled for an overall participation 
rate of 73%. The response rate was greater in Cameroon (71%) than in South Africa (59%), 
with the most common reason for non-participation being lack of time or interest and fear of 
the sampling procedure and of the results. Seventy-seven filled out the questionnaire and 
provided both nasal and hand swabs, six provided questionnaire and hand swabs only, while 
one withdrew before the sampling step.  
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Table 1 shows nasal and hand MRS carriage of exposed workers in relation to individual, 
clinical and abattoir-related characteristics. The prevalence of nasal MRS carriage was 
significantly higher in Cameroonian workers than South African ones (92.45% vs 29.17; 
p=0.000) as was hand MRS carriage (100% vs 23.3%). Workers with a lower educational level, 
lower monthly income and without training for their profession were more likely to be 
colonized by MRS for both types of samples. 
5.3.2. Risk factors of MRS carriage in humans 
Table 5.2 (univariate and multivariate logistic regression) shows the association between MRS 
carriage in humans and the main potential risk factors. Recent antibiotic use, recent 
hospitalization, occupation of relatives, years in the employment, intensity of contact with other 
animals and contact with poultry, were identified via univariate logistic regression as the main 
risk factors for nasal and hand MRS carriage. In contrast, training, protective working clothes 
and convenient handwashing were found to significantly reduce the odds of being colonized 
by MRS for both nares and hands (Table 2). 
Nasal MRS carriage was highly statistically associated with hand colonization of MRS 
(31.58% vs 86.21%; p=0.000) with an odds ratio (OR) of 13.54 (95% CI 3.99-45.95; p=0.015). 
The univariate analysis further reveals that nasal and hand MRS carriage were however not 
associated with rectal (OR=1.01, 95% CI 0.97-1.05; p=0.544; vs. OR=0.98, 95% CI 0.94-1.03; 
p=0.494) and nasal MRS contamination (OR=1.04, 95% CI 0.99-1.09; p=0.087 vs. OR=1.03, 
95% CI 0.99-1.08; p=0.146) in pigs, although without statistical significance. In contrast, nasal 
and hand MRS carriage in humans were associated with contact with other animals, especially 
poultry for both samples (OR=3.6, 95% CI 0.94-19.70, p=0.060; vs OR=13.68, 95% CI 1.72-
108.43, p=0.013; Table 5.2). 
5.3.3. MRS status in humans  
 
In total, out of 53 workers sampled in Cameroon, 49 (92%) and 53 (100%) were nasal and hand 
carriers of MRS, respectively. Due to financial constraint, further selection based on statistical 
analysis was carried out to select a subset of 21 non-duplicate (hand=11, nasal=10) human 
MRS isolates representative of the main population for phenotypic analysis. Out of these 
presumptive MRS isolated in Cameroon, 21 (100%) all were confirmed via VITEK 2 system 
as Staphylococcus spp. and antimicrobial susceptibility testing (with cefoxitin disc synergy and 
VITEK 2 system) revealed that 20/21 (95%) were MRS. The main species identified were S. 
haemolyticus (6), S. epidermidis (5), and S. lentus (4) (Table 5.3). In contrast, in South Africa, 
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MRS carriage was observed in 29% (7/24) and 23% (7/30) of nasal and hand swabs, 
respectively. All 14 (100%) isolates were phenotypically confirmed as Staphylococcus spp. 
with 100% being MRS and S. haemolyticus (n=9) being the main specie.   
5.3.4. Epidemiological background of MRS in pigs 
From the five abattoirs, 144 pooled nasal samples (three nasal swabs each, proportional to 
abattoir productivity, 72 per country) and 144 pooled rectal samples (three rectal swabs each, 
proportional to abattoir productivity, 72 per country) taken from 432 pigs were analysed. 
Altogether, MRS were isolated from 108/144 (75%) and 130/144 (90%) of the pooled nasal 
and rectal samples, respectively (Table 5.4). When comparing the results at country-level, a 
maximum level of MRS (100%) was detected in both type of pooled samples in Cameroon, 
whereas 50% (36/72) and 81% (58/72) MRS were isolated in nasal and rectal pooled samples, 
respectively, in South Africa with high statistical significance (p=0.000) (Table 5.4).  
Upon further selection, 13 pig isolates (nasal=7 and rectal=6) representative of the main 
population and detected from 15 pooled samples in Cameroon were phenotypically confirmed 
as staphylococci. S. lentus (10) was the main species identified in both type of samples (Table 
5.5). In South Africa, 30 presumptive MRS (9 nasal and 21 rectal) strains underwent 
phenotypic identification, with 24 (80%) being confirmed as MRS. S. lentus (14) and S. aureus 
(6) were the foremost species isolated in both type of pooled samples (Table 5.5).  
5.3.5. Prevalence of MRS based on time points 
Figures 5.1A and 5.1B illustrate the rectal and nasal MRS colonization in pigs per abattoir and 
at each time point, respectively. Overall, in South Africa, the prevalence of MRS was unsteady 
across time for both type of samples. At abattoir level, maximum prevalence of 91 and 90% 
MRS were recorded in SH005 during the first and second time point (p=0.000), respectively 
and for both sample type; whereas less than 40% prevalence was detected in SH004 at all time 
points for nasal sample (Figure 5.1). MRS positivity associated with rectal colonization was 
higher in the country at the second and third point of collection with 90 and 80% prevalence, 
respectively. In contrast, 100% MRS carriage was detected at all time-points and for both type 
of pooled samples in Cameroon. 
5.3.6. Antimicrobial resistance patterns in pig MRS isolates 
High resistance was observed for oxacillin (100%), cefoxitin (94%), penicillin (90%), 
tetracycline (90%), clindamycin (89%) and erythromycin (76%) with no resistance to 
ciprofloxacin, moxifloxacin, tigecycline, vancomycin, linezolid, 
trimethoprim/sulfamethoxazole and mupirocin in MRS isolated from pigs in South Africa. 
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Similarly, high resistance to oxacillin (100%), tetracycline (93%), penicillin (77%), cefoxitin 
(70%), fusidic acid (47%), erythromycin (30%) and clindamycin (30%) were detected in pig 
isolates originating from Cameroon, with one strain expressing resistance to teicoplanin, 
linezolid, and vancomycin (Table 5.5).  
All S. aureus isolated from pigs in South Africa showed the resistance profile 
Penicillin.Cefoxitin.Oxacillin.Erythromycin.Clindamycin.Tetracycline whereas the unique 
strain detected in Cameroon expressed the pattern Penicillin.Cefoxitin.Oxacillin.Tetracycline 
(Table 5.6). The resistance profiles 
Penicillin.Cefoxitin.Oxacillin.Gentamicin.Erythromycin.Clindamycin.Tetracycline and 
Oxacillin.Erythromycin.Clindamycin.Tetracycline were prevalent among S. lentus in South 
Africa while Penicillin.Cefoxitin.Oxacillin.Tetracycline. Fusidic acid and 
Penicillin.Oxacillin.Erythromycin.Tetracycline.Fusidic acid were the predominant patterns 
detected in the same species in Cameroon. Moreover, two S. lentus strains isolated from rectal 
pooled samples in Cameroon showed the profiles Penicillin.Cefoxitin.Oxacillin. 
Erythromycin.Clindamycin.Linezolid.Teicoplanin.Vancomycin.Rifampicin.Fusidic acid and 
Cefoxitin.Oxacillin.Linezolid.Clindamycin.Rifampicin.Fusidic acid with resistance to seven 
and five classes of antibiotics, respectively, including the last resort linezolid, vancomycin and 
teicoplanin antibiotics (Table 5.6). 
5.3.7. Antimicrobial resistance patterns in human MRS isolates 
Human MRS isolated from South African abattoirs expressed high resistance to penicillin 
(100%), cefoxitin (100%), oxacillin (96%), trimethoprim-sulfamethoxazole (80%), gentamicin 
(49%) and tetracycline (33%) (Table 3). In addition, two strains isolated from hand swabs were 
resistant to teicoplanin (MIC= 8, 16 µg/ml). Likewise, high resistance to oxacillin (100%), 
penicillin (96%), cefoxitin (92%), tetracycline (84%), erythromycin (51%) and fusidic acid 
(52%) was detected in human MRS strains from Cameroonian workers. However, no resistance 
to vancomycin, mupirocin, tigecyclin, linezolid and rifampicin was observed in human strains 
from both countries (Table 5.3).  









Sulfamethoxazole were the most relevant profiles observed in S. haemolyticus in hand and 
nasal samples, respectively, in Cameroon. Similarly, the most relevant resistance patterns 






Sulfamethoxazole in hand and nasal samples, respectively (Table 5.7). 
5.3.8. Genotypic relatedness 
All S. aureus and the most resistant S. lentus strains as the most prevalent CoPS and CoNS 
respectively, were genotyped by REP-PCR to determine their clonal relationships. REP-PCR 
allowed the differentiation of S. aureus strains into one major cluster and S. lentus into four 
clusters (Figure 5.2). One batch of S. aureus isolates (PN235B0, PN246B0, PN243B0 and 
PR243B0) detected in one South African abattoir (SH004) were closely related and share 
common ancestors as did a batch of S. lentus strains (PN085, PR226B0, and PR108) detected 
in pigs in two Cameroonian (SH002 and SH003) and one South African (SH004) abattoirs 
(Figure 5.2).  
5.4. Discussion 
S. aureus and especially MRSA, were recently recognized as high priority antibiotic resistant 
bacteria by the World Health Organization (WHO, 2017) as their existence at the animal-
human-environment interface leads to grave socio-economic repercussions globally. In this 
study, the carriage, antimicrobial resistance patterns and clonal relatedness of MRS isolated 
from apparently healthy pigs and exposed workers in Cameroon and South Africa were 
compared. All MRS strains formed yellow colonies on MSA+FOX, characteristic of mannitol-
fermenting isolates. Although the latter screening medium is intended for the detection of 
MRSA, our findings concur with a Nigerian study which reported that MRCoNS colonies were 
similar to MRSA ones (Ugwu et al. 2015). These results reinforce the need for appropriate 
diagnostic of mannitol-fermenting MRS. 
5.4.1. MRS in humans 
Among people working on pig abattoirs, absence of training, frequent contact with pigs and 
other animals were associated with MRS carriage. The overall prevalence of MRS carriage in 
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humans was highly statistically significant in hand [72% (60/84), p=0.000] and nasal samples 
[73% (56/77), p=0.000]. The prevalence reported in our study is consistent with a study from 
Switzerland where 49.3% of MRCoNS were detected among exposed workers (Huber et al., 
2011). Our results are however, higher than that reported by Gulani et al. (2016) where a 13.5% 
prevalence of MRSA was detected in animal handlers in Nigeria. The prevalence of MRS 
carriage was significantly higher in Cameroonian workers than South African ones for both 
nasal (92.45% vs 29.17; p=0.000) and hand (100% vs 23.3%; p=0.000) samples. These 
discrepancies between both countries could be because that abattoir regulations, 
implementation of Hazard Analysis Critical Control Points (HACCP) plans and compliance 
with international food safety standard ISO 22000 are stringent in South Africa whereas 
Cameroonian slaughterhouses/markets were characterized by precarious hygienic conditions 
with minimal or non-existent biosecurity measures and absence of regulations. This has been 
confirmed by Ndebi et al. (2009) who already reported that the pig production industry in 
Cameroon is undermined by a mosaic of problems such as insufficient funds, poor sanitary and 
feeding requirements, sub-optimal transport conditions, lack of veterinarian control that leads 
to the emergence and spread of ABR in the farm-to-plate continuum. Our results therefore 
suggest that the implementation of effective food safety measures contributes to the 
containment of ABR dissemination.  
The presence of MRS in nasal samples was highly statistically associated with hand 
colonization (31.58% vs 86.21%, p=0.000, OR=13.54; 95% CI 3.99-45.95; p=0.015). These 
findings reveal poor implementation of hygienic and sanitary conditions and suggest that these 
limited measures along with high prevalence of colonized food handlers represent an important 
food safety threat in both countries. It further suggests that food handlers represent a significant 
source of ABR dissemination for their relatives through person-to-person contact and for the 
general population through the contamination of food products occurring during food 
processing. 
5.4.2. MRS in animals 
The 75% and 70% positivity of all pooled nasal and rectal samples for MRS respectively, are 
higher than that reported from Nigeria where 31% and 52% of MRS were detected in pigs and 
pork, respectively (Ugwu et al., 2015; Igbinosa et al., 2016). They are however lower than that 
reported by Bhargava and Zhang (2012) where 100% of MRS were observed in nasal and rectal 
swabs of various food animals including pigs, sold during a livestock auction in Ohio. The high 
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prevalence reported in our study could be associated with extensive use of antimicrobials in 
the food production industry. 
When comparing the results at country-level, animals sampled in Cameroon were statistically 
significantly more colonized than those collected in South Africa with a maximum prevalence 
of MRS (100%) for both type of samples versus 50% and 81% MRS in nasal and rectal pooled 
samples, respectively, in South Africa (p=0.000). The elevated prevalence of MRS carriage 
detected in both type of pooled samples in South Africa and Cameroon is not surprising, as the 
use of antibiotics as growth promoters is legally approved in the former (Department of 
Agriculture, Forestry and Fisheries, 1996) and, policies promoting rational drug use are non-
existent in both animals and humans in the latter. Ndebi et al. (2009) already revealed that 
antibiotics of human medicine are frequently use for the prevention and treatment of infectious 
diseases in pig husbandry in Cameroon, that the current state of knowledge of antibiotic use 
and antibiotic resistance (ABR) in humans, (food) animals, and environment is minimal or non-
existent and that the debate about ABR-related consequences is neglected in the country.  
Our results further indicate that MRS are widespread in food animals and abattoirs in both 
countries, can spread actively in the farm-to-plate continuum and pose a serious food safety 
threat for these nations. The rectal colonization reported in our study could be attributed to 
widespread antibiotic use on farms either for therapeutic, prophylactic or growth promotion 
purposes whereas the nasal MRS carriage is likely associated with environmental 
contamination.  
5.4.3. MRS based on time points 
The overall high MRS prevalence observed across time points in both countries suggests that 
measures implemented in both countries are suub-optimal for the effective eradication and 
containment of MRS. This has been confirmed by the maximum MRS prevalence recorded 
during the first (91%) and second (90%) time point for rectal sample in SH005 whereas 92% 
and 86% of MRS was detected in SH004 at second and thrid time points for the same sample 
type  in South Africa (Figure 1). Similarly, the high nasal MRS prevalence observed in both 
countries evidences the persistance of MRS not only in living food animals but also on 
environmental surfaces that leads to their dissemination across the animal-human-
environmental interface. It further reveals that decontamination measures implemented in 
abattoirs should be updated and consider novel concepts that address environmental persistence 
of MRS.  
5.4.4. Antimicrobial resistance patterns 
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The analyses of resistance profiles revealed more than 80% resistance to β-lactams including 
penicillin, cefoxitin and oxacillin in both countries and for both populations. The phenotype 
P.FOX.OX.E.CLI.TET showing resistance to six antibiotics was the most common in MRSA 
strains isolated from rectal and nasal pooled samples in South Africa. One S. lentus strain 
isolated from rectal pooled sample in Cameroon displayed the profile 
P.FOX.OX.E.CLI.LIN.TEI.VAN.FA.RIF with resistance to ten antibiotics including the 
following last resort antibiotics; teicoplanin, vancomycin and linezolid. This confirms MRS as 
significant food contaminants, reservoir of and potential vectors for dissemination of ABR in 
the food chain.  
Co-resistance to non-beta-lactam antibiotics, including trimethoprim-sulfamethoxazole, 
erythromycin, clindamycin, fusidic acid, gentamicin and ciprofloxacin, was also observed. 
Such co-resistance to other antibiotic classes along with resistance to beta-lactams is frequent 
in MRS and could likely result from the indiscriminate and/or extensive antibiotic use in food 
animals in both countries (Asongalem et al., 2015). The presence of mobile genetic elements 
such as the Staphylococcal Cassette Chromosome (Scc) harbouring the mecA gene responsible 
for the methicillin resistance could also explained our results and be responsible of further 
resistance (Bhargava and Zhang, 2012). These results further reveal that MRS strains may 
transfer their resistance genes across susceptible species or genus through horizontal gene 
transfer in the farm-to-plate continuum.  
5.4.5. Genotypic relatedness 
REP-PCR analysis, demonstrated that isolates from pig origin exhibited varying levels of 
genetic variability and presented both related and unrelated patterns. The antibiotic resistance 
and REP patterns revealed relative association between animal and human strains within and 
across countries. Although no MRSA strains were detected in humans, some MRCoNS 
detected from humans share common ancestors with those isolated from pigs at the same or 
different abattoir. These results suggest that emergence of MRCoNS in humans may be of 
animal origin or vice-versa, and that these pathogens may be transferred to humans via the food 
chain, enabling them to subsequently enter community or healthcare settings. Similarly, MRSA 
strains detected in pigs revealed association within the same abattoir. Although not being an 
indication of MRS transmission dynamics, our results nonetheless show that some genetic 
relatedness exists between animal and human isolates due to similar clustering. This finding is 
of great concern as MRS originating from animals have been reported to be amongst the 
causative agents of clinical infections globally (Kluytmans, 2010).  
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5.4.6. Association of MRS carriage in humans and risk factors 
Twenty-one workers or their close relatives had been hospitalized within a year of the sample 
collection, leading to an overall 95.24% (p=0.007) and 85.71% (p=0.112) prevalence of nasal 
and hand MRS, respectively (Table 5.1). Likewise, 92.11% (p=0.000) and 92.11% (p=0.000) 
of workers who had consumed antibiotics the month preceding the sampling were colonized 
by MRS in nasal and hand samples, respectively (Table 5.1). Although the duration of MRS 
carriage and resistance genes involved were not investigated, the study reveals that no 
association between human MRS carriage and contact with MRS carrying pigs was observed 
for all type of samples, although not statistically significant (Table 5.2). In contrast, a clear 
association between human MRS carriage and contact with other animals, especially poultry, 
was observed and with high statistical significance (Table 5.2). We showed that when workers 
have been trained to practice their profession, convenient handwashing facilities were available 
and wearing of protective clothes was implemented, the odds of being colonized by MRS were 
significantly reduced. Our findings also reveal that the implementation of food safety measures 
is imperative to contain the dissemination of ABR in general and MRS in particular. 
The scarcity of similar studies precluded robust comparison of results. We therefore discussed 
our findings with data considered most appropriate and as close as possible to our own results. 
More research is required on MRS carriage in high risk human populations and other food 
animals such as poultry in order to improve our knowledge on the public health significance 
associated with the likely transmission of MRS through the farm-to-plate continuum. 
5.5. Conclusion  
Our findings indicate that MRS are emerging and serious foodborne pathogens of grave 
concern. The high prevalence of MRS reported in humans and animals in both Cameroon and 
South Africa highlights their active dissemination in the food chain, their contamination of 
food products and the subsequent food safety threat associated with these bacteria in these 
countries. It underscores the need for the implementation of appropriate and suitable food 
safety measures to contain their spread. 
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Table 5.1. Nasal and hand MRS carriage of exposed workers in relation to individual, clinical 
and abattoir-related characteristics6.  
Variables 








p-value n % n % 
Individual characteristics 
Country 
Cameroon 53 69 92.45 
0.000 
53 64 100 
0.000 
South Africa 24 31 29.17 30 36 23.3 
Gender 
Female 9 12 88.89 
0.247 
12 12 75 
0.821 
Male 68 88 70.59 71 88 71.83 
Age 
[21-30] 31 40 61.29 
0.231 
32 39 59.38 
0.229 
[31-40] 26 34 76.92 28 34 78.57 
[41-50] 13 7 84.62 14 7 85.71 
[51-60] 5 6 100 6 7 83.33 
Above 60 2 3 50 3 3 66.67 
Educational level 
Never been to school 4 5 50 
0.003 
5 6 60 
0.032 
Primary school not 
completed 
6 8 33.33 7 8 57.14 
Primary school 34 44 94.12 35 42 94.29 
Secondary school 27 35 59.26 27 33 55.56 
High school/university 6 8 66.67 8 10 62.50 
Average monthly income (US $) 
Below 55 8 11 100 
0.025 
8 14 100 
0.019 
55-110 14 19 85.75 14 29 85.71 
110-165 12 16 75 12 17 83.33 
165-220 10 13 80 10 17 80 
220-275 20 27 45 24 10 45.83 
Above 275 11 15 81.82 13 12 69.23 
Clinical factors 
Previous hospitalization (within the year of sampling) 
Yes 21 27 95.24 0.007 21 25 85.71 0.112 
                                                 
6 Six out of the 84 enrolled workers refused the nasal sampling, one withdrew prior to the sample 
collection, leading to a total of 77 nasal and 83 hand samples collected. Few questions were not 
answered by workers while other could not recall the exact information leading to missing information 
that were not considered in the analysis. 
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No 56 73 64.29 62 75 67.74 
Nasal problem 
Yes 11 14 63.64 
0.465 
11 13 63.64 
0.491 
No 66 86 74.24 72 87 73.61 
Skin problem 
Yes 14 18 71.43 
0.904 
14 17 64.29 
0.463 
No 63 82 73.02 69 83 73.91 
Antibiotic use (within the month of sampling) 
Yes 38 49 92.11 
0.000 
38 64 92.11 
0.000 
No 39 51 53.85 45 36 55.56 
Relative working at hospital or with animal 
Yes 42 55 90.48 
0.000 
44 53 88.64 
0.000 
No 35 45 51.43 39 47 53.85 
Abattoir-related factors 
Proximity of abattoir with house 
Yes 32 42 59.38 
0.027 
14 33 64.71 
0.199 
No 45 58 82.22 28 67 75.55 
Abattoir 
SH001 21 27 100 
0.000 
21 25 100 
0.000 
SH002 19 25 89.47 19 23 100 
SH003 13 17 84.62 13 16 100 
SH004 4 5 50 10 12 40 
SH005 20 26 25 20 24 15 
Principal activity or working area 
Slaughterer 34 44 76.47 
0.002 
34 41 76.47 
0.001 
Transport of pig/pork 5 7 80 5 6 80 
Wholesaler 7 9 100 7 8 100 
Butcher 5 7 100 5 6 80 
Retailer of viscera* 7 9 85.71 7 8 100 
Retailer of grilled pork# 1 1 0 1 1 100 
Scalding of pigs 3 4 0 3 4 33.33 
Evisceration 8 10 37.50 14 17 28.57 
Transport of 
viscera/blood 
1 1 0 1 1 0 
Veterinarian 5 7 100 5 6 100 
Meat inspector 1 1 0 1 1 0 
Training to practice profession 
Yes 28 36 39.29 
0.000 
34 41 32.35 
0.000 
No 49 64 91.84 49 59 100 
Year in profession 
[0-4] 31 43 51.61 
0.007 
31 39 51.61 
0.011 
[5-9] 6 8 83.33 8 10 100 
[10-14] 22 30 86.36 24 30 75 
Above 15 14 19 92.86 16 20 87.50 
Intensity of pig’s contact 
Always 35 45 68.57 
0.721 
35 42 77.14 
0.032 Almost always 32 42 75 38 46 60.53 
Sometimes 10 13 80 10 12 100 
Contact with other animals 
Yes 38 50 86.84 
0.009 
39 48 92.31 
0.001 
No 38 50 60.53 42 52 54.76 
Intensity animal contact 
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Always 8 21 87.50 
0.773 
8 20 100 
0.024 
Almost always 9 24 77.78 10 26 70 
Sometimes 17 45 88.24 17 44 100 
Rarely 4 10 100 4 10 100 
*retailer of viscera: street-vendor purchasing pig’s viscera from the abattoir, undertaking manual cleaning and 





Table 5.2. Univariate and multivariate logistic regression for methicillin resistant staphylococci (MRS) carriage among exposed workers 
a: Family members working at hospital, with food animals or crop production, b: Exposure within 12 months prior the date of sampling; c: Within one month prior 




Univariate Analysis Multivariate Analysis 
Nasal carriage of MRS Hand carriage of MRS Nasal carriage of MRS Hand carriage of MRS 
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Abattoir 0.28 (0.16-0.48) 0.000 0.08 (0.03-0.26) 0.000 ….  …..  
Hand MRS 13.54 (3.99-45.95) 0.000 … … …  …  
Nasal MRS … … 13.54 (3.99-45.95) 0.000 …  …  
Gender 0.3 (0.04-2.55) 0.271 0.85 (0.21-3.46) 0.682 ….  ….  
Educational level 0.98 (0.57-1.70) 0.960 0.76 (0.45-1.28) 0.306 ….  ….  
Monthly Income 0.67 (0.47-0.96) 0.031 0.60 (0.42-0.87) 0.006 …  …  
Training 0.06 (0.02-0.21) 0.000 1  …  …  
Principal Activities 0.71 (0.58-0.88) 0.001 0.7 (0.57-0.85) 0.000 …  …  
Occupation of relative a 8.97 (2.63-30.54) 0.000 6.68 (2.17-20.57) 0.001 7.09 (1.60-31.46) 0.010 3.51 (0.88-14.00) 0.076 
Year in Profession 2.66 (1.30-5.43) 0.007 2.28 (1.27-4.11) 0.006 2.18 (1.01-4.70) 0.046 4.11 (1.53-11.00) 0.005 
Age 1.45 (0.84-2.49) 0.177 1.39 (0.86-2.25) 0.178 …  …  
Recent hospitalization b 11.11 (1.38-89.06) 0.023 2.86 (0.75-10.84) 0.123 11.93 (1.23-115.76) 0.069 1.51 (0.28-7.98) 0.626 
Recent antibiotic use c 9.99 (2.63-38.06) 0.001 9.33 (2.50-34.85) 0.001 …  …  
Skin problem 0.92 (0.25-3.34) 0.904 0.63 (0.19-2.15) 0.465 …  …  
Nasal problem 0.61 (0.16-2.33) 0.468 0.63 (0.16-2.38) 0.494 …  …  
Proximity of house with abattoir 0.31 (0.11-0.89) 0.030 0.53 (0.20-1.40) 0.201 …  …  
Protective working clothes 0.05 (0.01-0.22) 0.000 1  …  …  
Inadequate Handwashing 1  3.38 (0.40-28.70) 0.264 …  …  
Convenient handwashing 0.07 (0.02-0.25) 0.000 0.07 (0.02-0.21) 0.000 …  …  
Intensity of contact with pigs 1.36 (0.64-2.88) 0.422 1.15 (0.56-2.38) 0.696 …  …  
Contact with other animals 1.37 (0.50-3.75) 0.530 1.73 (0.47-6.34) 0.407 …  …  
Intensity of contact with other animals 4.30 (1.37-13.51) 0.012 9.91 (2.63-37.31) 0.001 …  …  
Contact with poultry 3.6 (0.94-13.70) 0.060 13.68 (1.72-108.43) 0.013 …  …  
Pig contamination Nasal MRS (yes or no) 1.04 (0.99-1.09) 0.087 1.03 (0.99-1.08) 0.146 1.12 (0.93-1.35) 0.219 1.28 (1.09-1.50) 0.003 
Pig contamination Rectal MRS (yes or no) 1.01 (0.97-1.05) 0.544 0.98 (0.94-1.03) 0.494 0.91 (0.76-1.10) 0.352 0.77 (0.65-0.92) 0.004 
Sow 1.09 (1.01-1.18) 0.031 1.05 (0.99-1.13) 0.112 …  …  
Boar 0.84 (0.76-0.93) 0.001 0.68 (0.57-0.83) 0.000 …  …  
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Table 5.3.  Distribution of Staphylococcus spp. isolated from humans in Cameroon and South Africa according to their species diversity 
and multidrug resistance 
 
        0;    >0-10;      >10-20;     >20-30;      >30-40;      >40-50;      >50-60;      >60-70;      >70-80;     > 80-90;      >90-100
Staphylococcus spp. 
(n=isolates) 





















































































































































S. epidermidis (5) 100 100 100 60 0 0 80 0 0 0 0 80 0 20 0 40 
S. haemolyticus (6) 100 100 100 83 100 17 50 0 0 0 0 50 0 17 0 83 
S. hominis (2) 100 100 100 0 0 0 100 100 0 0 0 100 0 50 0 0 
S. lentus (4) 75 50 100 25 0 0 25 0 0 0 0 75 0 75 0 25 
S. sciuri (1) 100 100 100 0 0 0 0 0 0 0 0 100 0 100 0 0 
S. warneri (2) 100 100 100 0 0 0 50 0 0 0 0 100 0 50 0 0 
South Africa (n=14) 
S. epidermidis (1) 100 100 100 0 0 0 0 0 0 0 0 0 0 0 0 100 
S. haemolyticus (9) 100 100 78 44 33 0 44 0 0 11 0 67 0 22 0 100 
S. hominis (1) 100 100 100 0 0 0 0 0 0 0 0 0 0 0 0 0 
S. lentus (2) 100 100 100 100 100 0 100 0 0 0 0 100 0 0 0 100 
S. lugdunensis (1) 100 100 100 100 0 0 0 0 0 0 0 0 0 0 0 100 
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Cameroon 72 (50) 72 (100) 
0.000 
72 (50) 72 (100) 
0.000 
South Africa 72 (50) 36 (50) 72 (50) 58 (81) 
Gender 
Sow 79 (55) 67 (85) 
0.003 
79 (55) 76 (96) 
0.008 
Boar 65 (45) 41 (63) 65 (45) 54 (83) 
Abattoir 
SH001 43 (30) 43 (100) 
0.000 
43 (30) 43 (100) 
0.001 
SH002 19 (13) 19 (100) 19 (13) 19 (100) 
SH003 10 (7) 10 (100) 10 (7) 10 (100) 
SH004 40 (28) 12 (30) 40 (28) 30 (75) 
SH005 32 (22) 24 (75) 32 (22) 28 (88) 
Time point 
First 42 (29) 32 (76) 
0.221 
42 (29) 35 (83) 
0.102 Second 54 (38) 44 (82) 54 (38) 52 (96) 
Third 48 (33) 32 (67) 48 (33) 43 (90) 
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Table 5.5. Distribution of Staphylococcus spp. isolated from pigs in Cameroon and South Africa according to their species 















            0;    >0-10;      >10-20;     >20-30;      >30-40;      >40-50;      >50-60;      >60-70;      >70-80;     > 80-90;      >90-100
Staphylococcus spp. 
(n=isolates) 





























































































































































S. aureus (1) 100 100 100 0 0 0 0 0 0 0 0 100 0 0 0 0 0 
S. lentus (10) 80 60 100 0 0 0 40 40 20 10 10 80 0 0 90 20 10 
S. sciuri (2) 50 50 100 0 0 0 50 50 0 0 0 100 0 0 50 50 50 
South Africa (n=24) 
S. aureus (6) 100 100 100 0 0 0 100 100 0 0 0 100 0 0 0 0 0 
S. epidermidis (1) 100 100 100 100 0 0 100 100 0 100 0 100 0 0 0 0 0 
S. hominis (2) 100 100 100 50 0 0 100 100 0 0 0 50 0 0 0 0 0 
S. lentus (14) 50 70 100 14 0 0 79 43 0 0 0 100 0 0 57 14 0 
S. warneri (1) 100 100 100 0 0 0 0 100 0 0 0 100 0 0 0 0 0 
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Table 5.6. Antimicrobial resistance profiles of methicillin resistant staphylococci (MRS) 


















S. aureus (7) 
P.FOX.OX.TET 4 2 1 (14) 0 0 0 
P.FOX.OX.E.CLI.TET 6 4 0 0 3 (33) 3 (20) 
S. lentus (24) 
P.FOX.OX.TET 4 2 0 0 1 (11) 2 (13) 
OX.E.CLI.TET 4 4 0 0 0 1 (7) 
P.FOX.OX.GEN.E.TET 6 4 0 0 0 1 (7) 
FOX.OX.E.TET.FA 5 4 0 0 0 1 (7) 
FOX.OX.E.TET.FA.CLI 6 5 0 0 1 (11) 1 (7) 
OX.CLI.TET.FA 4 4 0 0 0 1 (7) 
OX.CLI.TET.FA.RIF 5 5 0 0 0 1 (7) 
P.FOX.OX.GEN.E.CLI.TET 7 5 0 0 1 (11) 0 
OX.E.TET.FA 4 4 0 0 1 (11) 0 
P.FOX.OX.TET.FA 5 3 1 (14) 2 (43) 0 0 
P.OX.E.TET.FA 5 4 2 (28) 0 0 0 
FOX.OX.TET.FA.RIF 5 4 1 (14) 0 0 0 
FOX.OX.LIN.CLI.FA.RIF 6 5 1 (14) 0 0 0 
P.FOX.OX.E.CLI.LIN.TEI.VAN.FA.RIF 10 7 0 1 (14) 0 0 
P.FOX.OX.E.CLI.TET.FA.TMP/SXT 8 6 0 1 (14) 0 0 
P.FOX.OX.CLI.TET 5 3 0 1 (14) 0 0 
P.FOX.OX.E.CLI.TET.FA.RIF 8 6 0 0 1 (11) 0 
FOX.OX.E.CLI.TET.FA 6 5 0 0 1 (11) 0 
S. hominis (2) 
P.FOX.OX.E.CLI 5 3 0 0 0 1 (7) 
P.FOX.OX.GEN.E.CLI.TET 7 5 0 0 0 1 (7) 
S. epidermidis (1) P.FOX.OX.GEN.E.CLI.TET 7 5 0 0 0 1 (7) 
S. warneri (1) P.FOX.OX.CLI.TET 5 3 0 0 0 1 (7) 
S. sciuri (2) 
P.FOX.OX.E.CLI.TET.FA.RIF.TMP/SXT 9 7 0 1 (14) 0 0 
OX.TET.FA 3 3 1 (14) 0 0 0 
Grand Total 7 (100) 6 (100) 9 (100) 15 (100) 
PEN: benzylpenicillin, OX: oxacillin, GEN: gentamicin, CIP: ciprofloxacin, MOX: moxifloxacin, E: 
erythromycin, CLI: clindamycin, LIN: linezolid, TEI: teicoplanin, VAN: vancomycin, TIG: tigecycline, FA: 
















Table 5.7. Antimicrobial resistance profiles of methicillin resistant staphylococci (MRS) 




















P.FOX.OX.TMP/SXT.E.TET 6 4 0 0 1 (13) 0 
P.FOX.OX.GEN.CIP.E.TMP/SXT 7 5 0 0 1 (13) 0 
P.FOX.OX.GEN.TMP/SXT.FA.TET 7 5 0 0 1 (13) 0 
P.FOX.OX.GEN.TMP/SXT.TET 6 4 0 0 1 (13) 0 
P.FOX.OX.TET.TMP/SXT 5 3 0 0 1 (13) 0 
P.FOX.OX.GEN.CIP.TMP/SXT 6 4 0 0 1 (13) 0 
P.FOX.OX.TMP/SXT 4 2 0 0 0 1 (17) 
P.FOX.CIP.E.TEI.TET.FA.TMP/SXT 8 7 0 0 0 1 (17) 
P.FOX.E.TMP/SXT.TET 5 4 0 0 0 1 (17) 
P.FOX.OX.CIP.MOX.E.TET.TMP/SXT 8 5 0 1 (9) 0 0 
P.FOX.OX.GEN.CIP.TET.TMP/SXT 7 5 0 1 (9) 0 0 
P.FOX.OX.TMP/SXT.GEN.CIP 6 4 1 (11) 0 0 0 
P.FOX.OX.GEN.CIP.E 6 4 1 (11) 0 0 0 
P.FOX.OX.TMP/SXT.GEN.CIP.TET 7 5 1 (11) 0 0 0 
P.FOX.OX.TMP/SXT.GEN.CIP.E.TET.FA 9 7 1 (11) 0 0 0 
S. epidermidis (6) 
P.FOX.OX.TMP/SXT 4 2 0 0 0 1 (17) 
P.FOX.OX.E.TET.TMP/SXT 6 4 0 1 (9) 0 0 
P.FOX.OX.GEN.E.TET.FA.TMP/SXT 8 6 0 1 (9) 0 0 
P.FOX.OX.GEN 4 2 0 1 (9) 0 0 
P.FOX.OX.GEN.E.TET 6 4 0 1 (9) 0 0 
P.FOX.OX.E.TET 5 3 0 1 (9) 0 0 
S. hominis (3) 
P.FOX.OX 3 1 0 0 0 1 (17) 
P.FOX.OX.TET 4 2 1 (11) 0 0 0 
P.FOX.OX.TET.FA 5 3 1 (11) 0 0 0 
S. lentus (6) 
P.FOX.OX.GEN.CIP.E.TET.TMP/SXT 8 6 0 0 1 (13) 1 (17) 
P.FOX.OX.GEN.TET 5 3 1 (11) 0 0 0 
P.OX.TET.FA.TMP/SXT 5 4 1 (11) 0 0 0 
P.FOX.OX.TET.FA 5 3 0 1 (9) 0 0 
OX.E.FA 3 3 0 1 (9) 0 0 
S. lugdunensis (1) P.FOX.OX.GEN.TMP/SXT 5 3 0 0 1 (13) 0 
S. sciuri (1) P.OX.TET.FA 4 3 0 1 (9) 0 0 
S. warneri (2) 
P.FOX.OX.TET.FA 5 3 0 1 (9) 0 0 
P.FOX.OX.E.TET 5 3 1 (11) 0 0 0 
Grand Total 9 (100) 
11 
(100) 
8 (100) 6 (100) 
PEN: benzylpenicillin, OX: oxacillin, GEN: gentamicin, CIP: ciprofloxacin, MOX: moxifloxacin, E: 
erythromycin, CLI: clindamycin, LIN: linezolid, TEI: teicoplanin, VAN: vancomycin, TIG: tigecycline, FA: 
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Figure 5.2. Genotypic relationship of methicillin resistant S. aureus (A) and S. lentus (B) isolated from pigs and humans in Cameroon and South Africa. 
Dendrogram established by the biostatistical analysis software Bionumerics using the Dice similarity coefficient and UPGMA method on the basis of the REP-
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Background and objectives: Food animals are considered reservoirs of methicillin resistant 
Staphylococcus aureus (MRSA) and are implicated in their zoonotic transmission in the farm-
to-plate continuum. MRSA sequence type (ST) 398, the prototype of livestock-associated 
MRSA (LA-MRSA), that first emerged in pigs, is an important public health threat worldwide 
due to its global zoonotic dissemination and implications in human infections and outbreaks. 
In this study, whole genome sequencing was used to describe the genetic environment 
(resistance mechanisms, virulence factors and mobile genetic elements), investigate the genetic 
lineages and determine the putative public health threat of circulating and closely related 
MRSA strains isolated from pigs in Cameroonian and South African abattoirs.  
Methods: During March–October 2016, 288 nasal and rectal pooled samples from 432 pigs as 
well as nasal and hand swabs from 82 humans were collected. Genomic DNA of MRSA strains 
was sequenced using an Illumina MiSeq platform. Generated reads were de novo assembled 
using the Qiagen CLC Genomics Workbench and SPAdes. The assembled contigs were 
annotated and antibiotic resistance genes, virulence factors, plasmids and phage elements 
identified with ResFinder, Virulence Finder, PlasmidFinder and PHAST, respectively.  
Results: A lower MRSA prevalence was observed in pigs in Cameroon (0.07%) compared 
with South Africa (16.66%) and none of the workers were colonized by MRSA. Genome 
analysis identified various antibiotic resistance genes associated with resistance to β–lactams 
(mecA, blaZ), fluoroquinolones (norA), macrolide, lincosamide and streptogramins [erm(B), 
erm(C)] and tetracycline [tet(M), tet(K), tet(L)]. All circulating MRSA isolates belong to the 
clonal lineage ST398 and showed chromosomal integration of several plasmid replicon types.  
Conclusion: Our study shows that the livestock-associated MRSA clonal lineage ST398 is 
already present in both Cameroon and South Africa and is probably underestimated in the 
absence of molecular epidemiological studies. It reveals the serious food safety and public 
health threat associated with this animal strain and underscores the urgent need for 








Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) is a bacterium 
that first emerged in pigs in the Netherlands in the early 2000s (Voss et al., 2005; van den 
Broek et al., 2008; Price et al., 2012; Chen, 2013). Some reports suggested that LA-MRSA 
originated from human methicillin-susceptible S. aureus (MSSA) sequence type (ST) 398, 
underwent a jump from humans to food animals where it has subsequently acquired tetracycline 
and methicillin resistance (Weese, 2010; Price et al., 2012; Mehndiratta and Bhalla, 2014). In 
fact, all LA-MRSA strains exhibit resistance to tetracycline and are normally susceptible to 
trimethoprim/sulfamethoxazole. They rarely harbor the Panton-Valentine Leukocidin (PVL) 
genes that characterize human community-acquired-MRSA (CA-MRSA) (Weese, 2010; 
Mehndiratta and Bhalla, 2014). Although (food) animals are often colonized by LA-MRSA ST 
398, clinical diseases associated with this resistant pathogen have rarely been reported (van 
Den Broek et al., 2008; Chen, 2013). Nasal and rectal asymptomatic carriage of the MRSA ST 
398, the prototype of LA-MRSA, has been frequently detected in pigs (Wulf and Voss, 2008; 
Wagenaar et al., 2009; Van Cleef et al., 2010; Graveland et al., 2011) which are considered the 
most important reservoir although other clonal lineages such as ST9 (Fang et al., 2014), ST5 
(Hau et al., 2015) and ST97 (Spoor et al., 2013) have also been identified. LA-MRSA ST398 
is largely a pig- or veal-calf-associated lineage characterized by its high capacity to colonize 
multiple hosts such as poultry (Murray et al., 2017), sheep (Weese et al., 2010), horses 
(Abdelbary et al., 2014) and pets (Weese et al., 2010). It is highly prevalent in Europe (van 
Den Broek et al., 2008; Harrison et al., 2017) and Northern America (Tegegne et al., 2017). 
LA-MRSA ST9 is a pandemic livestock-associated clone detected in pigs and exposed workers 
in Asian countries, including Thailand (Sinlapasorn et al., 2015), China (Ye et al., 2016) and 
Taiwan (Fang et al., 2014) and LA-MRSA ST5 is mostly associated with poultry globally 
(Murray et al., 2017).  
The asymptomatic carriage of LA-MRSA increases the risks of its zoonotic transmission 
among exposed workers, other animals and the environment, thus contributing to the complex 
variations, exchanges, and hosts adaptabilities (Wulf et al., 2008a; Van Cleef et al., 2010, 2011; 
Price et al., 2012; Köck et al., 2013; Smith, 2015). Graveland et al. (2011) revealed that four 
hours of narrow contact with colonized or sick animals were sufficient to infect or permanently 
colonize humans. Several studies thus concluded that pig farmers, abattoir workers, food 
handlers and veterinarians, have high occupation/profession-associated risks for LA-MRSA 
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colonization and infection (Van Cleef et al., 2010; Graveland et al., 2011; Price et al., 2012). 
These humans may in turn likely become reservoirs of LA-MRSA and drive its spread into the 
community and healthcare settings leading to the emergence of genetically diverse CA-MRSA 
and hospital-acquired-MRSA both representing serious global public health threat (Wulf and 
Voss, 2008; Price et al., 2012; Mehndiratta and Bhalla, 2014).  
Several reports have described the origin and evolution of MRSA of animal origin in the human 
population, highlighting its adaptation to various hosts, and subsequent spread of new clones 
widely into the general population (van Loo et al., 2007; van Den Broek et al., 2008; Graveland 
et al., 2011; Köck et al., 2013). In an international study of nine countries, Wulf et al., (2008a) 
reported a 12.5% (34/272) prevalence of MRSA in professionals (other than farmers and 
veterinarians) in contact with pigs. The study showed that 91% (31/34) of these strains were 
ST398, and were previously isolated from Dutch pigs, pig farmers and veterinarians (Wulf et 
al., 2008a). It further concluded that these strains could represent an important source of 
community-acquired MRSA (CA-MRSA) not only in Europe, but also worldwide, if their 
spread is not contained (Wulf et al., 2008a).  
Even though LA-MRSA virulence is almost null or likely lesser than in other human MRSA 
clones, numerous lineages of LA-MRSA including ST398, ST5, ST97, ST30, ST9 have been 
involved in outbreaks and human infections in hospitals particularly in regions with a high 
density of pig production activities (Wulf et al., 2008a, Wagenaar et al., 2009, Köck et al., 
2013). For instance, two hospital-acquired outbreaks of MRSA of livestock origin have been 
reported in Dutch health care settings and in nursing homes demonstrating the putative spread 
of LA-MRSA in the general population (Wulf et al., 2008a). Invasive LA-MRSA ST398 
infections have been associated with negative clinical outcomes ranging from mild to life-
threatening. Resistant strains originating from animals, are serious threats to the world as they 
could lead to the emergence of new strains with greater resistance, virulence and mobility 
(Wulf and Voss, 2008; Weese, 2010; Price et al., 2012).  
Understanding the epidemiology, molecular characteristics and clonal lineages of S. aureus at 
the animal, human and environmental interface is thus imperative to correlate the genetic 
diversity associated with the genetic exchange and spread of resistant bacteria through the 
farm-to-plate continuum. This is especially important in sub-Saharan African countries, such 
as Cameroon and South Africa where policies on antimicrobial use and antimicrobial 
stewardship programs in the food production industry are limited. The purpose of this study 
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was to investigate the antibiotic resistance genes, virulence factors, mobile genetic elements 
and genetic lineages of circulating MRSA isolated from pigs in Cameroonian and South 
African abattoirs using whole genome sequencing (WGS). 
6.2. Materials and methods 
6.2.1. Ethical considerations 
Ethical approvals from the Biomedical Research Ethics Committee (Ref. BE365/15) and 
Animal Research Ethics Committee (Ref. AREC/091/015D) of the University of KwaZulu-
Natal as well as from the National Ethics Committee for Research in Human Health of 
Cameroon (Ref. 2016/01/684/CE/CNERSH/SP) were obtained prior the implementation of 
the study. Ministerial approvals from the Cameroonian Ministry of Livestock, Fisheries and 
Animal Industries (Ref. 061/L/MINEPIA/SG/DREPIA/CE) and Ministry of Scientific 
Research and Innovation (Ref. 015/MINRESI/B00/C00/C10/C14) were also granted. 
6.2.2. Study design and bacterial isolates 
From March to October 2016, a multi-center study was carried out in three 
slaughterhouses/markets in Cameroon and two abattoirs in South Africa, encoded for ethical 
reasons as SH001, SH002, SH003 and SH004 and SH005, respectively. Three individual 
samples were pooled to yield 144 nasal and 144 rectal pools representing 432 individual nasal 
and rectal samples respectively collected from 432 pigs. A total of 288 swabs from the 144 
nasal and 144 rectal pools constituted the final sample. Nasal and hand swabs were also 
collected from 82 humans in both Cameroon and South Africa. All samples were cultured on 
Mannitol Salt agar supplemented with 6 mg/L cefoxitin and incubated for 18-24 h at 370C. All 
putative methicillin resistant staphylococci (MRS), were subjected to Gram staining, and the 
catalase and oxidase tests for phenotypic characterization of the isolates to the genus level. The 
isolates were thereafter phenotypically confirmed using the Vitek® 2 System (BioMérieuX, 
Marcy l’Etoile, France). The strains sequenced in this study were isolated from five pooled 
samples, one in Cameroon (PR041) and four in South Africa (PR243B0, PN243B0, PN246B0, 
PN235B0). The isolates, PN243B0, PN246B0 and PN235B0, were collected from the nares of 
pigs processed in abattoir SH004 in South Africa. Likewise, the strains, PR041 and PR243B0, 
originated from two different abattoirs, SH001 and SH004, respectively and were both 
collected from the rectum. These strains were the unique MRSA strains isolated in a previous 
study and were observed to be closely related via repetitive-palindromic-polymerase chain 
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reaction (REP-PCR) analysis. All MRSA isolates were subjected to WGS analysis in order to 
describe the genetic environment (resistance mechanisms, virulence factors and mobile genetic 
elements), investigate whether they were of livestock origin, and determine their putative threat 
for human health. 
6.2.3. Screening for methicillin resistance 
The cefoxitin disk test was used for the screening of the methicillin resistance as recommended 
by the Clinical Laboratory and Standards Institute (CLSI) (CLSI, 2016). An inhibition zone 
below 21 mm was regarded as putative proof for methicillin resistance. The Vitek® 2 System 
(BioMérieux, Marcy l’Etoile, France) was further used for phenotypic confirmation of 
methicillin resistance. S. aureus ATCC 29213 and ATCC 43300 were used as controls. 
6.2.4. Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing was performed to determine the resistance patterns of the 
selected strains. The minimum inhibitory concentrations (MIC) of benzylpenicillin, cefoxitin, 
oxacillin, clindamycin, erythromycin, gentamicin, ciprofloxacin, moxifloxacin, mupirocin, 
rifampicin, fusidic acid, teicoplanin, vancomycin, linezolid, tigecycline, trimethoprim-
sulfamethoxazole, were determined by broth micro-dilution method using Vitek® 2 System 
(BioMérieuX, Marcy l’Etoile, France) and Vitek® 2 Gram Positive Susceptibility card (AST-
P603) (BioMérieux, Marcy l’Etoile, France). The results were interpreted according to the 
CLSI guidelines (CLSI, 2016). 
6.2.5. DNA isolation  
Genomic DNA (gDNA) was extracted using GenElute® bacterial genomic DNA kit (Sigma-
Aldrich, St. Louis, MO, USA) according to the manufacturer’s instructions. The quantification 
of extracted gDNA was determined on a NanoDrop spectrophotometer with verification by 
agarose gel electrophoresis and fluorimetric analysis (Qubit®).  
6.2.6. Genome sequencing  
Multiplexed paired-end libraries (2×300 bp) were prepared using the Nextera XT DNA sample 
preparation kit (Illumina, San Diego, CA, USA) and followed by sequencing on an Illumina 
MiSeq platform with a depth of 100× per sample at the National Institute of Communicable 
Diseases Sequencing Core Facility, South Africa. 
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6.2.7. Genome assembly  
The resulting raw reads were checked for quality, trimmed and mapped to the reference genome 
of S. aureus RIVM3897 (CP013621) using the CLC Genomics Workbench version 10 (CLC, 
Bio-QIAGEN, Aarhus, Denmark). De novo assembling was further performed for all genomes 
with CLC Genomics and SPAdes version 3.5. (Bankevich et al., 2012) to overrule any inherent 
shortfall from both assembler.  
6.2.8. Genome analysis  
The de novo assembled contigs were uploaded to GenBank and annotated using NCBI 
prokaryotic genome annotation pipeline and RAST 2.0 server (http://rast.nmpdr.org; Aziz et 
al., 2008) which identified encoding proteins, rRNA and tRNA, assigned functions to the genes 
and predicted subsystems represented in the genome. The bacterial analysis pipeline of GoSeqIt 
tools was also used to annotate and identify known acquired antibiotic resistant genes via 
ResFinder (Zankari et al., 2012), virulence factors using VirulenceFinder (Joensen KG et al., 
2014) and mobile genetic elements through PlasmidFinder (Carattoli et al., 2014). The RAST 
SEED viewer was used to identify the presence of transposases, integrons and mobilization 
proteins flanking the resistance genes (Overbeek et al., 2014). PHAge Search Tool (PHAST) 
server was used for the identification, annotation and visualization of prophage sequences 
(Zhou et al., 2011). The multilocus sequence type (MLST) of the isolates was determined from 
the WGS data based on seven housekeeping genes (arc, aroe, glpf, gmk, pta, tpi, yqil). 
6.2.9. Whole genome phylogenetic analyses  
The assembled contigs were aligned against a reference genome of LA-MRSA ST398 
(CP013621) using the progressive Mauve genome alignment package version 2.3.1. Study 
genomes were contextualized against a collection of four LA-MRSA ST398 and one LA-
MRSA ST5, accession numbers AM990992, CP003808, CP020019, CP013621 and 
CP017090, respectively. Phylogenetic analysis was based on the core genomes and performed 
using the Rapid large-scale prokaryote pan genome analysis (Roary) (Page et al., 2015). 
The maximum likelihood phylogenetic tree encompassing, country, population, sample type 
metadata and MLST type was generated, edited and visualized using FastTree version 2.1.7. 
In addition, the contigs were mapped against the complete genome of S. aureus RIVM3897 




6.2.10. Nucleotide sequence accession number 
This whole-genome shotgun project PRJNA412434 of LA-MRSA strains PR041, PR243B0, 
PN243B0, PN246B0 and PN235B0 has been deposited at DDBJ/EMBL/GenBank under 
accession numbers PDVL00000000, PDVA00000000, PDUZ00000000, PDVB00000000 and 
PDUY00000000, respectively. The versions described in this paper are the versions 
PDVL00000000.1, PDVA00000000.1, PDUZ00000000.1, PDVB00000000.1 and 
PDUY00000000.1, respectively. 
6.3. Results  
6.3.1. Phenotypic analyses  
Out of the 288 pooled samples (144 nasal and 144 rectal pools) taken from 432 pigs in the five 
abattoirs, methicillin resistant staphylococci (MRS) were isolated from 108/144 (75%) and 
102/144 (70%) of the pooled nasal and rectal samples, respectively. In South Africa, 50% 
(36/72) and 81% (58/72) MRS were isolated in nasal and rectal pooled samples, whereas a 
maximum level of MRS (100%) was detected in both type of pooled samples in Cameroon. 
Despite all being mannitol-fermenting colonies, only one (0.07%) and four (16.66%) MRSA 
were detected in Cameroon and South Africa, respectively, whereas none of the workers were 
colonized by MRSA (unpublished data). Table 6.1 summarizes relevant population data, 
specimen source, and, phenotypic and genotypic characteristics. All South African strains 
(PN235B0, PN243B0, PR243B0 and PN246B0) exhibited the same phenotypic resistance 
profile P.FOX.OX.E.CLI.TET whereas the Cameroonian strain displayed the profile 
P.FOX.OX.TET with susceptibility to all other antibiotics tested (unpublished data). The MICs 
results of the MRSA isolates are summarized in Table 6.2, with the resistance observed being 
corroborated with WGS analyses.  
6.3.2. Genotypic analyses 
The WGS analyses revealed the presence of resistance genes and virulence factors in all 
isolates. Beta-lactamase encoding genes, especially blaZ and mecA were identified in all except 
one strain PN246B0 that did not harbor blaZ gene. Likewise, the co-presence of erm(B) and 
erm(C) encoding for resistance to macrolide, lincosamide, streptogramin B resistance (MLSB) 
was observed in all strains as were tetracycline resistance genes tet(M) and tet(K), with one 
strain PR041, additionally carrying the tet(L) gene (Tables 6.1 and 6.2). Although not 
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phenotypically resistant to fluoroquinolone, all MRSA strains harbored genes encoding related 
resistance products including the fluoroquinolone efflux transporter protein norA as well as 
two sub-unit topoisomerase IV (parC, parE) and DNA gyrase (gyrA, gyrB). In all strains, the 
tet(M) gene was flanked downstream by a plasmid recombination, MobE mobilization protein 
suggesting that this gene could likely be horizontally transferred to other species.  
Six virulence genes including aureolysin (aur), beta-hemolysin (hlb), gamma-hemolysin chain 
II precursor (hlgA), gamma-hemolysin component B precursor (hlgB), gamma-hemolysin 
component B precursor (hlgC) and enterotoxin B (seb) were identified in all isolates with the 
lukS-PV being detected in only one strain, PR243B0 (Table 6.1).  
6.3.3. In silico detection of plasmids and prophage sequences  
PlasmidFinder revealed that the plasmid replicon types repL(pDLK1), rep(SAP101A) and 
repC(Cassette) were detected in all strains. Two isolates PN235B0 [repL(pDLK1); 
rep(pKH13); rep(SAP101A); rep(SAP071A); repC(Cassette)] and PR041 [repL(pDLK1); 
rep(pKH13); rep(SAP101A); rep(pWBG754); repC(Cassette); repB(pUB110)] concomitantly 
harbored five plasmid replicon types. The three remaining isolates each harbored four plasmid 
replicon types (Table 6.3). A plasmid rolling-circle replication (RCR) was further hosted on all 
strains. 
Similarly, PHAST server revealed that all strains harbored prophage regions that were either 
intact or incomplete (Table 6.4). The Staphylococcus phage phiJB (phage accession 
NC_028669) and bacteriophage 47 (phage accession NC_007054), were hosted intact on the 
genome of three isolates, namely PN235B0, PR243B0 (Figure 1) and PN243B0. The phage 
Staphy_StauST398-2 was also detected but incomplete in two strains (PN235B0 and 
PN246B0).  
6.3.4. Multi-locus sequence typing  
MLST-analyses assigned all MRSA strains to ST398 with 100% identity among all seven 
housekeeping genes. The South African strains were isolated from three nasal and one rectal 
pooled samples from one of the biggest abattoir located in the KwaZulu-Natal province, while 
the Cameroonian strain originated from one rectal pooled sample from the principal abattoir of 
Yaoundé (Table 6.1).  
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6.3.5. Phylogenetic analysis 
The phylogenetic analysis revealed that all our strains fall within a clade of the known LA-
MRSA ST398. Figure 6.2 demonstrates that considerable similarity exists between our 
collection of LA-MRSA and two strains AM990992 and CP0220019 isolated from a human 
with endocarditis in Netherlands and fattened pig in Germany, respectively. On the other hand, 
a certain phylogenetic difference was observed when compared with LA-MRSA CP013621 
and CP003808 detected in human samples in Netherlands and Canada, respectively. Figure 6.3 
depicts the genomic organization of the MRSA PR243B0 mapped against the complete genome 
of S. aureus RIVM3897 (CP013621). 
6.4. Discussion 
In this study, whole genome sequencing was used to investigate antibiotic resistance genes, 
virulence factors, mobile genetic elements and genetic lineages of five circulating and closely 
related MRSA strains isolated from pigs in Cameroonian and South African abattoirs. Our 
findings reveal that the MRSA clonal lineage ST398 is present in pigs with a relatively low 
prevalence in both Cameroon (0.07%) and South Africa (16.66%) although none of the exposed 
workers were colonized. This concurs with a 2017 study from England, where a 0.82% LA-
MRSA prevalence was detected in humans during a one year-period (Harrison et al., 2017). To 
the best of our knowledge, this is the first report of a porcine LA-MRSA ST398 reservoir in 
these two nations. Moreover, the first report of MRSA ST398 harboring lukS-PV, one of the 
pro-toxin subunit encoding for PVL gene is also reported herein.  
This lineage was primarily detected in Europe where it colonized pigs and occupationally 
exposed workers (Armand-Lefevre et al., 2005; Voss et al., 2005; van Loo et al., 2007; Van 
Cleef et al., 2011) before being subsequently identified with various prevalence and clonal 
lineage in the USA (Smith, 2015), Canada (Khanna et al., 2008; Golding et al., 2010), Australia 
(Groves et al., 2013), South America (Arriola et al., 2011) and Asia (Wagenaar et al., 2009; 
Lim et al., 2012). In the African continent, the prevalence of MRSA colonization in animals is 
very low, ranging from 0% to 3% (Lozano et al., 2016) with only two studies emanating from 
Tunisia reporting the clonal lineage ST398 on the continent (Chairat et al., 2015; Elhani et al., 
2015). Chairat et al. (2015) reported a 1.2% (2/169) prevalence of MRSA in raw meat with 
only one being ST398 and harboring in addition to beta-lactam encoding genes, tet(M), erm(C), 
and four virulence genes (including sen, hla, hlg and hlgv), while Elhani et al. (2015) revealed 
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that one strain out of 24 tetracycline-resistant MRSA belonged to the ST398 and was isolated 
from nasal sample of a hospitalized farmer patient in Tunisia.  
The arsenal of S. aureus virulence factors is extensive, with both secreted and structural 
products involved in its pathogenicity and its ability to circumvent the host immune system 
(Otto, 2014). An interesting finding of this study, is the detection of various virulence 
determinants in all our isolates. In fact, the staphylococcal enterotoxin B (seb), considered a 
biological warfare weapon, was identified along with β-hemolysins (hlb) and γ-hemolysins 
(hlgA, hlgB and hlgC). Staphylococcal enterotoxins induce the release of serotonin into the 
intestine and thereby play a causative role in staphylococcal food poisoning while hemolysins 
are pore-forming exotoxins causing lysis and subsequently, death of blood cells including 
erythrocytes, endothelial cells, platelets and leukocytes (Fluit, 2012; Otto, 2014). The success 
of several community-acquired (CA)-MRSA clones such as the USA300 (ST8), the Taiwan 
clone USA1000 (ST59), the European clone (ST80) has been attributed to the presence of 
staphylococcal enterotoxin and hemolysins (David and Daum, 2010; Sowash and Uhleman, 
2014; Li et al., 2016). Although we did not quantify the production levels and mobilization of 
the virulence determinants, we postulated that, as with the global success of CA-MRSA, the 
repertoire of virulence factors identified in the LA-MRSA isolates in this study could signal 
their potential high pathogenicity if they become human pathogens. Moreno et al. (2016) 
already described a vancomycin intermediate LA-MRSA ST398 strain SA7112 responsible of 
exudative epidermitis in swine in Brazil (Moreno et al., 2016). Similarly, Lima et al. (2017) 
reported the genome of a multidrug-resistant LA-MRSA ST398 from a patient with cystic 
fibrosis in the same country. Interestingly, these Brazilian vancomycin intermediate and multi-
drug resistant LA-MRSA isolates displayed similar virulence characteristics to that of our 
isolates with the presence of aureolysin (aur), staphylococcal β-hemolysins (hlb) and γ-
hemolysins (hlgA, hlgB and hlgC). The above-mentioned studies give credence to our 
hypothesis that the detection of LA-MRSA in livestock is a public health threat with the 
potential for dissemination to humans via the food chain in Cameroon and South Africa. They 
further attest to the broad host range and rapid genetic evolution of LA-MRSA clones.  
The acquisition of the human virulence mechanism lukS-PV, subunit of the synergistic PVL 
toxin, by the LA-MRSA strain PR243B0 is another great concern. In a multicenter study 
involving five African towns, including Yaoundé, Breurec et al. (2010) showed that the three 
predominant clones detected in Yaoundé, were the major PVL-positive lineages ST5, ST8 and 
ST88, closely related to the hypervirulent USA300 (ST8). They harbored several virulence 
genes, including luk-PV, hlb and seb (Breurec et al., 2010). As with the LA-MRSA ST5, that 
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showed human-to-poultry host transition events, accompanied by host-adaptive evolution, 
genetic changes, including acquisition of novel mobile genetic elements (MGEs) and spread to 
poultry populations (Murray et al., 2017), it is highly plausible that the selective pressure and 
intimate contact between humans and animals will be driving forces behind the genetic 
exchanges and emerging fluidity of virulence genes that will enable LA-MRSA ST398 to 
undergo similar host-adaptive evolution and become a well-established human pathogen. It is 
therefore of paramount importance to closely monitor food animals and food products to 
alleviate the risk of development and contain the spread of emerging virulent and resistant 
strains. 
The typical presence of the mecA gene encoding methicillin resistance and complete resistance 
to the β-lactam family was evident in this clone along with several S. aureus genes supporting 
resistance against various antibiotic families that enhanced antibiotic resistance of these animal 
strains. The genomic analysis of our isolates attributed tetracycline resistance to the 
concomitant presence of tet(K) and tet(M) while the presence of erm(B) and erm(C) resulted 
in macrolide and lincosamide resistance in five out of six strains. This finding concurs with the 
study by Harrison et al. (2017) where erm(C), tet(K) and tet(M) were all present in the single 
ST398 detected in clinical isolates in England. All tet(K) gene detected in our study, were 
flanked by a plasmid rolling-circle replication (RCR) and a mobilization MobE protein, a 
conjugative mobilization protein that generally enables plasmid recombination in site specific 
manner. The presence of these genetic elements may contribute to tet(K) mobilization, 
especially when considering the extensive use of tetracycline in livestock. Wassenaar et al. 
(2016) showed that the qacC gene encoding resistance to quaternary ammonium compounds 
in staphylococci, was mobilized and transferred to rolling-circle plasmids in the absence of 
other genetic elements such as insertion sequences, plasmids or transposons and postulated 
rolling-circle plasmids as a novel gene transfer mechanism in staphylococci (Wassenaar et al., 
2016).  
Of further interest, is the presence of tet(L) along with tet(M) and tet(K) within the genome of 
the Cameroonian isolate PR041. While tet(M) and tet(K) are widespread and quite constant 
among LA-MRSA isolate, tet(L) is an uncommon resistance gene in staphylococci. In fact, it 
is a plasmid-mediated tetracycline resistance gene that first emerged in Bacillus spp. and 
subsequently spread to staphylococci via horizontal gene transfer (HGT). In this isolate 
(PR041), the tet(L) gene was hosted on a plasmid that had 100% homology with an, as yet, 
unnamed plasmid encoding tetracycline determinants tet(M) and tet(L), detected in a clinical 
isolate of Enterococcus faecium strain UW 8175 (accession number CP011830.1). This 
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suggests that HGT occurs not only within LA-MRSA and staphylococcal species but also 
between different bacterial species. 
Phenotypic characterization showed that all isolates were susceptible to ciprofloxacin (MIC 
≤0.5 µg/ml) and moxifloxacin (MIC ≤0.25 µg/ml). This initially led us to not suspect that they 
might contain gene encoding for resistance to fluoroquinolones. However, nor(A), parC, parE, 
gyrA and gyrB were detected in all isolates. Similarly, although not expressing phenotypic 
resistance to erythromycin (MIC ≤0.25 µg/ml) and clindamycin (MIC ≤0.25 µg/ml), the 
Cameroonian isolate PR041, harbored erm(B) and erm(C) genes, encoding for resistance to 
macrolides, lincosamides and streptogramin B. This finding thus indicate that these genes 
might be “silent” in circulating LA-MRSA in pigs in Cameroon and South Africa, and could 
likely be activated in response to the selective pressure of extensive antibiotic use. Although, 
novel or uncommon resistance genes such as the multi-resistant gene cfr, the phenicol exporter 
gene fexA, the lincosamide–streptogramin A–pleuromutilin resistance genes vga(C) and 
vga(E), the macrolide–lincosamide–streptogramin B resistance gene erm(T), the apramycin 
resistance gene apmA and the trimethoprim resistance gene dfrK, were not detected, the 
presence of several other resistance genes along with various virulence factors could contribute 
to the pathogenicity of the clonal lineage ST398. Even though none of the exposed workers 
were colonized by MRSA strains in this study, this porcine LA-MRSA ST398 reservoir 
highlights the high risk of foodborne infectious diseases and pandemic potential of this clone. 
Ateba et al. (2010) and Yannick et al. (2013) reported the presence of MRSA in raw milk 
(100%) and cooked pork (81.8%) in South Africa and Cameroon, respectively, suggesting 
dissemination of this pathogen throughout the food chain. The greatest threat in this respect, 
will therefore be the emergence and human adaptation of LA-MRSA ST398 with major 
virulence factors along with various resistance genes. 
The constant evolving, versatility and virulence mechanisms of S. aureus as well as the 
potential for genetic exchanges between LA-MRSA and other bacteria among several hosts are 
of significant issues. In fact, its successful pathogenicity and versatile host adaptation is 
facilitated by the acquisition of virulence factors encoded in MGEs such as prophages, 
plasmids, integrons, and genomic islands (Moon et al., 2014). Prophages play a role in rapid 
evolution, trigger adaptation to new environments and host species, and increase the 
pathogenicity of LA-MRSA ST398 (Diene et al, 2017). The φJB prophage of the family of 
Siphoviridae was detected in three out of five isolates. Varga et al. (2016) showed that φJB has 
efficient plasmid transduction abilities and can easily transfer antibiotic resistance genes with 
high frequency (Varga et al., 2016). The detected φJB showed a putative phage attachment site 
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which is involved in the transduction process. Although we did not specifically address the 
dissemination of resistance genes and virulence factors through the prophages detected in our 
LA-MRSA isolates, we hypothesized that with the various evolutionary changes and host 
adaptations inherent to LA-MRSA, mobilization of these genetic elements within and between 
bacterial species with ongoing acquisition of virulence and multiple antibiotic resistant genes 
will likely happen in a near future and cause more severe infections in animals and humans. 
In addition, three plasmids, repL(pDLK1), rep(SAP101A) and repC (Cassette), were conserved 
within our isolates. In silico analysis of these plasmids revealed that all rep(SAP101A) had 
99% homology with the S. aureus plasmid pRIVM4296 (accession number CP013626.1) 
detected in LA-MRSA ST398 in human clinical samples in Netherlands. Likewise, the 
repL(pDLK1), shared 100% homology with the Staphylococcus chromogenes 3688 plasmid 
pPV141 (accession number U82607.1), which is a plasmid associated with erythromycin 
resistance while the repC(Cassette) detected here, hosted all the tet(K) genes and was similar 
to a plasmid recombination protein (accession number WP 014532526.1). These findings 
reveal the ability of these strains to easily acquire either resistance and/or virulence genes, 
although further work is required to delineate whether these plasmids could be easily 
horizontally transferred to other epidemic MRSA strains. Accordingly, studies are needed 
around the world to correlate the genetic diversity associated with the epidemiological shifts 
and dissemination of LA-MRSA strain. Such studies are especially needed in low-and-middle-
income countries where policies about antimicrobial use and antimicrobial stewardship 
programs in food animal production are particularly limited. 
6.5. Conclusion 
Our study shows that the livestock-associated MRSA clonal lineage ST398 is already present 
in both Cameroon and South Africa and is probably underestimated considering the absence of 
molecular epidemiological studies in the farm-to-plate continuum. The emergence of LA-
MRSA ST398 is of great concern as it could disseminate throughout the food chain and 
contaminate other animals and humans, and potentially spread to healthcare settings where 
human infections would be inevitable. In keeping with this, routine screening for MRSA 
colonization in food animals, exposed workers, farms, abattoirs and food products is 
recommended for its effective containment. Continuous efforts and further well-designed 
epidemiological and molecular works not only for the conservation of antibiotics for future 
generations but also for understanding of the MRSA epidemiology, transmission dynamics and 
pathways, risk factors, extent of and related public health implications associated with the food 
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animal reservoir have still to be implemented to identify and design effective interventions 
measures for its containment. 
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Isolate name Country Sample type Abattoir Antibiotic resistance genes Virulence factors MLST 




mecA, blaZ, erm(B), erm(C), tet(M), tet(K), 
nor(A), parC, parE, gyrA, gyrB 
aur, hlb, hlgA, hlgB, hlgC, seb ST398 




mecA, blaZ, erm(B), erm(C), tet(M), tet(K), 
nor(A), parC, parE, gyrA, gyrB 
aur, hlb, hlgA, hlgB, hlgC, seb ST398 




mecA, blaZ, erm(B), erm(C), tet(M), tet(K), 
nor(A), parC, parE, gyrA, gyrB 
aur, hlb, hlgA, hlgB, hlgC, seb, lukS-
PV 
ST398 




mecA, erm(B), erm(C), tet(M), tet(K), 
nor(A), parC, parE, gyrA, gyrB 





mecA, blaZ, erm(B), erm(C), tet(M), tet(K), 
tet(L), nor(A), parC, parE, gyrA, gyrB 
aur, hlb, hlgA, hlgB, hlgC, seb ST398 
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Table 6.2. Minimum inhibitory concentration (MIC) of β-lactam and non-β-lactam antibiotics tested against individual MRSA isolates 
 
PEN: benzylpenicillin, OX: oxacillin, GEN: gentamicin, CIP: ciprofloxacin, MOX: moxifloxacin, E: erythromycin, CLI: clindamycin, LIN: linezolid, TEI: teicoplanin, VAN: 









β-lactams non-β-lactam antibiotics 
Antibiotic resistance genes 
PEN FOX OX GEN CIP MOX E CLI LIN TEI VAN TET TIG FA MUP RIF TMP/SXT 
PN235B0 ≥0.5 ≥4 ≥4 ≤0.5 ≤0.5 ≤0.25 ≥8 ≥8 1 ≤0.5 ≤0.5 ≥16 ≤0.12 ≤0.5 ≤2 ≤0.5 ≤10 
mecA, blaZ, erm(B), erm(C), tet(M), 
tet(K), nor(A), parC, parE, gyrA, gyrB 
PN243B0 ≥0.5 ≥4 ≥4 ≤0.5 ≤0.5 ≤0.25 ≥8 ≥8 1 ≤0.5 1 ≥16 ≤0.12 ≤0.5 ≤2 ≤0.5 ≤10 
mecA, blaZ, erm(B), erm(C), tet(M), 
tet(K), nor(A), parC, parE, gyrA, gyrB 
PR243B0 ≥0.5 ≥4 ≥4 ≤0.5 ≤0.5 ≤0.25 ≥8 ≥8 1 ≤0.5 1 ≥16 ≤0.12 ≤0.5 ≤2 ≤0.5 ≤10 
mecA, blaZ, erm(B), erm(C), tet(M), 
tet(K), nor(A), parC, parE, gyrA, gyrB 
PN246B0 ≥0.5 ≥4 ≥4 ≤0.5 ≤0.5 ≤0.25 ≥8 ≥8 1 ≤0.5 1 ≥16 ≤0.12 ≤0.5 ≤2 ≤0.5 ≤10 
mecA, erm(B), erm(C), tet(M), tet(K), 
nor(A), parC, parE, gyrA, gyrB 
PR041 ≥0.5 ≥4 ≥4 ≤0.5 ≤0.5 ≤0.25 ≤0.25 ≤0.25 2 ≤0.5 ≤0.5 ≥16 ≤0.12 ≤0.5 ≤2 ≤0.5 ≤10 
mecA, blaZ, erm(B), erm(C), tet(M), 































repL(pDLK1) 2173-2649 100 1261-1737 100 2380-2856 100 3676-4152 100 946-1422 100 
rep(pKH13) 3788-4627 91.91 3766-4605 91.91 3775-4614 91.91     
rep(SAP101A) 1346-2054 87.47 1324-2032 87.45 1333-2041 87.45 1449-2157 87.45 1449-2157 87.45 
rep(SAP071A) 2-470 83.80         
repC (Cassette) 3674-4628 98.85 3836-4790 98.85 3650-4604 98.85 3650-4604 98.85 3650-4604 100 
rep(pWBG754)       3825-4823 89.69 3825-4823 89.69 
repB(pUB110)         273-980 100 
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Table 6.4. Distribution of the prophage regions among the MRSA strains 
 
Isolate name Region* 
Length# 
(kb) 
Completeness No. CDS GC% Phage (hit genes count)& 
PN235B0 
1 58.1 Intact 60 33.89 Staphy 47 (28) 
2 59.1 Intact 70 34.56 Staphy phiJB (26) 
3 26.2 Incomplete 15 31.88 Acineto phiAbaA1 (3) 
4 10.3 Incomplete 10 30.13 Staphy Stau 398-2 (2) 
PN243B0 
1 23.8 Incomplete 17 31.52 Lactoc PLgT-1 (4) 
2 58 Intact 60 33.89 Staphy 47 (28) 
3 57.2 Intact 60 34.53 Staphy phiJB (27) 
4 17.1 Incomplete 17 32.32 Mycoba Phrann (4) 
5 6.6 Incomplete 10 29.76 Entero lato (2) 
PR243B0 
1 45.3 Intact 58 31.52 Staphy 47 (27) 
2 48.7 Intact 70 33.89 Staphy phiJB (26) 
3 18.4 Incomplete 14 34.53 Acineto phiAbaA1 (3) 
4 25.9 Incomplete 16 32.32 Entero lato (2) 
5 15.7 Incomplete 13 29.76 Entero lato (5) 
PN246B0 
1 22.6 Incomplete 16 30.14 Staphy Stau 398-2 (2) 
2 27.7 Incomplete 16 31.30 Gordon GAL1 (3) 
3 30.1 Incomplete 19 36.07 Strept phiARI0460 (3) 
PR041 
1 20.2 Incomplete 9 32.89 Bacill SP 15 (1) 
2 32 Incomplete 14 33.93 Bacill AR9 (4) 
*Intact and incomplete prophage region; #Region length of prophage regions; &Phage with the highest number 

































   A            B 
Figure 6.1. Graphical representation (A: circular view and B: linear view) of the prophage regions hosted in the MRSA strain PR243B0. Putative 










Figure 6.2. A maximum-likelihood phylogenetic tree of LA-MRSA ST398 isolates generated using FastTree version 2.1.7. The South African and Cameroonian 
isolates are coloured in red and blue, respectively. The following information is also provided for each isolated: name/reference, sequence type, type of sample, population, 







































Figure 6.3. MRSA PR243B0 ring representation using CGView Server V 1.0 (Grant et al. 2012). The inner 
ring displays the percent of identity comparing MRSA PR243B0 and the finished genome of S. aureus 
RIVM3897 (CP013621). The next two (inner) rings show the GC content and GC skew. The next ring alternating 
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Objectives met: This original research article investigates the antibiotic resistance genes, 
virulence factors, mobile genetic elements and genetic lineages of circulating ESBL-producing 
K. pneumoniae strains isolated from pigs and exposed workers in Cameroonian abattoirs using 






                                                 
8 This paper has been submitted to Frontiers in Microbiology and is currently under review.  It will reference the 
“Emergence and Spread of Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL-PE) in 
Pigs and Exposed Workers: A Multicentre Comparative Study Between Cameroon and South Africa” paper, 
which has been submitted and is expected to be published first. 
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Background and objectives:  Extended-spectrum β-lactamase (ESBL)-producing Klebsiella 
pneumoniae is a serious public health issue globally. In this study, the antibiotic resistance 
genes, virulence factors, mobile genetic elements and genetic lineages of circulating ESBL-
producing K. pneumoniae strains isolated from pigs and humans in Cameroonian abattoirs were 
investigated using whole genome sequencing (WGS), in order to ascertain zoonotic 
transmission (viz. from animals to humans and/or vice-versa) in the food chain. 
Methods: During March–October 2016, 288 nasal and rectal pooled samples from 432 pigs as 
well as nasal and hand swabs from 82 humans were collected. Seven circulating ESBL-
producing K. pneumoniae were selected and their genomic DNA sequenced using an Illumina 
MiSeq platform. Generated reads were de novo assembled using the Qiagen CLC Genomics 
Workbench and SPAdes. The assembled contigs were annotated using RAST and antibiotic 
resistance genes, virulence factors, plasmids and bacteriophages were identified with 
ResFinder, Virulence Finder, PlasmidFinder and PHAST, respectively.  
Results: ESBL-producing K. pneumoniae were detected in pigs (28%) and exposed workers 
(18%). The circulating K. pneumoniae strains were dominated principally by the sequence type 
(ST) 14 and 39. In addition, the “high-risk” ST307 clone and two novel STs assigned ST2958 
and ST2959 were detected. Genomic analysis identified various antibiotic resistance genes 
associated with resistance to β–lactams, aminoglycosides fluoroquinolones, macrolide, 
lincosamide and streptogramins, rifampicin, sulphonamide, trimethoprim, phenicol and 
tetracycline. Intermingled K. pneumoniae populations were observed between pig- and human-
source within and across abattoirs in the country. 
Conclusion: Our study shows that ESBL-producing K. pneumoniae is actively disseminating 
in the food chain in Cameroon and is probably underestimated in the absence of molecular 
epidemiological studies. It suggests pigs, abattoir workers and food products as potential 
reservoirs and sources of foodborne ESBL-producing K. pneumoniae infections in Cameroon. 
It underlines the existence of an unheeded food safety and public health threat associated with 
these resistant strains and reinforces the crucial importance of implementing appropriate food 





Klebsiella pneumoniae is an important Gram-negative bacillus associated with several clinical 
infections in humans (Perovic et al., 2014). Of particular concern is the emergence of extended-
spectrum β-lactamase (ESBL) producing K. pneumoniae in hospital settings (Perovic et al., 
2014) which has considerably increased during the last decade in response to the selection 
pressure of extensive antibiotic use. This resistant strain is considered a significant public 
health issue due to the limited therapeutic options and increased morbidity and mortality 
associated with it (WHO, 2017). However, the concern of ESBL-producing K. pneumoniae 
goes beyond healthcare settings to affect various ecological niches including (food) animals, 
food products, soil and wastewater. In fact, humans may become colonized or infected by 
ESBL-producing K. pneumoniae upon contact with blood, saliva, feces and urine of ESBL 
carrier animals or consumption of contaminated water or food products (Founou et al., 2016).  
The most frequent and clinically relevant ESBL genes belong to Temoneira (TEM), 
Sulfhydryl-variable (SHV) and Cefotaximase-München (CTX-M) families, with CTX-M 
enzymes emerging as the predominant type. CTX-M is divided into five groups namely CTX-
M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25 according to their amino-acid identities 
(Perovic et al., 2014). K. pneumoniae commonly produces all three groups of enzymes but the 
latest public health concern has been the emergence of carbapenemase-producing K. 
pneumoniae and colistin-resistant K. pneumoniae (Hudson et al., 2014; Perovic et al., 2016). 
These resistance genes are generally carried on mobile genetic elements (MGEs) facilitating 
their dissemination within and between bacterial species (Founou et al., 2016). The presence 
of MGEs likely increases the proportion of serious difficult-to-treat K. pneumoniae infections.  
The true prevalence of ESBL is not well-known in Africa and probably underestimated due to 
the gaps encountered in their detection on the continent. Nevertheless, some studies, have 
confirmed the global distribution and the high prevalence of ESBL-producing organisms in the 
region, albeit focusing on human health sector and ignoring the animal one (Gangoue-Pieboji 
et al., 2005; Breurec et al., 2013; Belbel et al., 2014; Lyonga et al., 2015; Jacobson et al., 2015; 
Nzalie et al., 2016). In Cameroon, antibiotics are used without restriction not only in the 
healthcare sector but also in the food production industry, where epidemiology of antibiotic 
resistant bacteria in food animals and associated public health implications is neglected. This 
study investigated the antibiotic resistance genes, virulence factors, mobile genetic elements 
and genetic lineages of circulating ESBL-producing K. pneumoniae strains isolated from pigs 
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and humans in Cameroonian abattoirs using whole genome sequencing (WGS), to ascertain 
zoonotic transmission (viz. from animals to humans and/or vice-versa) of ESBL-producing K. 
pneumoniae in the food chain. 
7.2. Materials and methods 
7.2.1. Ethical approvals 
Ethical approvals were obtained from the Biomedical Research Ethics Committee (Ref. 
BE365/15) and Animal Research Ethics Committee (Ref. AREC/091/015D) of the University 
of KwaZulu-Natal as well as from the National Ethics Committee for Research in Human 
Health of Cameroon (Ref. 2016/01/684/CE/CNERSH/SP) prior to the implementation of the 
study. Ministerial approvals were also obtained from the Cameroonian Ministry of Livestock, 
Fisheries and Animal Industries (Ref. 061/L/MINEPIA/SG/DREPIA/CE) and Ministry of 
Scientific Research and Innovation (Ref. 015/MINRESI/B00/C00/C10/C14). 
7.2.2. Study design and bacterial isolates 
From March to October 2016, a multi-center study was carried out in three 
slaughterhouses/markets in Cameroon and two abattoirs in South Africa, encoded for ethical 
reasons as SH001, SH002, SH003 and SH004 and SH005, respectively (unpublished data). 
Three individual samples were pooled to yield 144 nasal and 144 rectal pools representing 432 
original nasal and rectal samples respectively collected from 432 pigs. A total of 288 swabs 
from the 144 nasal and 144 rectal pools constituted the final sample. Nasal and hand swabs 
were also collected from 82 humans in both Cameroon and South Africa. All samples were 
cultured on MacConkey agar supplemented with 2 mg/L cefotaxime and incubated for 18-24 
h at 370C in normal atmosphere (unpublished data). All putative ESBL-producers, were 
subjected to Gram staining, and the catalase and oxidase tests for phenotypic characterization 
of the isolates to the genus level. The isolates were thereafter phenotypically confirmed using 
the Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France). The strains sequenced in this study 
were isolated from four pig pooled samples (PN030E4, PN089E1, PN085E1IA and PR042E3) 
and three exposed workers (HH510E2I, HH517E1II and HN523E1II) in Cameroon 
(unpublished data). The pig isolates, PN30E4 and PR042E3, originated from the same abattoir 
(SH001), although the former was collected from the nares and the latter from rectum. 
Likewise, the strains, PN089E1 and PN085E1IA, were both collected from the nares of pigs 
processed in abattoir SH002. The human strains, HH510E2I, HH517E1II and HN523E1II, 
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originated from three different abattoirs, SH001, SH002 and SH003, respectively, with 
HH510E2I and HH517E1II being collected from hands and HN523E1II from the nares. These 
strains were identified in a previous study, to be highly closely related via enterobacterial-
repetitive-polymerase chain reaction (ERIC-PCR) analysis where they were grouped into five 
clusters (unpublished data). Given that we aimed to highlight and provide evidence of zoonotic 
transmission (i.e. from animals to humans and vice-versa) of ESBL-K. pneumoniae in the food 
chain, within each generated cluster, only representative isolates of intermingled strains (i.e. 
strains isolated from animal and/or human of the same abattoir, having high genetic 
relationship with those from another abattoir) were considered for WGS. 
7.2.3. Screening for ESBL 
The standard double disk synergy test (DDST), using cefotaxime and ceftazidime, alone and 
in combination with clavulanic acid as recommended by the Clinical Laboratory and Standards 
Institute (CLSI) was performed for ESBL screening. An increase in size of the inhibition zone 
of more than 5 mm in the presence of clavulanic acid was regarded as proof for ESBL 
production (CLSI, 2016).  
7.2.4. Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing was performed to determine the resistance patterns of the 
selected strains. The minimum inhibitory concentrations (MIC) of ampicillin, amoxicillin + 
clavulanic acid, cefuroxime, cefotaxime, ceftazidime, cefoxitin, cefepime, ertapenem, 
imipenem, meropenem, gentamicin, amikacin, ciprofloxacin, tigecycline, nitrofurantoin, 
piperacillin/tazobactam, colistin and trimethoprim-sulfamethoxazole, were determined by 
broth microdilution method using Vitek® 2 System (BioMérieuX, Marcy l’Etoile, France) and 
Vitek® 2 Gram Negative Susceptibility card (AST-N255) (BioMérieux, Marcy l’Etoile, 
France). The results were interpreted according to the CLSI guidelines (CLSI, 2016) with the 
exception of colistin, amoxicillin + clavulanic acid, piperacillin/tazobactam, amikacin that 
were based on EUCAST breakpoints (EUCAST, 2016) with E. coli ATCC 25922 and K. 
pneumoniae ATCC700603 being used as controls.  
7.2.5. DNA isolation and sequencing 
Genomic DNA (gDNA) was extracted using GenElute® bacterial genomic DNA kit (Sigma-
Aldrich, St. Louis, MO, USA) according to the manufacturer’s instructions. The quantification 
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of extracted gDNA was determined on a NanoDrop spectrophotometer with verification by 
agarose gel electrophoresis and fluorimetric analysis (Qubit®). Multiplexed paired-end 
libraries (2×300 bp) were prepared using the Nextera XT DNA sample preparation kit 
(Illumina, San Diego, CA, USA) and sequences determined on an Illumina MiSeq platform 
with 100× coverage at the National Institute of Communicable Diseases Sequencing Core 
Facility, South Africa. 
7.2.6. Genome assembly  
The resulting raw reads were checked for quality, trimmed and de novo assembled into contigs 
using CLC Genomics Workbench version 10 (CLC, Bio-QIAGEN, Aarhus, Denmark) and 
SPAdes version 3.11 (Bankevich et al., 2012) to overrule any inherent shortfalls from both 
assemblers. 
7.2.7. Genome analysis  
The de novo assembled reads were uploaded in GenBank and annotated using NCBI 
prokaryotic genome annotation pipeline and RAST 2.0 server (http://rast.nmpdr.org; Aziz et 
al., 2008) which identified encoding proteins, rRNA and tRNA, assigned functions to the genes 
and predicted subsystems represented in the genome. The bacterial analysis pipeline of GoSeqIt 
tools was also used to annotate and identify known acquired antibiotic resistant genes via 
ResFinder (Zankari et al., 2012), virulence factors using VirulenceFinder (Joensen et al., 2014) 
and mobile genetic elements through PlasmidFinder (Carattoli et al., 2014). The RAST SEED 
viewer was used to identify the presence of transposases and integrons flanking the beta-
lactamase genes (Overbeek et al., 2014). PHAge Search Tool (PHAST) server was used for the 
identification, annotation and visualization of prophage sequences (Zhou et al., 2011). 
7.2.8. Multilocus sequence typing (MLST) 
In silico MLST-analyses was performed using the scheme of Diancourt et al. (2005), which 
consider allelic variation amongst seven housekeeping genes (gapa, infb, mdh, pgi, phoe, rpob 
and tonb) to assign STs. WGS data were used to generate a K. pneumoniae MLST assignment 
for each isolate with new or unknown STs being sent for curation at the Klebsiella pneumoniae 
MLST database at the Pasteur Institute (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html). 
7.2.9. Whole genome phylogenetic analyses  
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The assembled contigs were aligned against the complete genome of K. pneumoniae KPN528 
(CP020853) using the progressive Mauve genome alignment package version 2.3.1. Study 
genomes were contextualized against a collection of five relevant assembled K. pneumoniae 
genomes (accession numbers AYQE00000000, CP006918, CP020853, CP020847, 
CP020841). Phylogenetic analysis was based on the core genomes and performed using the 
Rapid large-scale prokaryote pan genome analysis (Roary) (Page et al., 2015). The 
maximum likelihood phylogenetic tree encompassing, country, population, sample type 
metadata and MLST type was generated, edited and visualized using FastTree version 2.1.7 
(http://www.microbesonline.org/fasttree/). In addition, the contigs were mapped against the 
complete genome of K. pneumoniae KPN528 (CP020853) for visualization of the genomic 
organization. 
7.2.10. Nucleotide sequence accession number 
This whole-genome shotgun project PRJNA412434 of K. pneumoniae strains PN030E4, 
HH510E2I, HN523E1II, PN089E1, PR042E3, HH517E1II and PN085E1IA has been 
deposited at DDBJ/EMBL/GenBank under accession numbers PDVM00000000, 
PDVF00000000, PDVG00000000, PDVC00000000, PDVE00000000, PDVU00000000 and 
PDVD00000000, respectively. The versions described in this paper are the versions, 
PDVM00000000.1, PDVF00000000.1, PDVG00000000.1, PDVC00000000.1, 
PDVE00000000.1, PDVU00000000.1 and PDVD00000000.1, respectively. 
7.3. Results  
7.3.1. Phenotypic and analyses  
Out of the 144 pooled nasal samples (three nasal swabs each) and 144 pooled rectal samples 
(three rectal swabs each) taken from 432 pigs in Cameroon and South Africa, ESBL-producing 
Enterobacteriaceae were detected in 108/144 (75%) and 102/144 (71%) nasal and rectal pools, 
respectively (unpublished data). Carriage of ESBL-producing Enterobacteriaceae was 
observed in Cameroonian workers only. Multiple colonies (up to ten) were isolated from both 
populations and countries, but due to financial constraints, post-stratification allowed the 
selection of 158 ESBL-PE in pigs and 71 in exposed workers, for phenotypic analysis 
(unpublished data). Out of these, ESBL-producing K. pneumoniae were only detected in 
Cameroon with 21.52% (34/158) and 11.26% (8/71) detected in pigs and exposed workers, 
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respectively (unpublished data). None of the South African pig or human samples were positive 
for ESBL-producing K. pneumoniae. Table 7.1 summarizes relevant population data, specimen 
source, phenotypic and genotypic characteristics for these isolates. All isolates displayed 
reduced susceptibility to the amino-penicillins, cephalosporins, trimethoprim-
sulfamethoxazole, with various resistance to gentamicin (n=5; 71%), ciprofloxacin (n=1; 14%) 
and nitrofurantoin (n=1; 14%). The antimicrobial susceptibility results of the ESBL-producing 
K. pneumoniae isolates are summarized in Table 7.2, with the resistance observed being 
corroborated with WGS analyses.  
7.3.2. Genotypic analyses  
All isolates carried sulphonamide (sul1), fosfomycin (fosA) and quinolone (oqxA and oqxB) 
resistance genes. Various beta-lactamase encoding determinants were detected with blaCTX-M-
15 (86%), blaTEM-1B (57%) and blaSCO-1 (43%) being the most prevalent. Four (PN089E1, 
PN085E1IA, HH517E1II and HH510E2II) and three (PR042E3, PN030E4 and HN523E1II) 
isolates concomitantly harbored four and three beta-lactamase encoding genes. Likewise, six 
(86%) strains harbour dfrA15 gene responsible for trimethoprim resistance, while co-presence 
of strA and strB encoding for aminoglycoside resistance was observed in five (71%) isolates 
as was the tet(A) gene responsible for tetracycline resistance. Interestingly, blaOXA-9, blaLEN12, 
blaSHV-134, blaTEM-1A were observed in the unique K. pneumoniae ST307 strain as were 
aac(6’)Ib-cr, catA2, sul2, tet(D), drfA27 and ARR-3 encoding resistance to aminoglycosides, 
phenicols, sulphonamides, tetracycline, trimethoprim and rifampicin respectively. Similarly, 
the β-lactamase genes blaTEM-116 and blaSHV-28, and plasmid mediated quinolone resistance 
(PMQR) genes QnrB1 were only identified in the two K. pneumoniae ST14 strains.  
7.3.3. Multilocus sequence typing 
In silico MLST-analyses revealed that K. pneumoniae strains belonging to five different 
sequence types, namely ST14 (n=2), ST39 (n=2), a single-locus variant ST307 and two new 
sequences. The two K. pneumoniae ST14 strains were isolated from a pig pooled nasal sample 
(PN30E4) and a human nasal swab (HN523E1II) located in two different abattoirs, SH001 and 
SH003, respectively (Table 7.1). The K. pneumoniae ST39 strains, HH517E1II and 
PN085E1IA, were also detected from an exposed worker and pooled nasal samples but both 
from the same abattoir SH002. In our collection of seven ESBL-producing K. pneumoniae 
isolates, two strains, PR042E3 and PN089E1 isolated from pigs in two different abattoirs 
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(SH001 and SH002), had a novel combination of known K. pneumoniae MLST alleles, that 
were assigned as ST2958 (n=1) and ST2959 (n=1), respectively. The sole K. pneumoniae 
ST307 strain was isolated from hand of an exposed worker and harbored a total of 22 resistance 
determinants encoding resistance to nine antibiotic classes.  
7.3.4. Phylogenetic analysis 
The phylogenetic analysis confirmed the intermingled reservoir of ESBL-producing K. 
pneumoniae strains and revealed that our strains fall within two clades of international K. 
pneumoniae isolates. Figure 7.2 demonstrates considerable similarity between our collection 
of K. pneumoniae ST14 and three strains CP020841 (ST37), CP006918 (ST258) and 
CP020847 (ST906), all isolated from clinically ill humans in United States. Similarly, the K. 
pneumoniae ST39 strains isolated from nares of healthy pig (PN085E1IA) and the hand of 
healthy human (HH517E1II) in abattoir SH002, were closely related K. pneumoniae ST307 
(HH510E2I) isolated from hand of a human in SH001 and a K. pneumoniae ST336 isolated in 
clinically ill patient in Lebanon (Figure 7.2). Figure 7.3 shows the genomic organization of the 
ESBL-producing K. pneumoniae HN523E1II mapped against the complete genome of K. 
pneumoniae KPN528 (CP020853). 
7.3.5. Detection of plasmids and phage-associated regions 
PlasmidFinder revealed that the colRNAI plasmid replicon type was identified in all strains 
whereas the IncFIB(K) plasmid incompatibility group was detected in six (86%) isolates. The 
two K. pneumoniae ST14 strains, PN030E4 and HN523E1II, concomitantly harbored two 
colRNAI plasmid replicon types as well as two IncFIA(HI1) and IncFIB(K) plasmid 
incompatibility groups, with the strain PN030E4 additionally harboring the IncY plasmid. 
Likewise, the K. pneumoniae ST307 harbor two colRNAI replicons as well as FIA (pBK30683) 
and IncR plasmid incompatibility groups while the K. pneumoniae ST 39 carries four colRNAI 
replicons along with IncHI1B and IncFIB(K) plasmid incompatibility groups. In silico plasmid 
MLST-analyses assigned the IncF plasmid incompatibility group as belonging to various 
sequence types including [K1:A13-like:B-], [K-:A10-like:B-], [K-:A13:B-] while the IncH 
plasmid belongs to a non-typeable ST. 
With regard to the phage-associated regions, all strains hosted at least one intact bacteriophage. 
Shigel SfII, pseudo JBD44, Entero lato and Escher HK639 were the predominant intact 
bacteriophages. Six phage regions were identified in one K. pneumoniae ST14 (HN523E1II) 
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isolated from hand of a worker using PHAST algorithm, while the other ST14 (PN030E4) and 
one ST39 (PN085E1IA) observed in pigs hosted three phage regions each. 
7.4. Discussion 
In this study, antibiotic resistance genes, virulence factors, mobile genetic elements and genetic 
lineages of seven circulating and closely related ESBL-producing K. pneumoniae strains 
isolated from pigs and occupationally exposed workers in Cameroonian abattoirs were 
investigated using whole genome sequencing.  
ESBL-producing K. pneumoniae have been observed at diverse rates in clinical samples in the 
Ivory Coast (16%), Morocco (13%), Cameroon (10%) and Madagascar (9%) (Breurec et al., 
2013). They were also responsible of community-acquired urinary tract infections in a 
Cameroonian city with an incidence of 16.4% (Nzalie et al., 2016). Our study, similarly 
revealed ESBL-producing K. pneumoniae strains in pigs (27.64%) and exposed workers 
(16.66%) in Cameroon as the first report ESBL-producing K. pneumoniae isolates in food 
animals and occupationally exposed workers in the country. The ESBL-producing K. 
pneumoniae strains were mainly circulating in two clonal lineages since four out of seven 
isolated strains belong to the ST14 (n=2) and ST39 (n=2). To the best of our knowledge, this 
is the first evidence of a porcine ESBL-producing K. pneumoniae reservoir in this country. 
Moreover, the first reports of blaCTX-M-15, blaTEM-1B, blaSHV-11, blaSCO-1 producing K. 
pneumoniae ST39 and blaCTX-M-15, blaTEM-116, blaSHV-28 producing K. pneumoniae ST14 in pigs 
and humans in Cameroon are presented here.  
The K. pneumoniae ST14 isolates were found to be resistant to ampicillin, cefuroxime, 
cefuroxime-axetil, cefotaxime, ceftazidime and trimethoprim-sulfamethoxazole. This 
resistance phenotype was corroborated by the identification of the CTX-M-15, SHV-28 and 
TEM-116 genes by WGS which also elucidated with multiple resistant determinants to non-β-
lactams antibiotic, notably the aminoglycoside resistant genes (strA, strB), plasmid-mediated 
quinolone resistance genes (QnrB1, oqxA, oqxB), fosfomycin resistant gene (fosA), and 
sulphonamide resistant gene (sul1 and sul2) which were not phenotypically evident. Although 
the two K. pneumoniae ST39 isolates displayed similar phenotypic profiles these were 
attributed to different resistance gene permutations. For example, the pig strain PN085E1IA 
harbored genes encoding for aminoglycoside [aad1, aac(3)-IIa], fluoroquinolones (oqxA, 
oqxB), fosfomycin (fosA), tetracycline [tet(A)], trimethoprim (dfrA15) and sulphonamide 
(sul1, sul2) resistance alongside blaCTX-M-15, blaTEM-1B and blaSHV-1 while aad1, aac(3)-IIa, 
oqxA, oqxB, fosA, sul1, tet(A), dfrA15, blaTEM-1B, blaCTX-M-15, blaSCO-1, blaSHV-11 were 
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observed in the human strain HH517E1II. CTX-M-15 detection is consistent with a multicenter 
study conducted in five African (including Yaoundé) and two Vietnamese towns where it was 
detected in 74% of isolates and was the predominant ESBL among the African isolates 
(Breurec et al., 2013). This study further reported the predominance of QnrB determinant 
among the African strains (Breurec et al., 2013). In addition, CTX-M-15-producing K. 
pneumoniae hosted on a plasmid has already been reported in patients with clinical urinary 
tract infections in Cameroon (Gangoue-Pieboji et al., 2005), confirming the widespread 
dissemination of this ESBL type. The preponderance of CTX-M-15 as the main ESBL genes 
(85.71%) in our K. pneumoniae isolates confirms that CTX-M-15 is currently the most largely 
distributed CTX-M enzyme worldwide. The potential role of K. pneumoniae as a reservoir for 
β-lactam and non-β-lactam resistance determinants is a major concern in countries with 
inadequate antibiotic resistance (ABR) surveillance, prevention and containment measures 
such as Cameroon. Key factors favouring the emergence and spread of ABR in the food chain 
in the country include irrational antibiotic use on farms, poor sanitary and feeding practices, 
sub-optimal transport conditions, lack of veterinarian control, inadequate diagnostic facilities, 
substandard quality of antibiotics, lack of antimicrobial monitoring and poor biosecurity 
measures (Ndebi et al., 2009).  
Our study showed that both ST14 and ST39 demonstrated overlap and intermingled 
populations between pig- and human-sources within and across abattoirs (Figure 1). 
Specifically, the K. pneumoniae ST14 strains colonized nares of both human and pigs located 
in two different abattoirs (SH001 and SH003) whereas K. pneumoniae ST39 was detected in 
nares of pigs and the hand of a worker present in the same abattoir, SH002 (Figure 1). This 
could be associated with neglected hygienic practices prevailing during production, transport, 
storage and/or retail stages. The virtual absence of physical barriers between community and 
healthcare settings in this country along with poverty and limited education may also be 
important contributory factors.  
The ST14 and ST39 clonal lineages are a major cause of nosocomial infections and outbreak 
situations around the world, although their evolutionary emergence is somewhat poorly 
documented in developing countries. In fact, OXA-181-producing K. pneumoniae ST14 was 
detected in South Africa where it was responsible of an outbreak of among hospitalized patients 
in a tertiary hospital (Jacobson et al., 2015), whereas, a multidrug resistant and biofilm 
producing K. pneumoniae strain belonging to the ST14 was detected in India also at tertiary 
care (Rafiq et al., 2016). Similarly, the K. pneumoniae ST39 was responsible for an outbreak 
in a pediatric hospital in Algeria (Belbel et al., 2014). The isolation of these STs always urged 
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the implementation of stringent infection and control measures and ongoing surveillance of 
antibiotic resistance in hospital settings. Similar strict interventions should thus be undertaken 
in the food production industry if we are to successfully contain their clonal dissemination in 
the food chain.  
The detection of the international K. pneumoniae ST307 in a human isolate is further evidence 
of the wide and increasing spread of ESBL-producing bacteria in the country. The K. 
pneumoniae ST307 has been recognized as candidate for becoming one of the prevalent high-
risk and clinically relevant clones since its worldwide emergence during the last five years 
(Villa et al., 2017). The K. pneumoniae ST307 lineage is generally capsulated, displays higher 
resistance to complement-mediating killing, has novel virulence arrays and is associated with 
CTX-M-15 and KPC encoding plasmids (Villa et al., 2017). Accordingly, Klebsiella 
pneumoniae Carbapenemase (KPC)-producing K. pneumoniae ST307 carrying a self-
transferable plasmid (IncX3-type) was detected among clinical specimens during a nosocomial 
outbreak in South Korea (Kim et al., 2017) as was KPC-producing K. pneumoniae ST307 
harboring pKPN-307 plasmid (Villa et al., 2017). In contrast to these reports, the K. 
pneumoniae ST307 detected in our study did not harbor the CTX-M-15 and KPC enzymes nor 
the IncX plasmid but rather TEM-1A, LEN12, OXA-9 and SHV-134 as β-lactamases, and 
colRNAI, IncR and FIA (pBK30683) plasmid incompatibility groups, suggesting a different 
phylogenetic evolution. The ability of this clonal lineage to acquire novel genetic features may 
contribute to its increased persistence in the environment and highlights its potential public 
health threat. 
Only K. pneumoniae ST11 and ST15 were detected from clinical samples in Yaoundé, 
Cameroon to date. The detection of two new genome sequences K. pneumoniae ST2958 and 
ST2959 in pigs with different antibiotic resistance profiles and genes, improve our 
understanding and scope of the molecular epidemiology and evolution of resistant bacteria in 
the country. The emergence of these ESBL-producing K. pneumoniae in pigs and exposed 
workers within and between abattoirs in Cameroon is of great significance as it confirms their 
active clonal dissemination via direct contact, and suggests their indirect spread throughout the 
food chain in the country. These findings further suggest that pigs, pork, and abattoir workers 
represent a potential reservoir and source of foodborne ESBL-producing K. pneumoniae 
infections in Cameroon and reinforce the crucial importance of implementing appropriate food 
safety measures and promoting rational antibiotic use.  
All isolates except HH510E2I (MIC ≥4 µg/ml) were susceptible to ciprofloxacin (MIC ≤0.5 
µg/ml) suggesting that they might not contain gene encoding for resistance to fluoroquinolones, 
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but oqxA and oqxB were detected in all isolates. Similarly, although not expressing phenotypic 
resistance to gentamicin (MIC ≤1 µg/ml), amikacin (MIC ≤ 2 µg/ml) and ciprofloxacin (MIC 
≤0.25 µg/ml), the pig and human isolates, PN030E4 and HN523E1II, harbored strA and strB 
encoding for resistance to aminoglycoside together with the fluoroquinolone resistance genes 
oqxA, oqxB and QnrB1. This finding thus indicate that these genes might be “silent” in ESBL-
producing K. pneumoniae circulating in pigs and humans in Cameroon, and could likely be 
triggered in response to the selective pressure of widespread antibiotic use.  
FosA gene a glutathione S-transferase that causes enzymatic inactivation of and resistance to 
fosfomycin, was detected in six out of seven isolates in our study with 100% homology. 
Fosfomycin is a broad-spectrum antibiotic used extensively in Europe and Africa for treatment 
of uncomplicated urinary tract infections (Xu et al., 2011). It is receiving renewed interest 
globally as a therapeutic option for the treatment of infections caused by carbapenem-resistant 
Enterobacteriaceae. Our finding of chromosomal fosA gene in 85.71% our isolates concurs 
with a report which revealed that several Gram-negative species including K. pneumoniae, K. 
oxytoca, Enterobacter cloacae, Enterobacter aerogenes, Serratia marcescens, carry fosA gene 
on their chromosome and are species with intrinsic reduced susceptibility or resistance to 
fosfomycin (Ito et al., 2017). The widely distribution of fosA gene in our study further suggests 
that K. pneumoniae could serve as a reservoir for this gene and facilitate its dissemination to 
species lacking fosA such as E. coli in the country. Although the contextualization of this 
finding is difficult due to the scarcity of molecular epidemiological studies in Africa, this 
finding concurs with several studies from Asian (Wachino et al., 2010; Hou et al., 2013; Chan 
et al., 2014) and European countries (Benzerara et al., 2017) which showed the presence of 
multiple lineages of fosA producing ESBL-E. coli. Any interest in repurposing use of old 
antibiotics should thus be considered with caution and in light of existing environmental 
reservoirs of resistance genes. 
The CGview analyses showed that major parts of the K. pneumoniae ST14 (HN523E1II), are 
present within the reference genome KPN528 (CP020853) (Figure 2). However, some 
discrepancies in both identity and coverage were observed, as part of the rings are lighter 
colored or missing, implicating the presence of other genetic elements or independent evolution 
of this isolate. This suggests that closure of our genomes would be essential to decipher and 
understand the evolutionary biology of ESBL-producing K. pneumoniae. Besides, 
investigation of the resistance genes and comparison along with the phage-associated regions 
harboured by our isolates, did not reveal the presence of a prophage-encoding resistance genes. 
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This suggests that prophages are unlikely to act as vectors for the dissemination of resistance 
within our isolates. Nonetheless, the acquisition of mobile genetic elements including the 
plasmids and bacteriophages contribute to the phenotypic and genetic plasticity of their 
bacterial host and can act as vector for the transfer of resistance determinants and virulence 
factors leading to increased prevalence. Routine screening for ESBL-producing K. pneumoniae 
colonization in food animals, exposed workers, farms, abattoirs and food products is thus 
essential for its effective containment.  
Even though our findings may not be extrapolated to the overall situation of the country, it is 
noteworthy that these highlight a serious food safety threat as the study took place in the main 
abattoirs of the country’s capital. Further high-resolution genotyping studies of ESBL-
producing K. pneumoniae collected over larger temporal and spatial scales are required to 
better understand the evolution, molecular epidemiology, and transmission dynamics of these 
resistant isolates.  
7.5. Conclusion 
Our study shows that ESBL-producing K. pneumoniae is actively disseminating in pigs and 
occupationally exposed workers in Cameroonian abattoirs and is probably under-estimated 
considering the absence of molecular epidemiological studies. It underlines the existence of a 
potential unheeded food safety and public health threat associated with these resistant strains 
in the country especially if they spread to susceptible people such as immunocompromised. 
Ongoing efforts and further well-designed epidemiological studies to understand the 
epidemiology, transmission dynamics and pathways, risk factors and public health implications 
associated with the food animal reservoir of ESBL-producing bacteria are essential to inform 
effective interventions for their containment. 
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Table 7.1. Summary of population, sample type, phenotypic and genotypic characteristics of ESBL-producing K. pneumoniae isolates 












strA, strB, blaTEM-116, blaSHV-28, blaCTX-M-15, oqxA, oqxB, QnrB1, 




HN523E1II Human Nasal swab SH003 
strA, strB, blaTEM-116, blaSHV-28, blaCTX-M-15, oqxA, oqxB, QnrB1, 




HH517E1II Human Hand swab SH002 
aac(3)-IIa , aadA1, blaTEM-1B, blaSHV-11, blaCTX-M-15, blaSCO-1, oqxA, 








aac(3)-IIa , aadA1, strA, strB, blaTEM-1B, blaSHV-27, blaSCO-1, blaCTX-









aac(3)-IIa , aadA1, strA, strB, blaTEM-1B, blaSHV-1, blaCTX-M-15, 
oqxA, oqxB, fosA, sul1, tet(A), dfrA15 





aac(3)-IIa , aadA1, strA, strB, blaTEM-1B, blaSHV-27, blaSCO-1, blaCTX-




HH510E2I Human Hand swab SH001 
aac(6')-Ib, strA, strB,  aac(3)-IId,  aac(6')Ib-cr*,  aadA1, aadA16, 
blaOXA-9, blaLEN-12, blaSHV-134, blaTEM-1A, oqxA, oqxB, fosA, catA2, 






Table 7.2. Minimum inhibitory concentrations (MICs) of selected β-lactam and non-β-lactam antibiotics for individual ESBL-producing 
K. pneumoniae isolates 
Isolate 
name 
β-lactam antibiotics non-β-lactam antibiotics 
Antibiotic resistance genes 
AMP AMC TZP CXM CTX CAZ FEP ETP MEM IMP GEN AN CIP TGC FT CS TMP/SXT 
HH510E2I ≥32 16 ≤4 16 4 ≥64 ≤1 ≤0.5 ≤0.25 ≤0.25 ≥16 ≥16 ≥4 ≤0.5 ≤16 ≤0.5 ≥320 
aac(6')-Ib, strA, strB,  aac(3)-IId,  
aac(6')Ib-cr,  aadA1, aadA16, blaOXA-
9, blaLEN-12, blaSHV-134, blaTEM-1A, oqxA, 
oqxB, fosA, catA2, ARR-3, sul1, sul2, 
tet(D), dfrA27 
HH517E1II ≥32 16 8 ≥64 ≥64 4 ≤1 ≤0.5 ≤0.25 ≤0.25 ≥16 ≤2 ≤0.25 1 128 ≤0.5 ≥320 
aac(3)-IIa , aadA1, blaTEM-1B, blaSHV-11, 
blaCTX-M-15, blaSCO-1, oqxA, oqxB, fosA, 
sul1, tet(A), dfrA15 
PN085E1IA ≥32 8 ≤4 ≥64 ≥64 16 2 ≤0.5 ≤0.25 ≤0.25 ≥16 ≤2 ≤0.25 1 32 ≤0.5 ≥320 
aac(3)-IIa , aadA1, strA, strB, blaTEM-
1B, blaSHV-27, blaSCO-1, blaCTX-M-15, oqxA, 
oqxB, fosA, catA1, sul1, sul2, tet(A), 
dfrA15 
PR042E3 ≥32 4 ≤4 ≥64 ≥64 2 2 ≤0.5 ≤0.25 ≤0.25 ≥16 ≤2 ≤0.25 1 32 ≤0.5 ≥320 
aac(3)-IIa , aadA1, strA, strB, blaTEM-
1B, blaSHV-1, blaCTX-M-15, oqxA, oqxB, 
fosA, sul1, tet(A), dfrA15 
PN089E1 ≥32 4 ≤4 ≥64 ≥64 8 2 ≤0.5 ≤0.25 ≤0.25 ≥16 ≤2 ≤0.25 1 32 ≤0.5 ≥320 
aac(3)-IIa , aadA1, strA, strB, blaTEM-
1B, blaSHV-27, blaSCO-1, blaCTX-M-15, oqxA, 




AMP: Ampicillin, AMC: Amoxicillin-clavulanic acid; TZP: Piperacillin-tazobactam; CXM: Cefuroxime; CTX: Cefotaxime; CAZ: Ceftazidime; ETP: Ertapenem; MEM: 
Meropenem; IMP: Imipenem; GEN: Gentamicin; AN: Amikacin; CIP: Ciprofloxacin; TGC: Tigecycline; FT: Nitrofurantoin; CS: Colistin; TMP/SXT: Trimethoprim-
Sulfamethoxazole 
PN030E4 ≥32 4 ≤4 ≥64 8 8 2 ≤0.5 ≤0.25 ≤0.25 ≤1 ≤2 ≤0.25 ≤0.5 ≤16 ≤0.5 ≥320 
strA, strB, blaTEM-116, blaSHV-28, blaCTX-
M-15, oqxA, oqxB, QnrB1, fosA, sul1, 
sul2, tet(A), dfrA15 
HN523E1II ≥32 4 ≤4 ≥64 ≥64 8 2 ≤0.5 ≤0.25 ≤0.25 ≤1 ≤2 ≤0.25 ≤0.5 64 ≤0.5 ≥320 
strA, strB, blaTEM-116, blaSHV-28, blaCTX-




Table 7.3. Distribution of intact prophage regions among the ESBL-producing K. 
pneumoniae strains 
 
Isolate name Regiona Lengthb (kb) No CDS GC% Phage (hit genes count)c 
HH510E2I 1 37.6 47 51.42 Salmon 103203 sal5 (13) 
HH517E1II 1 39.3 52 52.13 Salmon 64795 sal3 (15) 
HN523E1II 
1 30.3 37 51.02 Entero mEp390 (6) 
2 17.1 20 48.37 Entero lato (7) 
3 27.6 12 53.30 Shigel SfII (8) 
4 17.4 26 54.84 Shigel SfII (18) 
5 58.6 44 53.75 Escher HK639 (18) 
6 29.8 35 51.86 Entero c 1 (9) 
PN030E4 
1 29.6 35 51.54 Brucel BiPBO1 (6) 
2 23 28 53.03 Shigel SfII (20) 
3 48.6 49 53.27 Escher HK639 (19) 
PN085E1IA 
1 27.4 28 52.12 Pseudo JBD44 (9) 
2 31.4 25 52.93 Entero c 1 (12) 
3 33.1 12 49.24 Entero lato (7) 
PR089E1 
1 47.6 41 50.80 Salmon 118970 sal3 (11) 
2 27 34 55.25 Salmon Fels 2 (22) 






































Figure 7.1. Linear view of the prophage Escher HK639 isolated from the K. pneumoniae ST14 (HN523E1II). Putative genes are coloured 







Figure 7.2. A maximum-likelihood phylogenetic tree of ESBL-producing K. pneumoniae isolates generated using FastTree version 2.1.7. The Cameroonian 









































Figure 7.3. ESBL-producing K. pneumoniae HN523E1II ring representation using CGView Server 
V 1.0 (Grant et al., 2012). The inner ring displays the percent of identity comparing K. pneumoniae 
HN523E1II and the complete genome of K. pneumoniae KPN528 (CP020853). The two next (inner) rings 







































I. Introduction and general findings 
Antimicrobial resistance is a major public health concern for human and animal health. In the 
context of globalization, increasing trade and travel, this phenomenon can spread very quickly 
and pose a serious threat globally. In Africa, particularly in sub-Saharan African countries such 
as Cameroon and South Africa, antibiotic use in food animals is not necessarily well-regulated, 
and there is a dearth of studies relating to the zoonotic spread of ABR in both animal and human 
populations (Vila, 2010; Laxminarayan et al., 2013; WHO, 2014a,b). 
Between March and October 2016, ESBL-PE and MRSA were screened from the 288 nasal 
and rectal pooled samples collected from 432 pigs as well as from nasal and hand swabs 
sampled from 82 humans in both Cameroon and South Africa. Carriage, risk factors, 
antimicrobial resistance profiles and clonal relatedness of circulating ESBL-PE and MRSA in 
pigs and humans were investigated using various microbiological methods and compared using 
statistical tools including, the chi-square test, and, univariate and multivariate logistic 
regression analyses. WGS was further used to delineate the current molecular epidemiology, 
resistance genes, virulence factors, plasmids, phage-related regions and circulating clonal 
lineages of these isolates. 
The following main conclusions emanated from the study with respect to the study objectives: 
- ABR in the food chain affects both developed and developing countries. As there are no 
geographic bounders to impede its global dissemination, multi-faceted, comprehensive and 
integrated preventive and containment measures complying with the One Health approach 
should be implemented locally, nationally and regionally in other to ensure food safety and 
security, effectively combat infectious diseases, curb the emergence and spread of ABR 
and preserve the efficacy of antibiotics for future generations. 
- Studies investigating ABR in food animals in Africa are rare but overall pooled estimates 
showed high level of resistance (86%; p=0.000) and multi-drug resistance (73%; p=0.003) 
in food animals in Africa. The vast majority of studies were carried out in Nigeria, with a 
small number conducted in Eastern, Northern, Western and Southern Africa.  
- ESBL-PE prevalence in animal samples from Cameroon was higher than for South Africa 
and ESBL-PE carriage was observed in Cameroonian workers only. Human nasal ESBL-
PE colonization was statistically significantly associated with hand ESBL-PE (21.95% vs 
91.67%; p=0.000; OR=39.11; 95% CI 2.02-755.72; p=0.015).  
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- MRS prevalence of carriage in all pooled pig samples and exposed workers (nasal and 
hand) from Cameroon was higher than that of South Africa. Human nasal MRS 
colonization was highly statistically associated with hand MRS (31.58% vs 86.21%; 
p=0.000; OR=13.54; 95% CI 3.99-45.95; p=0.015).  
- Low level of education, previous hospitalization, recent antibiotic use, and contact with 
poultry were the common risk factors identified for ESBL-PE and MRS carriage in humans 
- A low MRSA prevalence was observed in Cameroon (0.07%) and South Africa (16.66%) 
in pigs and none of the workers was colonized by MRSA.  
- Genome analysis identified various antibiotic resistance genes and revealed that all 
circulating MRSA strains isolated in Cameroon and South Africa, belong to the clonal 
lineage ST398.  
- This is the first report of LA-MRSA ST398 in pigs in Cameroon and South Africa. 
- ESBL-producing K. pneumoniae were detected in pigs (28%) and exposed workers (18%) 
in Cameroon.  
- The circulating K. pneumoniae strains were dominated by the sequence type (ST) 14 and 
39. The “high-risk” clone ST307 and two novel STs assigned ST2958 and ST2959 were 
also detected.  
- Intermingled K. pneumoniae populations were observed between pig- and human-source 
within and across abattoirs in Cameroon suggesting their zoonotic transmission. 
The elevated ESBL-PE and MRSA prevalence among pigs in both Cameroon and South Africa 
demonstrates that food animals are potential reservoir and sources of foodborne ESBL-PE and 
MRSA infections and that occupationally exposed workers are at high risk of colonization in 
Cameroon and South Africa. The study shows that ESBL-PE and LA-MRSA are actively 
disseminating in the food chain in both Cameroon and South Africa and are probably 
underestimated considering the absence of molecular epidemiological studies in the food chain 
in these countries. The study further suggests that farmers, abattoir workers and food handlers, 
besides being at high risk of colonization, represent a significant source of ABR dissemination 
for their relatives through person-to-person contact and for the general population through the 
contamination of food products occurring during food processing. This finding is of great 
concern as ESBL-PE and MRSA originating from animals have been reported to be the main 
causative agents of foodborne infections globally (Huijdens et al., 2006; Cuny et al., 2013; de 
Balogh et al., 2013; Kock et al., 2013, Nordstrom et al., 2013; Cuny et al., 2015).  
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The study also highlights the food safety threat associated with the presence of ESBL-PE and 
LA-MRSA ST398 in the food chain and confirms that these bacteria are serious global public 
health threats requiring urgent, holistic, and stringent interventions in line with the One Health 
approach. It finally underlines the existence of an unheeded food safety and public health threat 
associated with these resistant strains and reinforces the imperative of implementing 
appropriate food safety measures and promoting rational antibiotic use in Cameroon and South 
Africa. 
II. Significance of the study 
Resistant foodborne infections are amongst the main public health issues associated with the 
threat of ABR in the food chain. This global concern equally affects developed and developing 
countries, and may cause outbreaks and pandemic situations (Padungtod et al., 2008). The 
problem is more serious in the developing world, where resistant infections significantly 
increase morbidity and mortality rates, whereas in developed countries, these infections will 
increase therapeutic costs (Harbarth et al., 2015).  
This work sought to investigate and provide evidence for the containment of the zoonotic 
transmission of multi-drug resistant bacteria through the implementation of the One Health 
approach, compliant with the directives of the WHO Global Action Plan on Antimicrobial 
Resistance (WHO, 2015), The FAO Action Plan on Antimicrobial Resistance 2016-2020 
(FAO, 2016) and the OIE Strategy on Antimicrobial Resistance and the Prudent Use of 
Antimicrobials (OIE, 2016). This was undertaken in two distinct countries where farming and 
intensive food animal production are amongst the most important economic growth and 
development factors.  
To the best of our knowledge, no study focusing on the occurrence of ABR conjointly in 
humans and animals has been carried out in both Cameroon and South Africa. The study 
contributes new knowledge on the burden, risk factors and molecular epidemiology of ESBL-
PE and LA-MRSA in both countries. It reveals gaps in the current state of knowledge about 
antibiotic use and ABR in food animals in Cameroon and South Africa, and suggests that the 
debate about ABR-related consequences in the farm-to-plate continuum is neglected and 
should be more seriously considered in these countries. More specifically, the study has 
demonstrated that the food production system in Cameroon currently needs critical appraisal 
in terms of prevention and control measures, essential to contain ABR and ensure food safety 
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and security as does South Africa. The study further shows not only the active ESBL-PE and 
LA-MRSA dissemination in the farm-to-plate continuum but also the contamination of 
abattoirs, more so in Cameroon than South Africa.  
The importance of Cameroonian and South African food safety is not only national but also 
regional. Farmers and slaughterhouses workers are not the only ones who should recognize the 
personal and societal impact of the emergence and spread of LA-MRSA and ESBL-producing 
Enterobacteriaceae. Awareness must be increased in the general population. The results 
generated in this study serve as evidence of the threat of AMR for agricultural practitioners, 
policy makers, scientific communities and health policies regionally and particularly in 
Cameroon and South Africa. The results will inform interventions for effective prevention 
measures and behaviour changes in the proper use of antibiotics to contain AMR in agricultural 
practice and in human health.  
III. Limitations 
The principal limitation of the study is that ESBL-PE and LA-MRSA were not investigated in 
pigs and humans at the farm-level nor in (ready-to-eat) food products at supermarket or 
restaurant-level. In fact, although the generated findings yielded an interesting overview at 
abattoir level, investigating ESBL-PE and LA-MRSA in farm settings would have provided 
further insights into the epidemiology, resistance genes, virulence factors, mobile genetic 
elements, risk factors and public health implications associated with these isolates in the whole 
farm-to-plate continuum.  
In addition, the molecular analyses were only carried out on the representative and not all 
isolates due to financial constraints associated with the impressive number of isolated bacteria. 
Comprehensive molecular analysis would have certainly allowed better understanding of the 
molecular evolution and genetic exchanges that are likely to occur within and between bacteria 
in this continuum. 
IV. Recommendations  
 
- The high ESBL-PE and MRSA carriage in pigs and humans underlines the need for routine 
surveillance and screening of high-risk populations for better containment measures and 
appropriate interventions.  
- The study calls for an urgent implementation of policies and activities on the rational 
antibiotic use in the food production industry in order to preserve the efficacy of last resort 
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antibiotics for future generations. Rational antibiotic use policies should also be strictly 
enforced in the food production industry in both countries and in human health in 
Cameroon. 
- Multi-faceted collaboration among human, animal, and environmental health, agriculture 
and other sectors, good agricultural practices and effective infection control measures 
should be implemented to prevent the zoonotic transmission of these resistant bacteria 
- Heightened awareness and education about ABR, its related consequences and effective 
prevention and containment measures should be provided not only to exposed populations 
including farmers, abattoir workers and, food handlers, but also to the general population 
where the consumers belong.  
- Decision-makers should recognize food safety as a public health priority, to bring together 
all stakeholders along the whole farm-to-plate continuum, from the food producers and 
suppliers to the consumers, and ensure that they operate responsibly to preserve the safety 
of food while ensuring food security. Farmers should for instance implement effective 
biosecurity measures to prevent ABR emergence and on-farm contamination with resistant 
bacteria and genes or external dissemination when contamination does occur, while food-
handlers and consumers should make use of the WHO tool “Five Keys to Safer Food” for 
their activities. 
- Further molecular studies investigating antibiotic-resistant bacteria in general and ESBL-
PE and MRSA in particular, should be carried out across the farm-to-plate continuum in 
order to better understanding the molecular epidemiology, evolution and transmission 
dynamics of these strains in Cameroon and South Africa 
V. Conclusion 
ABR in the food chain is a silent, pandemic threat. Its prevalence in the farm-to-plate 
continuum will not only endanger food safety, but also ultimately lead to the exhaustion of the 
available therapeutic pipeline. This represents an obstacle for sustainable development. 
Tackling ABR requires holistic actions and sustainable political will and commitment. It 
further requires rational antibiotic use in the food production system together with surveillance 
to monitor the transmission of resistance already present in the farm-to-plate continuum. 
Containing ABR throughout this continuum will substantially lessen the multi-sectorial 
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I am Luria Leslie Njoungang Yontchoung a Doctoral student of the University of KwaZulu-
Natal (UKZN) School of Health Sciences, College of Health Sciences in South Africa. I am responsible 
of a Doctoral Research Project entitled “Molecular Epidemiology of Livestock Associated 
Methicillin Resistant Staphylococcus aureus (LA-MRSA) and Extended-Spectrum Beta-
Lactamase-Producing Enterobacteriaceae in Food Animals, Particularly Pigs and Related 
Workers in Yaoundé-Cameroon” under the supervision of Professor Sabiha Yusuf Essack from the 
College of Health Sciences of University of KwaZulu-Natal and with the support of the University. The 
information concerning the different ethical approvals obtained in South Africa and in Cameroon are 
detailed above.  
This study which will take 3 years tries to examine the resistance to antibiotics of bacteria. We 
are examining some specific bacteria named S. aureus and Enterobacteriaceae and normally present 
on the skin of animal and human vertebrates as well as in the environment. These commensal bacteria 
have been recently identified to be non-susceptible at the activity of numerous antimicrobial agents. 
This means that despite the presence or consumption of antibiotic drugs, they are able to persist in your 
organism and to create disease. Because there is a limitation in the creation of new antibiotics, we 
arriving at the point where a simple injury could once again kill due to the inactivity of antibiotics on 
pathogens. The study aims to identify and determine the specific resistant strains S. aureus and 
Enterobacteriaceae family present in the pig slaughterhouses.  By doing this, the impact of these 
resistant pathogens in human and animal health will be evaluated in order to implement effective 
prevention measures, strategies and policies which will concur to the amelioration of human and animal 
health. 
Before taking part to this study, it is indispensable for you to read the following information 
concerning the project. In fact, the reason of this document is to explain you the objectives, procedures, 
potential risks, benefits and inconvenience of the study. If there is anything unclear or incomprehensible 
in this document, please do not hesitate to ask for clarification or more information from the study 
personnel for more explanation about that part of study. If you would like to participate to this study, 





GENERAL AIM AND OBJECTIVES OF THE STUDY 
The general aim of this research is to determine the elements involved in the resistance of 
Staphylococcus aureus and Enterobacteriaceae to the antimicrobial agents, in order to suggest adequate 
measures to improve health. The study considers the different risk factors, the frequency and 
characteristics of these bacteria found in pigs of slaughterhouses and in pig workers in Yaoundé. Male 
and female workers in the profession-related to pig’s slaughterhouses (such as pig’s slaughterer, pig’s 
carriers, pig’s seller, etc.) aged of 18 years and older are eligible to participate. I am soliciting your 
volunteer participation in this research because you are member of this category of persons. Please, be 
sure that your participation is completely voluntary. If you decline your participation in this study, there 
will not have any negative consequences for you. On the other hand, if you decide to take part, please, 
you also need to be conscious of the fact that you may stop participating at any time and you may decide 
not to answer any specific question.  
If you volunteer to participate in this study, the following will happen:  
- You will be assigned a unique participant identification number, which will be used to link 
your survey responses to results of your activities and provide confidentiality. Your name will 
not be asked or recorded on any study materials. 
- You will receive a questionnaire and I am going to ask you questions about your socioeconomics 
conditions (age, sex, education, incomes, etc.), your medical record (recent hospitalization, 
recent surgery, etc.), the utilization of antimicrobial and slaughterhouse practices; some of them 
might affect your privacy or in other words, your personal behaviour.  
- I will collect your anterior nares and hands to perform laboratories analysis.  
- I will collect anterior nares and rectum of pigs processing at the slaughter houses. 
TIME REQUIRED FOR PARTICIPATION 
Your participation will take about 30 minutes -answering questionnaire- and will require more time for 
pig’s sample collection in abattoir. 
POTENTIAL RISKS OF THE STUDY 
The researchers consider that the risks or discomforts to you and your animal are minimal. You can 
skip questions that make you uncomfortable or stop taking the survey at any time.  
BENEFITS 
You will not receive any payment for your participation in this study. Your participation will help to 
understand the resistance of antibiotics in Cameroon; will improve the current available data reports on 
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the different types of resistance existing and finally, will serve to proof to notify policy makers about 
the danger poses by these resistant pathogens in the Cameroon and around the world. 
CONFIDENTIALITY 
If you decide to leave the study, the material required for your identification including questionnaire, 
informed consent, data recorded will be destroyed except if you give authorization to the researcher to 
use it after your withdrawal. In case you decide to participate, all your responses will be confidential 
and stored appropriately with restrained access to authorized person only. Neither your name nor your 
address will be recorded and no other person will know your answers. Your data will be conserved as 
described by the following measures which are applied for all applicants. 
During the research: 
- Your name and any other person named during the study will be replaced by a code 
- Only the researcher and authorized persons will have access to the data containing names and 
codes which will be stored separately from the material of research, from the data and informed 
consent 
- All the research material including informed consent and data will be stored in a barred-
workbook and in a local locked 
- Numerical data will be protected in files with access granted by a password detained by the 
researcher 
During the dissemination of the results: 
- The names of the participant will never appear in a report 
- The results will be presented in a global form in order to avoid the communication of individual 
results 
- The results of the study will be published in scientific journals and nobody will be recognized  
- A brief résumé will be sent to participants who will have demonstrated the desire to have their 
results by indicating their Email or Postal address in the appropriate space provided below. 
THE ELECTRONIC/POSTAL ADDRESS WHERE I WOULD LIKE TO RECEIVE A 
SHORT RÉSUMÉ OF THE RESULTS IS THE FOLLOWING: 
__________________________________________ _______________________ 
At the end of the study: 
- All the material and data may be used later for other research  
- All the material and data will be destroyed at later in 10 years. 
- Measures have been done for persons desirous to know their results.  
o A short résumé of the results will be sent to participants who will have done the request 
by indicating their address at the space provided.  
o The results will not be available before the end of the year 2016.  
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o If this address changes by this date, I encourage you to inform us of your new address. 
VOLUNTARY CONSENT AND PARTICIPATION IN THE STUDY  
You have read the information above concerning the study; an opportunity has been given to you to ask 
questions about the process and risks of the study as well as any other doubt regarding this information 
sheet. You understand what the study is about and how and why it is being conducted. You voluntarily 
consent to participate in this study by signing the informed consent form below. A copy of this 
document will be dispatched to you for your record.  
THANKS 
Your collaboration is indispensable and precious for the accomplishment of this study. That’s why we 
would like to express you our profound gratitude for the time and attention that you have accepted to 
bring to your participation and to our study. 
 
In the event of any interrogation, please do not hesitate to contact the researcher or the 
Biomedical Research Ethics Committee as following detailed: 
Principal Investigator: Luria Leslie Njoungang Yontchoung 
BSc., MSc., PhD Student 
Department of Pharmaceutical Sciences 
School of Health Sciences 
College of Health Sciences 
University of KwaZulu-Natal 
Durban 4000 
South Africa 
Tel: +27 (0)63 276 8472 
Email: njoungangl@gmail.com 
Supervisor: Professor Sabiha Yusuf Essack 
B. Pharm., M. Pharm., PhD 
Dean: Teaching & Learning, 
College of Health Sciences 
University of KwaZulu-Natal 
Private Bag X54001 
Durban 4000 
South Africa 
Tel: +27 (0) 31 2604946 
Email: essacks@ukzn.ac 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office, Westville Campus  
Govan Mbeki Building  
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University of KwaZulu-Natal 
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: +27(0) 31 2602486   


































VIII. Informed consent 
I the undersigned…………………………………………………………………….. certify that I have 
been invited to participate in a study entitled “Molecular Epidemiology of Livestock Associated 
Methicillin Resistant Staphylococcus Aureus (MRSA) And Extended-Spectrum Beta-Lactamase-
Producing Enterobacteriaceae In Food Animals, Particularly Pigs And Related Workers In 
Yaoundé-Cameroon” with Ms Luria Leslie Njoungang Yontchoung from the School of Health 
Sciences, College of Health Sciences of the University of KwaZulu-Natal in Durban-South Africa as 
Principal Investigator. 
- I confirm that I have read and understood the contents of the information sheet.  
- I have well understood the aim and objectives of the research as well as the potential risks and 
benefits.  
- I confirm that the occasion has been given to me to ask any questions and I certify that I have 
received proper answers to any of my questions. 
- I understand that my personal information will be strictly confidential with limited access and that 
I have the right to withdraw from the study at any time, for any reason, without any consequence, 
and without any influence to my legal rights.  
- I understand that for further interrogation about the study I am free to contact the researcher Luria 
Leslie Njoungang Yontchoung at the address below mentioned: 
Principal Investigator: Luria Leslie Njoungang Yontchoung 
BSc., MSc., PhD Student 
Department of Pharmaceutical Sciences 
School of Health Sciences 
College of Health Sciences 
University of KwaZulu-Natal 
Durban 4000 
South Africa 
Tel: +27 (0)63 276 8472 
Email: njoungangl@gmail.com 
- I Also understand that for concerns related to my rights as participant or to the researcher, I can 
freely contact the Biomedical Research Ethics Committee at the below address: 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office, Westville Campus  
Govan Mbeki Building  
University of KwaZulu-Natal 
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: +27(0) 31 2602486   






By signing this document, I freely accept to take part to this study and give my permission under the 
conditions specified by the information document to the student researcher Ms Luria Leslie Njoungang 
Yontchoung from the University of KwaZulu-Natal to use my nasal and hands swabs, as well as nasal 
and rectal swabs of the pigs present in slaughterhouse (if applicable) for current and if useful, future 
studies involving antimicrobial resistance. 
I additionally consent to: 
Use any of my photographs for research  Yes  No 
 
Signature of the participant: ……………………………………. 
 
Date: ………… (dd) /…………… (mm)/……………. (yyyy) 
 
Subject ID code: ________________________ 
Site/Location/Region: ________________________ 
Gender:  Male       Female 
 
 
I have explained the aim, objectives, benefits, potential risks and drawback of the study to the 
participant. I have answered with the best of my knowledge the questions of the participant and I have 
verified his/her understanding. 
 
Signature of the researcher or study personnel     Date 
             (Names and signature) 
__________________________________________            _______________________ 
  





|           Subject ID        |  
|                                     |  
|                   |  
_____________________ 
 




This questionnaire is specific for slaughterhouse workers and should take approximately 30 minutes to 
complete. Please, understand that questions are personal to you and do not forget that your answers will 
be confidential. We need your honesty and complete response to each question. 
Instructions to all participants:  Check  the appropriate box or write your answer in the space provided.  
Section 1: Demographic Information  
These questions are about socio-demographic information. Remember, your answers will remain 
strictly confidential.  
1. What is your gender?  
 Male 
 Female 






 Above 52 
3. What is your highest educational level?  
 Never been to school 
 Attended some primary school but not completed 
 Graduate primary school  
 Graduate secondary school  
 Graduate high school/ university  
 Other (specify)______________________________________________ 
4. In what range is your average monthly income?   
 Below 55 US $ 
 55-110 US $ 
 110-165 US $ 
 165-220 US $ 
 220-275 US $ 
 Above 275 US $ 
5. Where is your current residence location?   
 District/Region _______________________ 













More than 5 
8. What is your principal profession?   
 Wholesaler of living pigs (consist to buy from the farm and provide it at market for 
merchandizing) 
Intermediary seller of living pigs (seller of pig inside market) 
Pig transporter (consist to handling living pigs to the slaughter house and from the slaughter 
house to the butcher place) 
Pig slaughterer (consist to kill and eviscerate pig) 
Butcher (consist to sell pork per kilogram to the population) 
Retailer of viscera (person who collects viscera of pigs, clean them and conserve them for 
other activities) 
Retailer of grilled pork (is a person who buys a pig for another activity related to pig, the 
merchandizing of grilled pork in street) 
Other (specify…………………………………..) 




 Above 15 
10. Do you have another occupation related to hospital?  
Yes   No 
11. Have any of your family members worked with animal or at a hospital (clinic)?   
Yes   No 






13. What of these professions does he practice? Check all that apply 
Pig’s slaughterer 
Pig-breeder  
Wholesaler of living pigs  
Intermediary seller of living pigs 
Retailer of viscera  
Butcher (seller of pork/ kg) 
Retailer of grilled pork 
Farmer (crop production and livestock) 
Medical practitioner  





Section 2: Clinical History  
The next questions are about medical history. Please answer honestly. Remember, your answers will 
remain strictly confidential.  
14. In the past 12 months have you or a family member been hospitalized? [If no, skip to question 
16] 
Yes   No 




6 or more  





More than 30 
Don’t know  
17. Have you or a family member recently (within one month) used an antibiotic? 
Yes   No 
18. If yes, please specify check all that apply. If no, please skip to question 20. 
 Cotrimoxazole 
 Oflocet/Levomax/ Ciprofloxacin 
 Ceftriaxone/Cefpodoxim/Imipenem 
Penicillin/Amoxicillin 
Other please specify……………………………………….. 
19. What might be the reason of your consumption? 
Malaria 
Typhoid fever 
Sexual transmissible infection 
Flu/cough 
Fever 
Other please specify……………………………………….. 
20. Where have you purchased these drugs? 
Public pharmacies (public Hospital, dispensaries, Health Centres, etc.) 
Private Pharmacies 
Market/Street seller 
Leftovers of relatives or past prescriptions 
Unknown 
21. Have you presented symptoms of or have you been diagnosed with any of the following?  Check 














Section 3: Slaughter house practices, accessibility and Implementation measures 
The next questions concern activities and practices in slaughterhouse. Please answer honestly. 
Remember, your answers will remain strictly confidential.  
22. Is the slaughter house close to your house? 
 Yes   No 
23. On the average how many times are you in contact with pigs per week? 
Always (100% of the time) 
Almost always (75-99% of the time) 
Sometimes (25-74% of the time) 
Rarely/Never (0-24% of the time) 
24. Are you in contact with other type of animal through your work or personal living? 
Yes   No 





Pets (cats, dogs) 
Other (Specify……………………………..) 
26. On the average how many times are you in contact with other animals per week? 
Always (100% of the time) 
Almost always (75-99% of the time) 
Sometimes (25-74% of the time) 
Rarely/Never (0-24% of the time) 








Hand washing without soap or bleach 
Convenient hand washing (means with soap or bleach during 30-45 s)  
Wheelbarrows for transport 
Other (specify) _____________________________________________________ 
28. How frequently do you clean your slaughterhouse? 
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Never [Skip to next questions] 
2-4 times daily 
One time every day 
2-3 times a week 
Monthly 
2-4 times monthly 
4 or more times monthly 
29. What type of method do you use to clean or uncontaminated your slaughterhouse? Check all 







Waste clearance  
Other (specify) _____________________________________________________ 
30. How do you handle waste disposal including blood, organ unfit for consumption and 
contaminated thing? Check all that apply 
Thrown in environment (river, lake, natural dustbin)  
Use as natural fertilizer for crop production 
Use as industrial waste 
Use for feeding of pigs and other animals 
Other (specify)_____________________________________________ 
 
 
 
 
 
 
 
 
